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Abstract 
Synthesis of Cribrostatin 6, Santiagonamine, and a N-Acyl Pyridinium Salt 
By Michael D. Markey under the direction of Professor T. Ross Kelly 
 
Chapter 1.  Cribrostatin 6 
 The synthesis of cribrostatin 6 (1.1) is described.  A regioselective bromination, a 
biaryl coupling, and an intramolecular cyclization are the key steps in the synthesis.  
Also, an account of our previous efforts to advance intermediate 1.88 to cribrostatin 6 are 
described. 
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Chapter 2.  Santiagonamine 
 The first total synthesis of santiagonamine (2.1) is achieved in 12 steps from 
isovanillin.  An Ullmann cross-coupling reaction and a photocyclization are the key steps 
in the synthesis.  Also, a description of our attempts to convert intermediate 2.74 to 
santiagonamine are presented. 
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Chapter 3. Troubleshooting a Molecular Motor: A Remarkably Stable N-Acyl 
Pyridinium Salt 
 With the objective of establishing why reaction of the proposed molecular motors 
3.3 and 3.28 with carbonyldiimidazole and phosgene does not result in unidirectional 
rotation, N-ethyl-2-[4-(N,N-dimethyl-amino)-2-pyridinyl]benzenamine [3.34, 2-(2-
(ethylamino)phenyl)DMAP] was examined as a model substrate.  The synthesis of 3.34 is 
described.  Compound 3.34 was found to react with phosgene to give the unexpectedly 
stable N-acyl pyridinium salt 3.36.  The latter (3.36) is so stable that it is effectively inert  
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to reaction with methanol.  At room temperature the two methyls in the Me2N-group of 
3.36 are nonequivalent (NMR) and the barrier to rotation around the Me2N-pyridinium  
bond is 18.5 kcal/mol.  To our knowledge, that is the first quantitative determination of 
the barrier to rotation around the bond between a 4-(N,N-dimethylamino)group and a N- 
acyl pyridinium unit.  The implications of the findings regarding 3.36 as to 
troubleshooting the proposed molecular motor 3.3, and possible strategies to follow, are 
discussed. 
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General Experimental Remarks 
Techniques                                                                                                                   
 Unless otherwise stated, all reactions were carried out under an atmosphere of 
argon (Ar) in flame-dried glassware.  Reactions were monitored by thin layer 
chromatography (TLC) using Whatman 250 micron silica gel plates with aluminum 
backing and UV254 nm fluorescent indicator or Analtech 200 micron neutral aluminum 
oxide plates with aluminum backing and UV254 nm fluorescent indicator.  All TLC plates 
were visualized by UV fluorescence quenching unless otherwise stated.  All solution pH 
values were measured using EM colorpHast pH strips (purchased from Fisher, catalog 
number M95903).  The phrase ‘removal of solvents in vacuo’ means that solvents were 
removed on a rotary evaporator using a diaphragm pump (ca. 8 Torr) and that remaining 
traces of volatiles were then removed on a high-vacuum oil pump (ca. 0.05 Torr).  
Melting points were recorded on either a Fisher-Johns melting point apparatus or a Lab 
Devices Mel-Temp II (mp>300 °C) and are uncorrected.   
Solvents                                                                                                                       
 The reaction solvents acetonitrile (MeCN), dichloromethane (CH2Cl2), diethyl 
ether (Et2O), hexanes, and tetrahydrofuran (THF) were purified by passage through 
activated alumina columns.1  ACS reagent grade chloroform (CHCl3) was purchased 
from Doe and Ingalls (catalog number 4440-19) and was used without further purification 
unless otherwise stated. 1,4-Dioxane was purchased from Aldrich (catalog number 
                                                 
(1) Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. .; Timmers, F. J. Organometallics 1996, 
15, 1518–1520. 
 iv
D20,186-3) and distilled over Na and benzophenone at ambient pressure.  Trifluoroacetic 
acid (TFA) was purchased from Aldrich (catalog number T62200) and distilled over P2O5 
at ambient pressure.  N,N-dimethylformamide (DMF) was purchased from ACROS 
(catalog number 34843), distilled over activated 4 Å molecular sieves at reduced pressure 
(ca. 0.05 Torr), and stored over activated 4 Å molecular sieves.  Molecular sieves (4 Å) 
were activated by heating in an oven (125 ºC) for a period of at least 48 hours. 
Reagents                                                                                               
 Trifluoromethanesulfonic anhydride was purchased from Aldrich (catalog number 
176176) and fractionally distilled under Ar at ambient pressure.  Triethylamine (NEt3) 
was purchased from Aldrich (catalog number 471283) and distilled over CaH2 at ambient 
pressure.  Methanesulfonyl chloride (MsCl) was purchased from Aldrich (catalog number 
471259) and distilled over P2O5 at reduced pressure (ca. 0.05 Torr).  Pyridine was 
purchased from Aldrich (catalog number 360570) and stored over KOH pellets.  Celite 
545 was purchased from Fisher (catalog number C212).  All other reagents and solvents 
were used as received from the manufacturer unless otherwise stated.   
Chromatography                                                                                                            
 Flash column chromatography was carried out using Bodman reagent silica gel 60 
Å or activated Brockman I neutral aluminum oxide 58 Å (purchased from Aldrich, 
catalog number 199974).  Prior to use, activated Brockman I neutral aluminum oxide was 
 v
adjusted2 to Brockman III activity by adding 6% (w/w) water (H2O).  Medium pressure 
liquid chromatography (MPLC) was carried out using a Biotage Horizon HPFC™ system 
with pre-packed KPsilica gel 60 Å (32-63 micron) cartridges.   
Spectroscopy                                                                                                              
 Infrared spectra were recorded using either a Nicolet Avatar 360 FT-IR 
spectrometer or a Bruker Alpha-p.  1H NMR spectra were recorded on either a Varian 
Gemini-400 (400 MHz) spectrometer or a Varian Unity INOVA-500 (500 MHz) 
spectrometer and are reported in parts per million using TMS (0.00 ppm) or residual 
solvent protons [CHCl3 = 7.26 ppm, (CH3)2SO = 2.50 ppm, CH3OH = 3.30 ppm, and 
CH2Cl2 = 5.32 ppm] as an internal standard.  Data are reported as: δ (shift) [(s = singlet, d 
= doublet, ap d = apparent doublet, dd = doublet of doublets, ddd = doublet of doublet of 
doublets, dt = doublet of triplets, td = triplet of doublets, t = triplet, q = quartet, m = 
multiplet, br = broad), (J = coupling constant in Hz), and (integration)].  Proton-
decoupled 13C NMR spectra were recorded on either a Varian Gemini-400 (100 MHz) 
spectrometer or a Varian Unity INOVA-500 (125 MHz) spectrometer and are reported in 
parts per million using solvent [CDCl3 = 77.0 ppm, (CD3)2SO = 39.5 ppm, CD3OD = 
49.0 ppm, and CD2Cl2 = 54.0 ppm] as an internal standard.  High resolution mass spectra 
were obtained at the Boston College mass spectrometry laboratory.  X-ray 
crystallography and structure analysis for 1.71, 2.98, and 3.36 were performed at the 
                                                 
(2) Furniss, B. S.; Hannaford, A. J.; Smith, P. W. G.; Tatchell, A. R. Vogel’s Textbook of Practical 
Organic Chemistry, 5th ed.; Longman Scientific and Technical: Essex, UK, 1989; p 212. 
 vi
Boston College X-ray facility.  Elemental analyses were performed by Atlantic Microlab, 
Inc. (Norcross, GA). 
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Cribrostatin 6 
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Introduction 
Cribrostatin 6: Isolation and Structure Determination 
 In 2003, Pettit and colleagues reported1 the isolation and structure determination 
of a novel isoquinoline alkaloid, cribrostatin 6 (1.1, Figure 1.1).  Cribrostatin 6 was 
isolated off the coast of the Republic of Maldives from the marine sponge Cribrochalina 
sp. and was assigned1 structure 1.1 based on spectral and X-ray crystallographic data.  
Cribrostatin 6 belongs to a family (1.2–1.7, Figure 1.1)2,3 of natural products which all 
contain an isoquinolinequinone.  In addition to inhibiting the growth of a number of 
pathogenic bacteria and fungi,4 cribrostatin 6 is the first known example of a naturally 
occurring imidazo[5,1-a]isoquinoline ring system.   
 
Isoquinoline Alkaloids 
 Generally speaking, alkaloids are secondary metabolites of living organisms that 
contain nitrogen–usually in a heterocyclic ring–and are often cytotoxic.  Organisms have  
                                                 
(1) Pettit, G. R.; Collins, J. C.; Knight, J. C.; Herald, D. L.; Nieman, R. A.; Williams, M. D.; Pettit, R. K. J. Nat. Prod. 2003, 66, 544–547. 
(2) For the isolation of cribrostatins 1 and 2, see: (a) Pettit, G. R.; Collins, J. C.; Herald, D. L.; Doubek, 
D. L.; Boyd, M. R.; Schmidt, J. M.; Hooper, J. N. A.; Tackett, L. P. Can. J. Chem. 1992, 70, 1170–1175. 
For the isolation of cribrostatins 3, 4, and 5, see: (b) Pettit, G. R.; Knight, J. C.; Collins, J. C.; Herald, D. L.; 
Pettit, R. K.; Boyd, M. R.; Young, V. G. J. Nat. Prod. 2000, 63, 793–798. For the isolation of cribrostatin 
7, see: (c) Sandoval, I. T.; Davis, R. A.; Bugni, T. S.; Concepcion, G. P.; Harper, M. K.; Ireland, C. M. Nat. 
Prod. Res. 2004, 18, 89–93. 
(3) For the synthesis of cribrostatins 1 and 2, see: (a) Nakahara, S.; Numata, R.; Tanaka, Y.; Kubo, A. 
Heterocycles 1995, 41, 651–653.  For syntheses of cribrostatin 4, see: (b) Chan, C.; Heid, R.; Zheng, S.; 
Guo, J.; Zhou, B.; Furuuchi, T.; Danishefsky, S. J. J. Am. Chem. Soc. 2005, 127, 4596–4598; (c) Vincent, 
G.; Williams, R. M. Angew. Chem., Int. Ed. 2007, 46, 1517–1520; (d) Chen, X.; Zhu, J. Angew. Chem., Int. 
Ed. 2007, 46, 3962–3965.  For syntheses of cribrostatin 6, see: (e) Nakahara, S.; Kubo, A. Heterocycles 
2004, 63, 2355–2362; (f) Nakahara, S.; Kubo, A.; Mikami, Y.; Ito, J. Heterocycles 2006, 68, 515–520.  For 
a previous effort towards the synthesis of cribrostatin 6, see: (g) Searcy, J. Part I: Synthesis of 4-Aza-
podophyllotoxin Structural Modifications.  Part II: A Modified Synthetic Approach to Cribrostatin 6.  Ph. 
D. Thesis, Arizona State University, Tempe, AZ, July 2006. 
(4) Pettit, R. K.; Fakoury, B. R.; Knight, J. C.; Weber, C. A.; Pettit, G. R.; Cage, G. D.; Pon, S. J. Med. 
Microbiol. 2004, 53, 61–65. 
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used the cytotoxicity of the alkaloids to protect themselves from predators, parasites, and 
diseases.5  Alkaloids of various structural complexity have been isolated6 from plants, 
animals, bacteria, and fungi.  While not by design, alkaloids have shown a range of 
pharmacological effects in humans and many have found applications in the 
pharmaceutical area.7  
 Cribrostatin 6 (1.1) can be classified as an isoquinoline (or benzopyridine) 
alkaloid.8  Benzopyridines (Figure 1.2) are nitrogen-containing heterocycles in which a  
                                                 
(5) (a) Proksch, P. Toxicon 1994, 32, 639–655.  (b) Porter, J. W.; Targett, N. M. Biol. Bull. 1988, 175, 
230–239. 
(6) Mann, J.; Davidson, R. S.; Hobbs, J. B.; Banthorpe, D. V.; Harborne, J. B. Natural Products: Their 
Chemistry and Biological Significance; Longman Scientific & Technical: Essex, U.K., 1994; pp 389–446. 
(7) Schmeller, T.; Wink, M. Utilization of Alkaloids in Modern Medicine. In Alkaloids: Biochemistry, 
Ecology, and Medicinal Applications; Roberts, M. F., Wink, M., Eds.; Plenum Press: New York, 1998; pp 
435–459. 
(8) (a) The Chemistry and Biology of the Isoquinoline Alkaloids; Phillipson, J. D., Roberts, M. F., Zenk, 
M. H., Eds.; Springer-Verlag: Berlin, 1985. (b) Kametani, T. The Chemistry of the Isoquinoline Alkaloids; 
Elsevier: Amsterdam, 1969. 
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Figure 1.2 Benzopyridines.  
benzene ring and a pyridine ring are fused together.  Two isomers of benzopyridine are 
possible, benzo[b]pyridine (1.8, quinoline) or benzo[c]pyridine (1.9, isoquinoline).  Both 
are naturally-occurring ring systems, however since the first discovery8 in 1806 of 
morphine (1.10) by the German pharmacist Serthürner, the isoquinoline ring system has 
been found more frequently in the alkaloids. 
 
Biosynthesis of Isoquinoline and Tetrahydroisoquinoline Alkaloids 
 To gain a better understanding of the chemistry behind the alkaloids, scientists 
have often studied their biosynthetic origins.  The biosynthetic origins (Figure 1.3) of the 
isoquinoline alkaloids can be traced9 to chorismic acid (1.12).  Through a series of 
complex enzymatic processes chorismic acid, derived from shikimic acid (1.11), is  
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Figure 1.3 Biosynthesis of aromatic amino acids.
                                                 
(9) Kelly, J. W. Overview of the Biosynthesis of Amino Acids, Peptides, Porphyrins, and Alkaloids with 
a Focus on the Biosynthesis of Aromatic Amino Acids. In Comprehensive Natural Product Chemistry; 
Kelly, J. W., Barton, D., Nakanishi, K., Meth-Cohn, O., Eds.; Elsevier: Amsterdam, 1999; Vol. 4, pp 1–12.  
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transformed to the amino acids tyrosine (1.13), phenylalanine (1.14), and tryptophan 
(1.15).  Tyrosine can then be involved in organism-specific secondary metabolic 
processes which lead10 to various derivatives of isoquinoline alkaloids.  While there have 
been no studies directly related to the biosynthesis of cribrostatin 6, it has been 
proposed11 that similar isoquinoline alkaloids (vide infra) are degradation products and/or 
artifacts of saframycin and renieramycin-type tetrahydroisoquinoline alkaloids with 
general structure 1.16 shown in Figure 1.4.   
Figure 1.4 General structure of saframycin and renieramycin-type alkaloids.
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 The tetrahydroisoquinoline alkaloids12,13 represent a family of structurally diverse 
and biologically active natural products.  These metabolites–which have been 
independently isolated14 from bacteria, marine sponges, and tunicates–include potent 
cytotoxic agents that display12 a range of antitumor and antibiotic activity.  
                                                 
(10) (a) Lundström, J. In The Alkaloids. Chemistry and Pharmacology; Manske, R. H. F., Brossi, A., 
Eds.; Academic Press: New York, 1983; Vol. 21, Chapter 6.  (b) McDonald, E. In Isoquinolines; Grethe, 
G., Ed; John Wiley & Sons: New York, 1981; Vol. 38, Chapter 3. 
(11) (a) He, H.; Faulkner, D. J. J. Org. Chem. 1989, 54, 5822–5824.  (b) Saito, N.; Koizumi, Y.; Tanaka, 
C.; Suwanborirux, K.; Amnuoypol, S.; Kubo, A. Heterocycles 2003, 61, 79–86.  (c) Saito, N.; Tanaka, C.; 
Koizumi, Y.; Suwanborirux, K.; Amnuoypol, S.; Pummangura, S.; Kubo, A. Tetrahedron 2004, 60, 3873–
3881. 
(12) For a review on the chemistry and biology of tetrahydroisoquinoline alkaloids related to 1.16, see: 
Scott, J. D.; Williams, R. M. Chem. Rev. 2002, 102, 1669–1730. 
(13) Arai, T.; Kubo, A. In The Alkaloids. Chemistry and Pharmacology; Manske, R. H. F., Brossi, A., 
Eds.; Academic Press: New York, 1983; Vol. 21, Chapter 3. 
(14) Fontana, A.; Cavaliere, P.; Wahidulla, S.; Naik, C. G.; Cimino, G. Tetrahedron 2000, 56, 7305–
7308 and references therein. 
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 Radiolabelled amino acid feeding experiments have linked12,15 the biosynthetic 
origins of saframycin and ecteinascidin-type alkaloids to the amino acid tyrosine (1.13).  
Rinehart et al. have proposed16 a biosynthesis for the formation of ecteinascidin 743-type 
(1.23) alkaloids shown in Scheme 1.1 which may apply to the biosynthesis of alkaloids 
which contain the general structure 1.16.  The proposed16 pathway involves initial 
condensation of two tyrosine (1.13) units to form a diketopiperazine15b (1.17).  Reduction  
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(15) (a) Yazawa, K.; Takahasi, K.; Mikami, Y.; Arai, T.; Saito, N.; Kubo, A. J. Antibiot. 1986, 39, 1639–
1650.  (b) Jeedigunta, S.; Krenisky, J. M.; Kerr, R. G. Tetrahedron 2000, 56, 3303–3307. 
(16) Sakai, R.; Jares-Erijman, E. A.; Manzanares, I.; Elipe, M. V. S.; Rinehart, K. L. J. Am. Chem. Soc. 
1996, 118, 9017–9023.   
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of the diketopiperazine would give hemiaminal 1.18 which could then cyclize and 
complete the tetrahydroisoquinoline ring system (1.21) with a Pictet-Spengler reaction17 
between 1.19 and a serine-derived aldehyde (1.20).  Introduction of additional ring 
oxygens and methylation by S-adenosylmethionine could be carried out at various stages 
to give 1.22, which can be further functionalized18 to give ecteinascidin 743-type 
products (1.23).   
 
Oxidative Degradation of Some Tetrahydroisoquinoline Alkaloids  
 As mentioned before, it has been proposed11 that monomeric isoquinolinequinone 
alkaloids like cribrostatin 6 (1.1) are not directly biosynthesized by organisms but are 
rather artifacts and/or degradants of more complex tetrahydroisoquinoline alkaloids.  For 
example, during the isolation of renieramycins E (1.24, eq 1.1) and F (1.25, eq 1.1), He 
and Faulkner observed11a that these tetrahydroisoquinoline alkaloids were decomposing 
upon storage and that the rate of decomposition was fastest in chloroform solutions  
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(17) Kürti, L.; Czakó, B. Strategic Applications of Named Reactions in Organic Synthesis; Elsevier: 
Amsterdam, 2005; pp 348–349. 
(18) For details about the proposed biosynthetic steps to convert 1.22 into ecteinascidin 743-type (1.23) 
products, see: ref 16. 
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exposed to air.  Among the degradation products obtained (eq 1.1) were the known 
isoquinoline alkaloids renierone19 (1.26) and mimosamycin20 (1.27).   
  During related research, Saito et al. were able to show11b,c that the structurally 
similar tetrahydroisoquinoline alkaloids jorumycin (1.28) and saframycin S (1.30) both 
underwent oxidative cleavage to generate known isoquinoline alkaloids.  As shown in 
equations 1.2 and 1.3, jorumycin degraded to renierol acetate21 (1.29) and mimosamycin 
(1.27) whereas saframycin S deteriorated to mimocin22 (1.31) and mimosamycin. 
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(19) McIntyre, D. E.; Faulkner, D. J.; Engen, D. V.; Clardy, J. Tetrahedron Lett. 1979, 20, 4163–4166. 
(20) Fukumi, H.; Kurihara, H.; Hata, T.; Tamura, C.; Mishima, H.; Kubo, A.; Arai, T. Tetrahedron Lett. 
1977, 18, 3825–3828. 
(21) Kuwabara, N.; Hayashi, H.; Hiramatsu, N.; Choshi, T.; Kumemura, T.; Nobuhiro, J.; Hibino, S. 
Tetrahedron 2004, 60, 2943–2952. 
(22) Kubo, A.; Nakahara, S.; Iwata, R.; Takahashi, K.; Arai, T. Tetrahedron Lett. 1980, 21, 3207–3208. 
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 To better understand the oxidative degradation of saframycin S (1.30), Saito et al. 
synthesized11b 1.32 (eq 1.4) and studied 1.32’s reaction with trifluoracetic acid (TFA) in 
air.  They found11b that these conditions (eq 1.4) transformed 1.32 into mimosamycin 
(1.27).  Although the mechanism for this degradation (eq 1.4) is not clear, Saito et al. 
propose11b (Scheme 1.2) protonation of the quinone 1.32 could give 1.33 which may 
release 1.34 through a series of bond breakings and electron reorganizations to afford, 
after protonation of 1.35, hydroquinone tautomer 1.36.  Hydroquinone 1.36 could then 
oxidize to the carboxylic acid 1.37, suffer loss of a proton to give 1.38, and decarboxylate 
to afford 1.39.  Protonation of 1.39 could produce tautomer 1.40, which could oxidize to 
1.41.  Reaction of 1.41 with water followed by another oxidation could generate 
mimosamycin (1.27).  It is plausible that this mechanism may also operate during the 
oxidative degradation of more complex tetrahydroisoquinoline alkaloids into simple 
monomeric isoquinoline alkaloids, where instead of losing 1.34 the entire left half of the 
intact tetrahydroisoquinoline alkaloid is released (as in 1.26, 1.29, and 1.31). 
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Oxidative Degradation: Possible Biosynthetic Origin of Cribrostatin 6 
 The degradation observations made11 during the studies related to renieramycins 
E and F (eq 1.1), jorumycin (eq 1.2), and saframycin S (eq 1.3) may also explain the  
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biosynthetic origins of cribrostatin 6 (1.1).  If a tetrahydroisoquinoline alkaloid with 
structure 1.4223 (Scheme 1.3) was present in the Cribrochalina sp., and 1.42 degraded in 
a similar manner as those shown in equations 1.1-1.3, then one would expect to obtain  
                                                 
(23) (a) Perhaps coincidently, a tetrahydroisoquinoline alkaloid–namely cribrostatin 4 (1.5)–with a 
structure very similar to that of 1.42 was isolated from the Cribrochalina sp., see: ref 2b.  (b) For a similar 
proposal of a novel tetrahydroisoquinoline alkaloid based on the isolation of a new isoquinoline alkaloid, 
see: Saito, N.; Tanaka, C.; Satomi, T.; Oyama, C.; Kubo, A. Chem. Pharm. Bull. 2004, 52, 282–286.  
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1.1
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1.42
 
acetamide 1.43 and cribrostatin 224 (1.3).  It is conceivable that acetamide 1.43 could 
cyclize and dehydrate (vide infra) to afford the observed alkaloid cribrostatin 6 (1.1).  
This hypothesis may explain the biosynthetic origins of the novel isoquinoline alkaloid 
(1.1), or it may be that cribrostatin 6 (1.1) represents one of the first ‘true’ 
isoquinolinequinones to be synthesized by an organism. 
 
Synthetic Approaches to the Imidazo[5,1-a]isoquinoline Ring System 
 While cribrostatin 6 (1.1) is the first example of a naturally occurring 
imidazo[5,1-a]isoquinoline ring system, there have been several reports25 on the 
                                                 
(24) During an earlier extraction of the Cribrochalina sp. both cribrostatin 2 (1.3) and mimosamycin 
(1.27) were isolated from the natural source: see ref 2a. 
(25) For a leading reference to some previous syntheses of the imidazo[5,1-a]isoquinoline ring system, 
see: Hajos, G.; Riedl, Z. In Science of Synthesis: Houben-Weyl methods of molecular transformations; 
Neier, R., Bellus, D., Eds.; Category 2: Hetarenes and related ring systems; Georg Thieme Verlag: 
Stuttgart, Germany, 2002; Vol. 12, pp 643–648. 
 12
synthesis of this ring system.  These approaches, shown in Scheme 1.4, date back to 1931 
and include: (i) utilizing26 phosphorous oxychloride to cyclize an acetamide (1.44) onto a  
       
N
N
H
O
Me
N
N
Me
POCl3,
toluene, Δ
N N
N
Me
O
O
S
Li
Li
NC
-70 °C − 0 °C
N
NH2
N
N
NaOH, CHCl3,
TPAB, DME,
H2O, 50 °C
N
N
MeO2C
Br
Bu3SnH, AIBN,
toluene, Δ N
N
MeO2C
N
N
hν (254 nm), N
N
PhBr PhMeCN
Phosphorous oxychloride-mediated cyclization:
1,3-Dipolar cyclization:
Carbene-induced cyclization:
Bu3SnH-mediated radical cyclization:
Photochemical-initiated rad ical cyclization:
Scheme 1.4
1.44
1.45
1.9
1.46
1.461.47
1.48 1.49
1.511.50  
                                                 
(26) (a) Child, R.; Pyman, F. L. J. Chem. Soc. 1931, 36-49. (b) Zimmer, H.; Glasgow, D. G.; 
McClanahan, M.; Novinson, T. Tetrahedron Lett. 1968, 9, 2805-2807. (c) Reimlinger, H.; Vandewalle, J. J. 
M.; Lingier, W. R. F.; de Ruiter, E. Chem. Ber. 1975, 108, 3771-3779. (d) Langry, K. C. Org. Prep. 
Proced. Int. 1994, 26, 429–438. (e) Also, see references 3e, 3f, and 3g. 
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neighboring isoquinoline ring; (ii) using dilithio-tosylmethyl isocyanide27 in a 1,3-dipolar 
cyclization with isoquinoline (1.9); (iii) carbene-induced cyclization28 of an α-
(aminomethyl)isoquinoline (1.47) with chloroform; (iv) intramolecular metal hydride 
mediated aryl radical cyclization29 of halogenated imidazole rings (1.48); and (v) 
intramolecular (1.50) photochemical cyclization conditions.30 
  In 1976, Cooper and Irwin reported31 their attempts to form the imidazo[5,1-
a]isoquinoline ring systems through photodehydrocyclization (Scheme 1.5) of substituted 
1-styrylimidazoles (1.52), however they only observed the imidazo[2,1-a]isoquinoline 
ring systems (1.56).  They propose the outcome of this reaction, as shown in Scheme 1.5,  
               
N
N hν
N
N
N
N
N
N
H
H
N
N
N
N
N
N
H
HN
N
1.52 1.53 1.57
1.581.54
1.461.551.56
I2
I2
Scheme 1.5
                             
                                                 
(27) van Nispen, S. P. J. M.; Mensink, C.; van Leusen, A. M. Tetrahedron Lett. 1980, 21, 3723–3726. 
(28) Langry, K. C. J. Org. Chem. 1991, 56, 2400–2404. 
(29) Allin, S. M.; Bowman, W. R.; Elsegood, M. R. J.; McKee, V.; Karim, R.; Rahman, S. S. 
Tetrahedron 2005, 61, 2689–2696. 
(30) Aldabbagh, F.; Clyne, M. A. Letters in Organic Chemistry 2006, 3, 510–513. 
(31) Cooper, G.; Irwin, W. J. J. Chem. Soc., Perkin Trans. 1 1976, 75–80. 
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is dictated by the fact that compound 1.54, in which the negative charge is delocalized 
over a nitrogen and carbon atom, would be more stable than compound 1.57, in which 
delocalization of the negative charge can only occur over carbon atoms. 
 
Purpose of Research  
 Shortly after our efforts towards the synthesis of cribrostatin 6 (1.1) were 
underway, Nakahara and Kubo confirmed3e,f the structure of cribrostatin 6 through total 
synthesis.  Their synthesis is summarized in equation 1.5.  Although that work 
represented the first synthesis of the natural product, we continued our efforts because 
our route provides a new approach to both the imidazo[5,1-a]isoquinoline ring system 
and the natural product cribrostatin 6.   
 
1.1 (1.5)
OEt
Me
EtO
OBn
CHO
N
OAc
OAc
EtO
Me
CN
N
OEt
Me
EtO
OBn
1.59 1.60 1.61
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Results and Discussion 
 Retrosynthetic analysis (eq 1.6) suggested that cribrostatin 6 (1.1) might be 
derived from biaryl 1.62 through an intramolecular dehydrative cyclization of the 
imidazole ring onto the neighboring aldehyde followed by a deprotection and an 
oxidation.  Biaryl 1.62 was envisioned to originate from an appropriate cross-coupling 
reaction between monocycles 1.63 and 1.64, followed by functional group manipulation.  
Both 1.63 and 1.64 should be derivable from commercially available starting materials. 
 
(1.6)
O
N
H
N
Me
OEt
Me
EtO X
OEt
Me
EtO N
N
PG
Y Me
1.62
1.64
1.63
+
1.1
N
N
O
O
EtO
Me
Me
OPG OPG
 
 The synthesis began32 (Scheme 1.6) with the known protected imidazole 1.66, 
available33 in one step from 2-methylimidazole (1.65) and 2-(trimethylsilyl)ethoxymethyl 
chloride (SEMCl).  Directed ortho-metalation of 1.66 with n-butyllithium (nBuLi) and  
 
Scheme 1.6
N
H
N Me
N
N Me
SEM
N
N Me
SEM
Bu3SnNaH, SEMCl,
DMF, 0 °C
(95 %)
nBuLi, Bu3SnCl,
Et2O, 0 °C - rt
(64%)
1.65 1.66 1.67  
                                                 
(32) Markey, M. D.; Kelly, T. R. J. Org. Chem. 2008, 73, 7441–7443.  
(33) Clader, J. W.; Berger, J. G.; Burrier, R. E.; Davis, H. R.; Domalski, M.; Dugar, S.; Kogan, T. P.; 
Salisbury, B.; Vaccaro, W. J. Med. Chem. 1995, 38, 1600–1607. 
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subsequent quenching with tributyltin chloride gave the desired specific embodiment 
(1.67) of 1.64.34  
 Preparation of the unit (1.72) corresponding to 1.63 commenced (Scheme 1.7) 
with the known35 diethyl ether 1.69 of commercially available 2-methylresorcinol (1.68).  
Hydroxylation36 of 1.69 with hydrogen peroxide in acetic acid gave phenol 1.70 
directly.37  It has been speculated36 that peracetic acid, which is formed in situ from  
the reaction between hydrogen peroxide and acetic acid, is the active hydroxylating agent  
OH
Me
HO
OEt
Me
EtO
Me
EtO
OH
OEt
Me
EtO
OH
Br
OEt
Me
EtO
OTIPS
Br
diethyl sulfate, K2CO3,
acetone, 65 °C
(92%)
1.68 1.69
H2O2, H3PO4,
CH3CO2H
(42%)
1.70
DCM, -78 °C
(88%)
1.71
NaH, TIPSCl,
THF, 0 °C - rt
(84%)
1.72
OEt
OEt
Me
EtO
TIPSO N
N
SEM
Me
1.73
1.67,
Pd(PPh3)4 (5 mole %),
1,4-dioxane, 105 °C
(89%)
C4H8O2 Br2, K2CO3,
Scheme 1.7
                                                 
(34) (a) Compare: Keenan, R. M.; Weinstock, J.; Finkelstein, J. A.; Franz, R. G.; Gaitanopoulos, D. E.; 
Girard, G. R.; Hill, D. T.; Morgan, T. M.; Samanen, J. M.; Hempel, J.; Eggleston, D. S.; Aiyar, N.; Griffin, 
E.; Ohlstein, E. H.; Stack, E. J.; Weidley, E. F.; Edwards, R. J. Med. Chem. 1992, 35, 3858–3872. (b) For a 
recent review of directed metalations, see: Whisler, M. C.; MacNeil, S.; Snieckus, V.; Beak, P. Angew. 
Chem., Int. Ed. 2004, 43, 2206–2225. 
(35) Doyle, F. P.; Hardy, K.; Nayler, J. H. C.; Soulal, M. J.; Stove, E. R.; Waddington, H. R. J. J. Chem. 
Soc. 1962, 1453–1458. 
(36) Bjørsvik, H.-R.; Occhipinti, G.; Gambarotti, C.; Cerasino, L.; Jensen, V. R. J. Org. Chem. 2005, 70, 
7290–7296. 
(37) For a three-step conversion of 1.69 to 1.70, see: ref 3e. 
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H2O2, acid,
OEt
Me
EtO
Me
EtO
OH
OEt
Run Acid (equiv)H2O2 (equiv) 1.69:1.70 *^Time
CH3CO2H, rt
1 - p-TsOH (0.1) 44 h 1:0
2 2 - 21 h 8:2
3 2 p-TsOH (0.1) 20 h 0:0
4 1 H3PO4 (1) 16 h 7:3
5 1 H3PO4 (4) 20 h 1:1
6 2 H3PO4 (1) 21 h 1:1
7 2 H3PO4 (2) 21 h 2:3
8 2 H3PO4 (3) 21 h 3:7
9 2 H3PO4 (4) 21 h 0:1
10 2 H3PO4 (4) 11 h 2:3
11 4 H3PO4 (1) 17 h 1:3
12 - CH3CO3H (1) 16 h 1:1
13 - CH3CO3H (2) 16 h 0:1
^ = all results determined by crude NMR
* = in al l cases conversion of 1.69 to 1.70 was accompanied by decomposition and
a mixture of side-products (quinone and possibly other over -oxidized products)
1.69
1.70
Table 1.1. Hydroxylation conditions for the conversion of 1.69 into 1.70.     
for this reaction.  Table 1.1 shows several conditions which were screened to optimize 
this transformation.  It was discovered that phenol 1.70 is somewhat unstable to the 
reaction conditions and a better yield is obtained38 if the reaction is not run to completion 
and if peracetic acid is formed in situ.39  
 Monobromination of phenol 1.70 with bromine-1,4-dioxane40 produced bromide 
1.71 whose identity was confirmed with an X-ray crystal structure (see Figure 1.5 also   
                                                 
(38) When run with 5.0 g of 1.69 and a total reaction time of 15 h, one obtains 2.3 g (42% or 53% based 
on unreacted 1.69) of phenol 1.70.  
(39) A better yield to form 1.70 from 1.69 is obtained with the conditions described in run 9 of Table 1.1 
rather than those described in run 13 of Table 1.1.  Presumably, there is a higher concentration of peracetic 
acid in the conditions described for run 13 than in those described for run 9.  It is possible that the 
instability of 1.70 to the reaction conditions is related to the concentration of peracetic acid.  
(40) Finkelstein, B. L.  In Encyclopedia of Reagents for Organic Synthesis; Paquette, L. A., Ed.; John 
Wiley: Chichester, UK, 1995; Vol. 1, p 686–687. 
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Figure 1.5.  X-ray crystal structure of bromide 1.71. 
see experimental section for bond lengths and angles for bromide 1.71).  Protection of the 
hydroxyl group41 in bromide 1.71 as its triisopropylsilyl (TIPS) ether gave bromide 1.72, 
which underwent a Stille cross-coupling reaction42 with stannane 1.67 to forge the biaryl 
bond of intermediate 1.73. 
                                                 
(41) Cursory attempts to achieve a palladium-catalyzed cross-coupling reaction between 1.71 and 1.67 
failed to give any of the desired biaryl product 1.74.  Compounds 1.71 and 1.66 (protodestannylated 1.67) 
were recovered from the reaction mixture. 
OEt
Me
EtO
OH N
N
SEM
Me
1.74  
(42) For a recent review, see: Espinet, P.; Echavarren, A. M. Angew. Chem., Int. Ed. 2004, 43, 4704–
4734. 
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 Introduction of the final two carbons began (Scheme 1.8) with a regioselective 
bromination of intermediate 1.73 with bromine-1,4-dioxane in a 1:1 (v:v) solvent mixture  
of Et2O and TFA to give bromide 1.75.  We speculate that the TFA deactivates the 
imidazole ring toward electrophilic bromination by protonation.  As shown in Table 1.2, 
if the bromination of 1.73 is carried out in the absence of TFA, only the brominated  
 
OEt
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EtO
TIPSO N
N
SEM
Me
OEt
Me
EtO
TIPSO N
N
SEM
Me
Br
Et2O, 0 °C
(73%)
OEt
Me
EtO
TIPSO N
N
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Me
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Pd(PPh3)4 (4 mole %),
DMF, 105 °C
(98%)
OEt
Me
EtO
TIPSO N
H
N
Me
TFA
OsO4 (11 mole %),
NaIO4, H2O,
tBuOH, THF
(81%)
OEt
Me
EtO
TIPSO N
N
Me
OH
OEt
Me
EtO
TIPSO N
N
Me
NEt3, MsCl,
DCM, 0 °C
(74%)
OEt
Me
EtO
OH N
N
Me
TBAF,
THF, 0°C
(97%)
14 M HNO3,
0 °C
(45%)
1.73
1.76
1.79
1.75
1.77
1.78
1.80
C4H8O2 Br2, TFA,
(86%)
N
N
O
O
Me
EtO Me
1.1
Scheme 1.8
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Run TFA (equiv)Br2 complex (equiv) TempSolvent 1.73:1.75:1.81*
1
2
3
4
5
6
0
0
0
80
175
375
1
1
1
2.5
2.5
2.5
-78
0
23
0
0
0
DCM
DCM
DCM
Ether
Ether
Ether
4:0:1
3:0:2
3:0:2
0:0:1
0:1:1
0:1:0
*Results determined f rom crude NMR
Table 1.2. Conditions to regioselectively brominate 1.73.
 
imidazole product 1.81 is obtained.  As the equivalents of TFA increase from 0 to 375 so 
does the selectivity to form bromide 1.75. 
OEt
Me
EtO
TIPSO N
N
SEM
Me
1.81
Br
 
 Side chain introduction was accomplished with another palladium-catalyzed 
cross-coupling reaction, this time between 1.75 and allyltributyltin to give allyl biaryl 
1.76.  Deprotection of biaryl 1.76 with TFA then gave imidazole biaryl 1.77 and set the 
stage for the intramolecular cyclization.  Imidazole biaryl 1.77 underwent intramolecular 
cyclization upon exposure to catalytic osmium tetroxide and excess sodium periodate to 
generate aminal 1.78.  Dehydration of 1.78 was performed with triethylamine and 
methanesulfonyl chloride (MsCl) to give imidazo[5,1-a]isoquinoline 1.79.  Finally, 
removal of the TIPS group from 1.79 with tetrabutylammonium fluoride (TBAF) 
followed by the known3f oxidation of phenol 1.80 with HNO3 delivered cribrostatin 6 
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(1.1).43  The spectra of synthetic 1.1 are in agreement with those reported for the natural 
product.1 
 The route described above was not our first attempt at the total synthesis of 
cribrostatin 6.  Below is an account of our earlier efforts towards the synthesis of 1.1 and 
an explanation for why we modified our original approach (eq 1.7) to the one given in 
equation 1.6. 
 
(1.7)
O
N
H
N
Me
OR
Me
EtO X
OEt
Me
EtO N
N
PG
Y Me
1.83
1.641.84
+
1.1
N
N
O
O
EtO
Me
Me
 
 Initially, retrosynthetic analysis (eq 1.7) suggested cribrostatin 6 (1.1) might be 
derived from biaryl 1.83 through an intramolecular dehydrative cyclization of the 
imidazole ring onto the neighboring aldehyde followed by a deprotection (if R = Et) 
and/or an oxidation (R = H).  Biaryl 1.83 was envisioned to come from a cross-coupling 
reaction between monocycle 1.84 and the previously described 1.64.  Monocycle 1.84 
should be derivable from commercially available starting material.  
                                                 
(43) If the oxidation of phenol 1.80 was run at room temperature then a ca. 1:1 mixture of 1.1:1.82 was 
obtained: 
N
N
Me
OEt
Me
O
O
1.82  
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 Accordingly (Scheme 1.9), monobromination of 1.69 with bromine-1,4-dioxane 
gave bromide 1.85,44 which was converted to aniline 1.8645 by an elimination-addition 
mechanism,46 presumably involving a benzyne intermediate.  The likely mechanism 
(Scheme 1.10) for this transformation involves a concerted 1,2-elimination46 of hydrogen 
bromide from 1.85 with potassium amide (1.89)47 to generate benzyne intermediate 1.90.  
Subsequent attack by ammonia (1.91) onto benzyne intermediate 1.90 is then directed by 
the inductive effect induced by the ethoxy group to occur exclusively in the position para 
to the methyl group.  Also, as shown with benzyne resonance structure 1.90c (Figure  
Scheme 1.9
OH
Me
HO
diethyl sulfate, K2CO3,
acetone, reflux
(92%)
OEt
Me
EtO
Et2O, 0 °C
(94%)
Fe(NO3)3 9H2O (1 mole %),
K0, NH3 (l),
-78 °C -33 °C
(60%)
1.2 M HCl, NaNO2,
Tf2O, pyridine,
DCM, 0 °C
(87%)
H2O, 0 °C
(71%)
OEt
Me
EtO NH2
OEt
Me
EtO OH
OEt
Me
EtO OTf
OEt
Me
EtO
Br
C4H8O2 Br2,
1.68 1.69
1.861.85
1.87 1.88          
                                                 
(44) Compare: Doyle, F. P.; Nayler, J. H. C.; Waddington, H. R. J.; Hanson, J. C.; Thomas, G. R. J. 
Chem. Soc. 1963, 497–506. 
(45) Compare: Roth, B.; Aig, E.; Rauckman, B. S.; Strelitz, J. Z.; Phillips, A. P.; Ferone, R.; Bushby, S. 
R. M.; Sigel, C. W. J. Med. Chem. 1981, 24, 933–941. 
(46) Roberts, J. D.; Semenow, D. A.; Simmons, H. W.; Carlsmith, L. A. J. Am. Chem. Soc. 1956, 78, 
601–611. 
(47) Potassium amide (1.89) is generated from a solution of potassium in ammonia (Scheme 1.10).  This 
reaction is catalyzed by iron (III) nitrate nonahydrate, see: Hampton, K. G.; Harris, T. M.; Hauser, C. R. In 
Organic Syntheses; Baumgarten, H. E., Ed.; Wiley & Sons: New York, 1973; Vol. V, pp 848–851. 
 23
        
Scheme 1.10
OEt
Me
EtO NH2
OEt
Me
EtO
Br
1.86
1.85
2NH3 + 2K0 2KNH2 + H2
Fe(NO3)3 9H2O
H
OEt
Me
EtO
1.90
KNH2
+ KNH3 + Br
OEt
Me
EtO
1.90
NH3
1.89
1.89
1.91
1.91               
1.6), attack by ammonia ortho to the ethoxy group is disfavored because of the negative 
charge which is placed into this position by the lone pair of electrons on the ethoxy 
group. 
 
Figure 1.6. Resonance structures of 1.90.
OEt
Me
EtO
1.90a
OEt
Me
EtO
1.90
OEt
Me
EtO
1.90c
OEt
Me
EtO
1.90b
 
 Continuing with the synthesis, diazotization (Scheme 1.9) of aniline 1.86 
followed by hydroylsis48 of the diazonium salt gave phenol 1.87.  Phenol 1.87 was then 
transformed into the triflate ester 1.88, which was capable of undergoing a Stille cross-
coupling reaction with stannane 1.67.   
                                                 
(48) (a) Ussing, B. R.; Singleton, D. A. J. Am. Chem. Soc. 2005, 127, 2888–2899.  (b) Cohen, T.; Dietz, 
A. G.; Miser, J. R. J. Org. Chem. 1977, 42, 2053–2058.  (c) Swain, C. G.; Sheats, J. E.; Harbison, K. G. J. 
Am. Chem. Soc. 1975, 97, 783–790. 
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 As shown in Scheme 1.11, a palladium-catalyzed cross-coupling reaction between 
triflate 1.88 and stannane 1.67 forged the biaryl bond to afford intermediate 1.92. 
Intermediate 1.92 then underwent a regioselective bromination with bromine-1,4-dioxane 
and five equivalents of trifluoroacetic acid (TFA) in chloroform to give bromide 1.93.  
Again (vide supra), we speculate that the TFA deactivates the imidazole ring toward 
electrophilic bromination by protonation.  If the bromination of 1.92 is carried out in the 
absence of TFA, only the brominated imidazole product 1.99 is obtained. 
Scheme 1.11
OEt
Me
EtO
N
N
SEM
Me
Br
OEt
Me
EtO
N
N
SEM
Me
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Pd(PPh3)4 (5 mole %),
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1.92
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[O]5
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OEt
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EtO OTf
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Pd(PPh3)4 (8 mole %),
1,4-dioxane, 110 °C
(96%)
NaSMe,
DMF, 170 °C
(50%)
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OEt
Me
EtO
N
N
SEM
Me
1.99
Br
 
 The side chain was introduced (Scheme 1.11) with a palladium-catalyzed cross-
coupling reaction, this time between 1.93 and allyltributyltin to produce allyl biaryl 1.94.   
Removal of the SEM group from 1.94 was accomplished with TFA to afford imidazole 
biaryl 1.95 and this set the stage for the intramolecular cyclization.  Upon exposure to 
catalytic osmium tetroxide and excess sodium periodate, biaryl 1.95 underwent 
intramolecular cyclization to generate aminal 1.96. 
 Attempts to dehydrate aminal 1.96 (to give 1.97) with acidic conditions49 or 
neutral conditions50 either produced no reaction or some conversion of 1.96 to a mixture 
of 1.97 and the Friedel-Crafts product 1.100.  Ultimately (Scheme 1.11), aminal 1.96 was 
transformed to imidazo[5,1-a]isoquinoline 1.97 with methanesulfonyl chloride (MsCl) 
and triethylamine. 
 
OEt
Me
EtO
HN
N
1.100
Me
 
                                                 
(49) Aminal 1.96 was both stirred at room temperature and heated at reflux in hydrochloric acid (1, 6, 
and 12 M), neat TFA, acetic acid in THF, and acetic acid in 1,4-dioxane. 
(50) Aminal 1.96 was heated at 100 °C as a solution in anhydrous benzene. 
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 Attempts to remove the ethyl group from the 7 position of intermediate 1.97 with 
one,51 two,52 or four52 equivalents of either boron trichloride or boron tribromide failed to 
give any of the desired phenol 1.98 (or 1.101).  As well, efforts to directly oxidize 1.97 to 
cribrostatin 6 with ceric ammonium nitrate (CAN)53 did not generate any of the natural 
product.   
OEt
Me
HO
N
N
Me
1.101  
 At this point in the synthesis I had run out of material and would have needed to 
resynthesize compound 1.97 from 2-methylresorcinol (1.68).  In order to avoid the 
troubles encountered while trying to deprotect 1.97, we devised an alternative approach 
to the natural product (see eq 1.6) and I began working on both routes.  In a relatively 
short amount of time I was able to make a significant amount of progress with the 
modified approach (eq 1.6) and thus focused my attention on the alternative route and 
temporarily put the original route on hold. After we completed our synthesis of 
cribrostatin 6, I went back to the original route and remade compound 1.97.  
 This time around one of the ethyl groups was removed from diether 1.97 with 
sodium thiomethoxide54 to produce a single product.  The 1H NMR proton spectrum of 
this product clearly showed the product contained only one ethoxy group, but did not 
                                                 
(51) For a similar strategy to selectively demethylate hindered aryl methyl ethers, see: Carvalho, C. F.; 
Sargent, M. V. J. Chem. Soc., Chem. Commun. 1984, 227–229. 
(52) Excess reagent was used to complex with the imidazole nitrogen.  For a similar strategy, see: Bierle, 
J. M.; Osimboni, E. B.; Metallinos, C.; Zhao, Y.; Kelly, T. R. J. Org. Chem. 2003, 68, 4970–4972. 
(53) Musgrave, O. C. Chem. Rev. 1969, 69, 499–531. 
(54) Cornella, I.; Kelly, T. R. J. Org. Chem. 2004, 69, 2191–2193. 
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unequivocally distinguish between structures 1.98 and 1.101.  Fortunately, 1D NOE 
difference and 2D NOESY experiments (see Appendix) showed NOE correlations 
consistent with structure 1.98 and ruled out 1.101 as a possible structure.   
 In order to account for the selectivity of sodium thiomethoxide to deprotect the 
ethyl group in the 7 position of 1.97, we reasoned that the ethoxy group in the 7 position 
is twisted out of plane with the benzene ring more than the ethoxy group in the 9 position 
because of an unfavorable steric interaction between the ethoxy group in the 7 position 
and the peri-hydrogen in the 6 position.  This conformation could make ethyl group in the 
7 position more prone to attack by sodium thiomethoxide than the ethyl group in the 9 
position. 
  Regretfully, I ran out of material and time to work out conditions55 to oxidize 
phenol 1.98 to cribrostatin 6.   
   
 
 
 
 
 
 
 
                                                 
(55) An attempt to oxidize phenol 1.98 with Fremy’s salt was unsuccessful.  It is possible this oxidation 
did not work due to steric interactions, see: (a) Deya, P. M.; Dopico, M.; Raso, A. G.; Morey, J.; Saa, J. M. 
Tetrahedron 1987, 43, 3523–3532.  (b) Ishii, H.; Hanaoka, T.; Asaka, T.; Harada, Y.; Ikeda, N. 
Tetrahedron 1976, 32, 2693–2698.  For a review on Fremy’s salt, see: (c) Zimmer, H.; Lankin, D. C.; 
Horgan, S. W. Chem. Rev. 1971, 71, 229–246.   
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Experimental Section 
For general experimental remarks see page iii–vi. 
 
N
H
N Me
N
N Me
SEM
1.65 1.66  
2-Methyl-1-[[2-(trimethylsilyl)ethoxy]methyl]-1H-imidazole (1.66).  2-Methyl-
imidazole (1.65, 2.34 g, 28.5 mmol, 99%) was converted to 1.66 (5.72 g, 95%) by a 
known procedure.56  SEM ether 1.66 was purified by Kugelrohr distillation to give a 
clear oil: bp 110-112 °C (0.05 torr).  1H NMR (400 MHz, CDCl3) δ 6.89 (s, 2H), 5.17 (s, 
2H), 3.45 (t, J = 8.0 Hz, 2H), 2.41 (s, 3H), 0.87 (t, J = 8.0 Hz, 2H), -0.04 (s, 9H); 13C 
NMR (100 MHz, CDCl3) δ 144.9, 126.9, 119.4, 74.7, 65.7, 17.5, 12.8, -1.6; IR (NaCl, 
neat) ν 3395, 3110, 2954, 1530, 1500 cm-1; HRMS (ESI) calcd for C10H21ON2Si (MH+) 
213.1423, found 213.1420.  The spectra of 1.66 are in agreement with those previously 
reported.56   
 
 
 
 
 
 
 
 
                                                 
(56) (a) Lipshutz, B. H.; Vaccaro, W.; Huff, B.  Tetrahedron Lett. 1986, 27, 4095–4098. Also, see: (b) 
ref. 33. 
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N
N Me
SEM
N
N Me
SEM
Bu3Sn
1.66 1.67  
2-Methyl-5-(tributylstannyl)-1-[[2-(trimethylsilyl)ethoxy]methyl]-1H-imidazole 
(1.67).  To a 50 mL round-bottomed flask were added 1.66 (600 mg, 2.83 mmol), 
anhydrous Et2O (15 mL), and a stir bar.  The colorless solution was stirred, the flask was 
placed in an ice bath (0 °C), and to the flask was added n-BuLi (1.13 mL, 2.5 M in  
hexanes, 2.8 mmol) dropwise over 10 min.  The yellow mixture was allowed to stir for an 
additional 10 min in the ice bath and the flask was then removed from the ice bath.  After 
stirring for 50 min at room temperature, the flask was placed back in an ice bath (0 °C) 
and to the flask was added tributyltin chloride (967 μL, 2.97 mmol) dropwise over 5 min.  
The flask was removed from the ice bath, stirred at room temperature for 2 h, and then 
the solution was quenched with H2O (40 mL).  The mixture was transferred to a 
separatory funnel, the organic layer was separated, and the aqueous layer was extracted 
with Et2O (2 x 15 mL).  The organic layer and extracts were pooled, washed with H2O (1 
x 25 mL) and saturated NaCl solution (1 x 40 mL), dried with MgSO4, and filtered.  
Removal of the solvent in vacuo gave a yellow oil.  The oil was purified by flash column 
chromatography (15 cm x 4 cm; silica) where the silica gel was loaded as a slurry in 
40:60:1 hexanes:EtOAc:triethylamine (1 L) and eluted with the same solvent system to 
afford 900 mg (64%) of 1.67 (Rf = 0.4; 60% EtOAc in hexanes; silica; visualized with an 
I2 stain) as a colorless oil: 1H NMR (400 MHz, CDCl3) δ 6.88 (s, 1H), 5.12 (s, 2H), 3.40 
(t, J = 8.0 Hz, 2H), 2.45 (s, 3H), 1.54-1.46 (m, 6H), 1.36-1.27 (m, 6H), 1.07-1.03 (m, 
6H), 0.92-0.86 (m, 11H), -0.02 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 148.2, 137.2, 
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128.9, 75.7, 65.4, 28.9, 27.2, 17.8, 13.6, 13.4, 10.1, -1.5; IR (NaCl, neat) ν 2956, 1526, 
1457 cm-1; HRMS (ESI) calcd for C22H47N2O29Si119Sn (MH+) 503.2486, found 503.2463; 
Anal. Calcd for C22H46N2OSiSn: C, 52.70; H, 9.25; N, 5.59.  Found: C, 52.87; H, 9.24; 
N, 5.54.       
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OH
Me
HO
OEt
Me
EtO
1.68 1.69  
2,6-Diethoxytoluene (1.69).  A 500 mL round-bottomed flask fitted with a reflux 
condenser was charged with 2-methylresorcinol (1.68, 10.3 g, ca. 75 mmol, 90% 
technical grade, purchased from Aldrich, catalog number M80407), acetone (150 mL, 
ACS reagent grade), diethyl sulfate (29 mL, 220 mmol), anhydrous potassium carbonate 
(45.9 g, 332 mmol, purchased from Aldrich, catalog number P5833), and a stir bar.  The 
flask and its contents were placed in an oil bath and the oil bath was heated at 65 ºC.  The 
mixture was stirred vigorously and allowed to reflux open to the air.  After 12 h of 
stirring the mixture was cooled to room temperature and the acetone was removed in 
vacuo.  The resulting off-white solid was dissolved in a mixture of CH2Cl2 (75 mL) and 
H2O (150 mL) and transferred to a separatory funnel.  The organic layer was separated 
and the aqueous layer was extracted with CH2Cl2 (2 x 75 mL).  The organic layer and 
extracts were pooled, washed with H2O (2 x 75 mL) and saturated NaCl solution (1 x 100 
mL), dried with MgSO4, and filtered.  Removal of the solvent in vacuo gave a yellow oil 
which solidified upon cooling to -25 ºC.  Recrystallization of the solid from cold (-25 °C) 
methanol (100 mL) gave 12.4 g (ca. 92%) of 1.69 as white prisms: mp 44-47 ºC (lit. mp 
44-48 ºC57 and 45-48 °C3g); 1H NMR (400 MHz, CDCl3) δ 7.06 (t, J = 8.0 Hz, 1H), 6.50 
(d, J = 8.0 Hz, 2H), 4.02 (q, J = 7.6 Hz, 4H), 2.11 (s, 3H), 1.41 (t, J = 7.6 Hz, 6H); 13C 
NMR (100 MHz, CDCl3) δ 157.7, 125.9, 115.1, 104.5, 63.9, 15.0, 8.3; IR (KBr) ν 3019, 
                                                 
(57) Aldrich Catalog. Aldrich Chemical Co.: Milwaukee, WI, 2007; p. 931. 
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2979, 2931, 2881, 1595, 1464 cm-1; HRMS (ESI) calcd for C11H17O2 (MH+) 181.1229, 
found 181.1219; Anal. Calcd for C11H16O2: C, 73.30; H, 8.95.  Found: C, 73.40; H, 8.99. 
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OEt
Me
EtO
OEt
Me
EtO
1.69 OH
1.70  
2,4-Diethoxy-3-methylphenol (1.70).  To a 250 mL round-bottomed flask, open to the 
air, were added 1.69 (5.00 g, 27.8 mmol), glacial acetic acid (125 mL, purchased from 
Aldrich, catalog number 537020), phosphoric acid (7.9 mL, ≥85% wt solution in H2O, 
purchased from Aldrich, catalog number 215104), hydrogen peroxide (5.8 mL, ca. 56 
mmol, 30-32% wt solution in H2O, purchased from Aldrich, catalog number 216763), 
and a stir bar.  The solution was stirred open to the air at room temperature for 15 h and 
then quenched with sat. NaHSO3 (75 mL).  The solution was transferred to a 500 mL 
Erlenmeyer flask and stirred until the peroxides (CAUTION: Explosion Hazard) were 
quenched (ca. 15 min, checked with peroxide test paper, EM Science catalog # 10011-1).  
The solution was transferred to a separatory funnel containing saturated NaCl solution 
(230 mL).  The resulting mixture was extracted with CH2Cl2 (4 x 175 mL).   The extracts 
were pooled, washed with saturated NaCl solution (1 x 200 mL), dried with MgSO4, and 
filtered.  Removal of the solvent in vacuo gave a brown oil.  This oil was purified by 
flash column chromatography (24 cm x 4 cm; silica gel) with 15% Et2O in hexanes (1 L) 
to afford 1.00 g of 1.69 and 2.30 g (42%, or 53% based on unrecovered 1.69) of 1.7058 as 
a white solid (Rf = 0.3; 20% Et2O in hexanes; silica).  An analytically pure sample of 
1.70 could be obtained by recrystalization from cold (-25 °C) pentane to give a white 
                                                 
(58) Phenol 1.70 is somewhat unstable to the reaction conditions.  A better yield of 1.70 is obtained if the 
reaction is not run to completion. 
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solid: mp 42-43 ºC; 1H NMR (400 MHz, CDCl3) δ 6.72 (d, J = 8.8 Hz, 1H), 6.52 (d, J = 
8.8 Hz, 1H), 5.25 (s, 1H), 3.98-3.91 (m, 4H), 2.17 (s, 3H), 1.42 (t, J = 7.2 Hz, 3H), 1.39 
(t, J = 7.2 Hz, 3H);  13C NMR (100 MHz, CDCl3) δ 151.1, 144.8, 143.1, 120.4, 111.4, 
108.0, 69.2, 64.5, 15.7, 15.0, 9.7; IR (neat) ν 3375, 2977, 1488 cm-1; HRMS (ESI) calcd 
for C11H17O3 (MH+) 197.1178, found 197.1177; Anal. Calcd for C11H16O3: C, 67.32; H, 
8.22.  Found: C, 67.03; H, 8.15.    
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1.71
OEt
Me
EtO
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1.70
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6-Bromo-2,4-diethoxy-3-methylphenol (1.71).  Bromine-1,4-dioxane was prepared as 
follows (for a related procedure, see: Billimoria, J. D.; Maclagan, N. F. J. Chem. Soc. 
1954, 3257–3262): a 50 mL round-bottomed flask was charged with distilled (see general 
experimental remarks) 1,4-dioxane (24 mL) and a stir bar open to the air.  The flask was 
placed in an ice bath (0 °C), the contents were stirred, and to the flask was added bromine 
(3.0 mL) dropwise over 10 min.  After stirring for an additional 5 min at 0 °C, the flask 
was removed from the cooling bath and the yellow/orange precipitate was collected by 
suction filtration.  The solid (9.3 g, 64%) was washed with ice-cold pentane (2 x 5 mL), 
dried with passage of air through the filter paper (ca. 5 min), and stored in a freezer (-25 
°C) sealed in a screw-cap vial.  
 
A 250 mL round-bottomed flask was charged with 1.70 (3.65 g, 18.6 mmol), anhydrous 
potassium carbonate (3.85 g, 27.8 mmol, purchased from Aldrich, catalog number 
P5833), anhydrous CH2Cl2 (100 mL), and a stir bar.  The mixture was stirred vigorously 
and the flask was placed in a -78 °C bath.  To a separate 50 mL pear-shaped flask were 
added bromine-1,4-dioxane (4.87 g, 19.6 mmol) and anhydrous CH2Cl2 (25 mL).  The 
pear-shaped flask was shaken and the resulting brown solution was added to the flask 
containing 1.70 dropwise over 15 min.  The mixture was stirred for an additional 15 min 
at -78 °C, the flask was removed from the cooling bath, stirred for 25 min at room 
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temperature, and then quenched with a solution of NaHCO3 (10 g) and Na2S2O3 (10 g) in 
H2O (200 mL).  The biphasic mixture was transferred to a separatory funnel, the organic 
layer was separated and the aqueous layer was extracted with CH2Cl2 (2 x 60 mL).  The 
organic layer and extracts were pooled, washed with H2O (2 x 50 mL) and saturated NaCl 
solution (1 x 50 mL), dried with MgSO4, and filtered.  Removal of the solvent in vacuo 
gave a yellow solid.  The solid was recrystallized from cold (-25 °C) hexanes (75 mL) to 
afford 4.50 g (88%) of 1.7159 (Rf = 0.5; 20% Et2O in hexanes; silica) as colorless 
needles: mp 64-66 ºC; 1H NMR (400 MHz, CDCl3) δ 6.72 (s, 1H), 5.44 (s, 1H), 3.97 (q, J 
= 7.2 Hz, 2H), 3.93 (q, J = 7.2 Hz, 2H), 2.11 (s, 3H), 1.41 (t, J = 7.2 Hz, 3H), 1.39 (t, J = 
7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 151.2, 145.4, 140.8, 120.4, 110.9, 104.7, 
69.3, 64.5, 15.6, 14.8, 9.6; IR (neat) ν 3486, 2981, 1595 cm-1; HRMS (ESI) calcd for 
C11H16BrO3 (MH+) 275.0283, found 275.0274; Anal. Calcd for C11H15BrO3: C, 48.02; H, 
5.50.  Found: C, 48.07; H, 5.46.     
 
Crystal data and structure refinement for 1.71. 
 
Identification code  1.71 
Empirical formula  C11 H15 Br O3 
Formula weight  275.14 
Temperature  193(2) K 
Wavelength  0.71073 Å 
                                                 
(59) The structure of 1.71 was confirmed by X-ray crystallography, see Figure 1.5. 
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Crystal system  Monoclinic 
Space group  P 21/c  
Unit cell dimensions a = 8.8986(14) Å α= 90°. 
 b = 12.6670(19) Å β= 97.923(2)°. 
 c = 10.1926(16) Å γ = 90°. 
Volume 1137.9(3) Å3 
Z 4 
Density (calculated) 1.606 Mg/m3 
Absorption coefficient 3.597 mm-1 
F(000) 560 
Crystal size 0.08 x 0.05 x 0.02 mm3 
Theta range for data collection 2.31 to 28.29°. 
Index ranges -11<=h<=11, 0<=k<=16, 0<=l<=13 
Reflections collected 2771 
Independent reflections 2771 [R(int) = 0.0460] 
Completeness to theta = 28.29° 97.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9315 and 0.7618 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2771 / 1 / 140 
Goodness-of-fit on F2 1.074 
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Final R indices [I>2sigma(I)] R1 = 0.0468, wR2 = 0.0843 
R indices (all data) R1 = 0.0727, wR2 = 0.0929 
Extinction coefficient na 
Largest diff. peak and hole 0.573 and -0.389 e.Å-3 
 
Bond lengths [Å] and angles [°] for 1.71. 
 
Br(1)-C(1)  1.902(3) 
O(1)-C(2)  1.372(4) 
O(2)-C(3)  1.383(4) 
O(2)-C(7)  1.448(4) 
O(3)-C(5)  1.368(4) 
O(3)-C(10)  1.431(4) 
C(1)-C(2)  1.366(5) 
C(1)-C(6)  1.388(5) 
C(2)-C(3)  1.401(4) 
C(3)-C(4)  1.378(5) 
C(4)-C(5)  1.407(5) 
C(4)-C(9)  1.500(5) 
C(5)-C(6)  1.378(4) 
C(7)-C(8)  1.489(5) 
C(10)-C(11)  1.493(5) 
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C(3)-O(2)-C(7) 113.6(2) 
C(5)-O(3)-C(10) 117.9(3) 
C(2)-C(1)-C(6) 122.0(3) 
C(2)-C(1)-Br(1) 119.4(2) 
C(6)-C(1)-Br(1) 118.5(3) 
C(1)-C(2)-O(1) 121.9(3) 
C(1)-C(2)-C(3) 117.8(3) 
O(1)-C(2)-C(3) 120.3(3) 
C(4)-C(3)-O(2) 121.7(3) 
C(4)-C(3)-C(2) 122.5(3) 
O(2)-C(3)-C(2) 115.8(3) 
C(3)-C(4)-C(5) 117.4(3) 
C(3)-C(4)-C(9) 122.5(3) 
C(5)-C(4)-C(9) 120.1(3) 
O(3)-C(5)-C(6) 124.2(3) 
O(3)-C(5)-C(4) 114.5(3) 
C(6)-C(5)-C(4) 121.2(3) 
C(5)-C(6)-C(1) 119.0(3) 
O(2)-C(7)-C(8) 108.7(3) 
O(3)-C(10)-C(11) 106.6(3) 
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Torsion angles [°] for 1.71. 
 
C(6)-C(1)-C(2)-O(1) -178.6(3) 
Br(1)-C(1)-C(2)-O(1) 1.8(4) 
C(6)-C(1)-C(2)-C(3) 0.4(5) 
Br(1)-C(1)-C(2)-C(3) -179.1(2) 
C(7)-O(2)-C(3)-C(4) -78.1(4) 
C(7)-O(2)-C(3)-C(2) 104.6(3) 
C(1)-C(2)-C(3)-C(4) 0.8(5) 
O(1)-C(2)-C(3)-C(4) 179.9(3) 
C(1)-C(2)-C(3)-O(2) 178.1(3) 
O(1)-C(2)-C(3)-O(2) -2.8(4) 
O(2)-C(3)-C(4)-C(5) -178.5(3) 
C(2)-C(3)-C(4)-C(5) -1.3(5) 
O(2)-C(3)-C(4)-C(9) 1.0(5) 
C(2)-C(3)-C(4)-C(9) 178.2(3) 
C(10)-O(3)-C(5)-C(6) -0.6(5) 
C(10)-O(3)-C(5)-C(4) 179.7(3) 
C(3)-C(4)-C(5)-O(3) -179.6(3) 
C(9)-C(4)-C(5)-O(3) 0.8(4) 
C(3)-C(4)-C(5)-C(6) 0.7(5) 
C(9)-C(4)-C(5)-C(6) -178.9(3) 
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O(3)-C(5)-C(6)-C(1) -179.2(3) 
C(4)-C(5)-C(6)-C(1) 0.5(5) 
C(2)-C(1)-C(6)-C(5) -1.0(5) 
Br(1)-C(1)-C(6)-C(5) 178.5(2) 
C(3)-O(2)-C(7)-C(8) 162.4(3) 
C(5)-O(3)-C(10)-C(11) -179.3(3) 
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(6-Bromo-2,4-diethoxy-3-methylphenoxy)tris(1-methylethyl)silane (1.72).  To a 100 
mL round-bottomed flask were added 1.71 (955 mg, 3.47 mmol), anhydrous THF (30 
mL), and a stir bar.  The flask was stirred, fitted with a mineral oil bubbler, placed in an 
ice bath (0 °C), and to the flask was carefully added (CAUTION: Rapid evolution of H2 
gas!) NaH (60% dispersed in mineral oil, 146 mg, ca. 3.6 mmol, purchased from Aldrich, 
catalog number 452912) in 5 portions over a 10 minute period.  The flask was removed 
from the cooling bath and stirred for 45 minutes at room temperature. The flask was 
again placed in the ice bath (0 °C) and to the mixture was added triisopropylsilyl chloride 
(781 μL, 3.65 mmol, purchased from Aldrich, catalog number 241725) dropwise over a 5 
minute period.  The flask was removed from the cooling bath, the solution was stirred at 
room temperature, and the progress of the reaction was monitored by TLC (Rf of 1.72 = 
0.8; 15% Et2O in hexanes; silica).  Once the reaction was complete (ca. 2 h), the solution 
was quenched (CAUTION: residual NaH may be present) with H2O (30 mL), 
transferred to a separatory funnel, the layers were separated, and the aqueous layer was 
extracted with Et2O (3 x 30 mL).  The organic layer and extracts were pooled, washed 
with H2O (1 x 50 mL) and saturated NaCl solution (1 x 50 mL), dried with MgSO4, and 
filtered.  Removal of the solvent in vacuo gave an amber oil.  The amber oil was purified 
by flash column chromatography (15 cm x 4 cm; silica) with 5% Et2O in hexanes (1 L) to 
give 1.25 g (84%) of 1.72 as a white solid: mp 56-58 ºC; 1H NMR (400 MHz, CDCl3) δ 
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6.72 (s, 1H), 3.93 (q, J = 6.8 Hz, 2H), 3.86 (q, J = 6.8 Hz, 2H), 2.08 (s, 3H), 1.45-1.32 
(m, 9H), 1.11-1.09 (d, 18H); 13C NMR (100 MHz, CDCl3) δ 151.9, 149.8, 141.9, 121.0, 
111.9, 111.1, 68.7, 64.2, 18.1, 15.3, 14.9, 14.1, 9.6; IR (neat) ν 2865, 1569, 1483 cm-1; 
HRMS (ESI) calcd for C20H36BrO3Si (MH+) 433.1597, found 433.1607; Anal. Calcd for 
C20H35BrO3Si: C, 55.67; H, 8.18.  Found: C, 55.96; H, 8.27.   
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5-[3,5-Diethoxy-4-methyl-2-(triisopropylsilyloxy)phenyl]-2-methyl-1-[[2-
(trimethylsilyl)ethoxy]methyl]-1H-imidazole (1.73).  This reaction was set up in a 
glove box under an atmosphere of N2.  Prior to use, distilled (see general experimental 
remarks) 1,4-dioxane was freeze-pump-thaw-degassed four times.  A 25 x 95 mm screw-
thread vial (purchased from Fisher, catalog number 03-339-21H) was charged with 1.72 
(397 mg, 0.921 mmol), 1.67 (462 mg, 0.922 mmol), 
tetrakis(triphenylphosphine)palladium(0) (52 mg, 0.045 mmol, purchased from Strem, 
catalog number 46-2150), degassed 1,4-dioxane (9 mL), and a stir bar.  The vial was 
tightly capped in the glove box, transferred to a fume hood, and placed in an oil bath.  
The oil bath was heated at 105 °C and the reaction solution was stirred behind a blast 
shield.  After stirring for 20 h, the solution was cooled to room temperature and filtered 
through a pad of Celite.  The Celite was rinsed with Et2O, and the volatiles in the 
combined filtrate and rinse were removed in vacuo to give an amber oil.  The oil was 
purified by flash column chromatography (18 cm x 3 cm; silica) with 60% Et2O in 
hexanes (1 L) to afford 460 mg (89%) of 1.73 (Rf = 0.2; 60% Et2O in hexanes; silica) as a 
colorless oil: 1H NMR (400 MHz, CDCl3) δ 6.80 (s, 1H), 6.45 (s, 1H), 5.15 (s, 2H), 3.95-
3.87 (m, 4H), 3.03 (t, J = 8.2 Hz, 2H), 2.45 (s, 3H), 2.15 (s, 3H), 1.38 (t, J = 7.2 Hz, 3H), 
1.35 (t, J = 7.2 Hz, 3H), 0.91-0.86 (m, 21H), 0.62 (t, J = 8.2 Hz, 2H), -0.16 (s, 9H); 13C 
 45
NMR (100 MHz, CDCl3) δ 151.9, 149.6, 145.9, 141.1, 131.4, 125.7, 122.1, 120.0, 109.8, 
72.9, 68.6, 65.7, 63.9, 17.8, 17.5, 15.2, 14.8, 13.5, 13.4, 9.6, -1.7; IR (neat) ν 2946, 2867, 
1512, 1462, 1426 cm-1; HRMS (ESI) calcd for C30H55N2O4Si2 (MH+) 563.3700, found 
563.3708; Anal. Calcd for C30H54N2O4Si2: C, 64.01; H, 9.67; N, 4.98.  Found: C, 63.88; 
H, 9.77; N, 4.92.       
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4-Bromo-5-[3,5-diethoxy-4-methyl-6-(triisopropylsilyloxy)phenyl]-2-methyl-1-[[2-
(trimethylsilyl)ethoxy]methyl]-1H-imidazole (1.82).  A 25 mL round-bottomed flask 
was charged with 1.73 (142 mg, 0.253 mmol), Et2O (7 mL), and a stir bar.  The solution 
was stirred open to the air at room temperature.  In a separate 10 mL pear-shaped flask 
was added bromine-1,4-dioxane (see preparation of 1.71, 69 mg, 0.28 mmol) and Et2O (2 
mL).  The pear-shaped flask was shaken and the brown solution was added to the flask 
containing 1.73 by dropwise addition over a period of ca. 2 min.  The orange solution 
was stirred for 10 min and then quenched with a solution of NaHCO3 (100 mg) and 
Na2S2O3 (100 mg) in H2O (2 mL).  The biphasic mixture was transferred to a separatory 
funnel, the organic layer was separated and the aqueous layer was extracted with Et2O (2 
x 10 mL).  The organic layer and extracts were pooled, washed with H2O (2 x 15 mL) 
and saturated NaCl solution (1 x 20 mL), dried with MgSO4, and filtered.  Removal of 
the solvent in vacuo gave an oil.  The oil was purified by flash column chromatography 
(18 cm x 2 cm; silica) with 40% Et2O in hexanes (150 mL) followed by 100% Et2O (75 
mL) to afford 87 mg of 1.82 and 63 mg (39%, or 100% based on unrecovered 1.73) of 
1.82 (Rf = 0.4; 40% Et2O in hexanes; silica) as a colorless oil: 1H NMR (400 MHz, 
CDCl3) δ 6.53 (s, 1H), 5.25 (d, J = 11.4 Hz, 1H), 5.02 (d, J = 11.4 Hz, 1H), 4.11-4.03 (m, 
1H), 3.99-3.92 (m, 2H), 3.74-3.66 (m, 1H), 3.20-3.13 (m, 1H), 2.93-2.86 (m, 1H), 2.44 
(s, 3H), 2.17 (s, 3H), 1.41-1.34 (m, 6H), 1.02-0.86 (m, 21H), 0.63-0.58 (m, 2H), -0.16 (s, 
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9H); 13C NMR (100 MHz, CDCl3) δ 151.9, 149.7, 145.6, 141.3, 128.1, 122.9, 118.1, 
113.2, 110.2, 73.5, 68.7, 66.1, 64.0, 18.1, 17.8, 17.5, 15.3, 14.8, 13.5, 13.4, 9.8, -1.6; IR 
(NaCl, neat) ν 2947, 2867, 1461, 1426, 1385, 1247, 1216 cm-1; HRMS (ESI) calcd for 
C30H54BrN2O4Si2 (MH+) 643.2785, found 643.2806. 
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5-[2-Bromo-3,5-diethoxy-4-methyl-6-(triisopropylsilyloxy)phenyl]-2-methyl-1-[[2-
(trimethylsilyl)ethoxy]methyl]-1H-imidazole (1.75).  To a 250 mL round-bottomed 
flask were added 1.73 (950 mg, 1.69 mmol), anhydrous Et2O (40 mL), and a stir bar.  The 
flask was stirred, placed in an ice bath (0 °C), and to this was added distilled (see general 
experimental remarks) trifluoroacetic acid (40 mL) over a period of 15 min.  The solution 
was stirred at 0 °C for 10 min and then bromine-1,4-dioxane (see preparation of 1.71, 831 
mg, 3.35 mmol) was added in 1 portion.  The orange solution was stirred at 0 °C for 15 
min and then slowly (ca. 15 min) quenched with 6 M NaOH (100 mL).  The flask was 
removed from the ice bath and neutralized (ca. pH = 7) with solid NaOH (ca. 2 g).  The 
mixture was transferred to a separatory funnel, the Et2O layer was separated, and the 
aqueous layer was extracted with Et2O (3 x 40 mL).  The Et2O layer and extracts were 
pooled, washed with 1 M NaOH (1 x 50 mL), H2O (1 x 50 mL) and saturated NaCl 
solution (1 x 50 mL), dried with MgSO4, and filtered.  Removal of the solvent in vacuo 
gave an orange oil.  The oil was purified by flash column chromatography (18 cm x 4 cm; 
silica) with 45% Et2O in hexanes (1 L) to afford 788 mg (73%) of 1.75 (Rf = 0.3; 50% 
Et2O in hexanes; silica) as a white solid: mp 96-98 °C; 1H NMR (400 MHz, CDCl3) δ 
6.88 (s, 1H), 5.18 (d, J = 11.6 Hz, 1H), 4.82 (d, J = 11.6 Hz, 1H), 4.08-3.83 (m, 3H), 
3.72-3.64 (m, 1H), 3.34-3.28 (m, 1H), 3.06-2.99 (m, 1H), 2.47 (s, 3H), 2.26 (s, 3H), 1.41 
(t, J = 6.8 Hz, 3H), 1.35 (t, J = 6.8 Hz, 3H), 0.94-0.84 (m, 21 H), 0.71-0.66 (m, 2H), -
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0.11 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 149.5, 148.3, 145.3, 145.2, 128.3, 127.9, 
127.8, 121.8, 115.7, 72.6, 68.3, 68.2, 65.2, 17.6, 17.4, 17.3, 15.1, 14.9, 13.3, 13.2, 10.7, -
1.7; IR (neat) ν 2942, 2865, 1415, 1381 cm-1; HRMS (ESI) calcd for C30H54BrN2O4Si2 
(MH+) 641.2806, found 641.2810; Anal. Calcd for C30H53BrN2O4Si2: C, 56.14; H, 8.32; 
N, 4.36.  Found: C, 56.28; H, 8.31; N, 4.30. 
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5-[3,5-Diethoxy-4-methyl-2-(2-propen-1-yl)-6-(triisopropylsilyloxy)phenyl]-2-
methyl-1-[[2-(trimethylsilyl)ethoxy]methyl]-1H-imidazole (1.76).  This reaction was 
set up in a glove box under an atmosphere of N2.  Prior to use, distilled (see general 
experimental remarks) DMF was freeze-pump-thaw-degassed four times.  A 27 x 57 mm 
screw-thread vial (purchased from Fisher, catalog number 03-339-21J) was charged with 
1.75 (346 mg, 0.540 mmol), allyltributylstannane (249 μL, 0.803 mmol), 
tetrakis(triphenylphosphine)palladium(0) (26 mg, 0.023 mmol, purchased from Strem, 
catalog number 46-2150), degassed DMF (5 mL), and a stir bar.  The vial was tightly 
capped in the glove box, transferred to a fume hood, and placed in an oil bath.  The oil 
bath was heated at 105 °C and the reaction solution was stirred behind a blast shield.  
After stirring for 15 h, the solution was cooled to room temperature, filtered through a 
pad of Celite, and the Celite was rinsed with Et2O.  The combined filtrate and rinse were 
transferred to a separatory funnel, H2O (25 mL) was added, the layers were shaken and 
then separated, and the aqueous layer was extracted with Et2O (3 x 20 mL).  The organic 
layer and extracts were pooled, washed with H2O (1 x 25 mL) and saturated NaCl 
solution (1 x 25 mL), dried with MgSO4, and filtered.  Removal of the solvent in vacuo 
gave an amber oil.  The oil was purified by flash column chromatography (16 cm x 3 cm; 
silica) with 45% Et2O in hexanes (500 mL) to afford 319 mg (98%) of 1.76 (Rf = 0.3; 
45% Et2O in hexanes; silica) as a colorless oil: 1H NMR (400 MHz, CDCl3) δ 6.86 (s, 
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1H), 5.98-5.88 (m, 1H), 5.14 (d, J = 11.2 Hz, 1H), 4.98 (dd, J = 10.2, 1.8 Hz, 1H), 4.83-
4.76 (m, 2H), 4.10-4.03 (m, 1H), 3.90-3.83 (m, 1H), 3.79-3.64 (m, 2H), 3.43 (dd, J = 
15.4, 5.4 Hz, 1H), 3.19-3.13 (m, 1H), 3.03-2.94 (m, 2H), 2.47 (s, 3H), 2.24 (s, 3H), 1.71-
1.60 (m, 1H), 1.39-1.25 (m, 8H), 0.92-0.85 (m, 18H), 0.68-0.63 (m, 2H), -0.11 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ 151.1, 147.7, 145.6, 144.6, 138.6, 129.1, 128.6, 127.4, 
126.7, 120.8, 114.6, 72.8, 68.7, 68.4, 65.5, 32.3, 17.9, 17.7, 17.6, 15.5, 15.3, 13.6, 13.5, 
10.5, -1.5; IR (neat) ν 2946, 2867, 1637, 1422, 1384, 1248, 833 cm-1; HRMS (ESI) calcd 
for C33H59N2O4Si2 (MH+) 603.4013, found 603.4013. 
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5-[3,5-Diethoxy-4-methyl-2-(2-propen-1-yl)-6-(triisopropylsilyloxy)phenyl]-2-
methyl-1H-imidazole (1.77).  To a 25 mL round-bottomed flask were added 1.76 (137 
mg, 0.228 mmol), distilled (see general experimental remarks) trifluoroacetic acid (4 
mL), and a stir bar.  The colorless solution was stirred open to the air at room temperature 
for 12 h and the remaining solvent was removed in vacuo.  The residue was dissolved in a 
mixture of 1 M NaOH (10 mL) and Et2O (10 mL) and transferred to a separatory funnel.  
The layers were separated and the aqueous layer was extracted with Et2O (2 x 10 mL).  
The organic layer and extracts were pooled, washed with saturated NaCl solution (1 x 25 
mL), dried with MgSO4, and filtered.  Removal of the solvent in vacuo gave a solid 
residue.  The residue was recrystallized from 1:1 Et2O:hexanes to give 92 mg (86%) of 
1.77 (Rf = 0.45; 75% Et2O in hexanes; silica) as white needles: mp 169-171 °C; 1H NMR 
(400 MHz, CDCl3) δ 6.81 (s, 1H), 5.90-5.80 (m, 1H), 4.88 (d, J = 8.8 Hz, 1H), 4.69 (dd, J 
= 17.2, 2.0 Hz, 1H), 3.82 (q, J = 6.8 Hz, 2H), 3.76 (q, J = 6.8 Hz, 2H), 3.26 (d, J = 5.2 
Hz, 2H), 2.29 (s, 3H), 2.18 (s, 3H), 1.35-1.28 (m, 6H), 0.90 (br s, 21H); 13C NMR (100 
MHz, CDCl3) δ 150.5, 147.8, 144.8, 143.3, 138.7, 127.9, 125.6, 114.3, 68.7, 68.3, 32.0, 
18.0, 15.5, 15.3, 13.8, 13.7, 10.4; IR (neat) ν 2866, 1424, 1382, 1127, 1073 cm-1; HRMS 
(ESI) calcd for C27H45N2O3Si (MH+) 473.3199, found 473.3201. 
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7,9-Diethoxy-5,6-dihydro-3,8-dimethyl-10-(triisopropylsilyloxy)imidazo[5,1-
a]isoquinolin-5-ol (1.78).  To a 25 mL round-bottomed flask were added 1.77 (75 mg, 
0.16 mmol), THF (5 mL), tert-butanol (2.5 mL), H2O (2.5 mL), OsO4 (110 μL, ca. 0.018 
mmol, 4 wt% in H2O, purchased from Strem, catalog number 76-2952), NaIO4 (105 mg, 
0.491 mmol), and a stir bar.  The solution was stirred open to the air at room temperature 
and the progress of the reaction was monitored by TLC (Rf of 1.78 = 0.2; 100% EtOAc; 
silica).  Once the reaction was complete (ca. 21 h), the mixture (as the reaction progresses 
a white precipitate forms) was transferred to a separatory funnel, and to the funnel was 
added a mixture of H2O (20 mL) and Et2O (20 mL).  The layers were separated and the 
aqueous layer was extracted with Et2O (2 x 20 mL).  The organic layer and extracts were 
pooled, washed with H2O (1 x 25 mL) and saturated NaCl solution (1 x 25 mL), dried 
with MgSO4, and filtered.  Removal of the solvent in vacuo gave a crude solid.  The solid 
was purified by flash column chromatography (13 cm x 2 cm; silica) with 100% EtOAc 
(300 mL) to afford 60 mg (81%) of 1.78 as a white solid: mp 190-192 °C; 1H NMR (400 
MHz, CDCl3) δ 7.48 (s, 1H), 5.81 (br s, 1H), 4.63 (br s, 1H), 4.10-4.03 (m, 1H), 3.84-
3.70 (m, 3H), 3.55 (dd, J = 16.0, 2.2 Hz, 1H), 2.88 (dd, J = 16.0, 3.8 Hz, 1H), 2.35 (s, 
3H), 2.20 (s, 3H), 1.43-1.34 (m, 9H), 1.05-0.99 (m, 18H); 13C NMR (100 MHz, CDCl3) δ 
150.5, 148.5, 142.4, 142.3, 126.1, 124.5, 124.2, 118.0, 116.3, 72.6, 68.9, 68.8, 31.5, 18.1, 
18.0, 15.6, 15.4, 14.1, 12.4, 10.3; IR (neat) ν 3089, 2931, 2702, 2865, 1460, 1386, 1083 
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cm-1; HRMS (ESI) calcd for C26H43N2O4Si (MH+) 475.2992, found 475.3001; Anal. 
Calcd for C26H42N2O4Si: C, 65.78; H, 8.92; N, 5.90.  Found: C, 65.34; H, 8.88; N, 5.79.   
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7,9-Diethoxy-3,8-dimethyl-10-(triisopropylsilyloxy)imidazo[5,1-a]isoquinoline (1.79).  
To a 25 mL round-bottomed flask were added 1.78 (52 mg, 0.11 mmol), anhydrous 
CH2Cl2 (5 mL), distilled (see general experimental remarks) NEt3 (77 μL), and a stir bar.  
The solution was stirred, placed in an ice bath (0 °C), and to it was added distilled (see 
general experimental remarks) methanesulfonyl chloride (9 μL, 0.1 mmol).  The solution 
was stirred at 0 °C and the progress of the reaction was monitored by TLC (Rf of 1.79 = 
0.4; 75% EtOAc in hexanes; silica).  Once the reaction was complete (ca. 2.5 h), the 
solution was transferred to a separatory funnel.  To the separatory funnel was added H2O 
(20 mL), the organic layer was separated, and the aqueous layer was extracted with 
CH2Cl2 (3 x 20 mL).  The organic layer and extracts were pooled, washed with H2O (1 x 
25 mL) and saturated NaCl solution (1 x 25 mL), dried with MgSO4, and filtered.  
Removal of the solvent in vacuo gave a crude solid.  The solid was purified by flash 
column chromatography (10 cm x 2 cm; silica) with 75% EtOAc in hexanes (300 mL) to 
afford 37 mg (74%) of 1.79 as a beige solid: mp 134-136 °C; 1H NMR (400 MHz, 
CDCl3) δ 7.97 (s, 1H), 7.44 (d, J = 7.6 Hz, 1H), 7.00 (d, J = 7.6 Hz, 1H), 3.96-3.88 (m, 
4H), 2.63 (s, 3H), 2.28 (s, 3H), 1.54-1.43 (m, 6H), 1.36 (t, J = 7.2 Hz, 3H), 1.03 (d, J = 
7.2 Hz, 18H); 13C NMR (100 MHz, CDCl3) δ 148.9, 147.7, 141.7, 136.6, 125.6, 123.6, 
122.9, 118.4, 117.7, 117.6, 107.8, 69.8, 69.1, 18.1, 15.6, 15.4, 14.1, 12.8, 10.4; IR (neat) 
ν 2865, 1459, 1367, 1255, 1015 cm-1; HRMS (ESI) calcd for C26H41N2O3Si (MH+) 
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457.2886, found 457.2888; Anal. Calcd for C26H40N2O3Si: C, 68.38; H, 8.83; N, 6.13.  
Found: C, 68.40; H, 8.98; N, 5.89.         
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7,9-Diethoxy-3,8-dimethyl-10-hydroxyimidazo[5,1-a]isoquinoline (1.80).  To a 15 mL 
round-bottomed flask were added 1.79 (37 mg, 0.081 mmol), anhydrous THF (5 mL), 
and a stir bar.  The solution was stirred, placed in an ice bath (0 °C), and to this was 
added tetrabutylammonium fluoride (81 µL, ca. 0.08 mmol, 1 M in THF, purchased from 
Aldrich, catalog number 216143) by dropwise addition over ca. 2 min.  The solution was 
stirred at room temperature and the progress of the reaction was monitored by TLC (Rf of 
1.80 = 0.2; 100% EtOAc; silica).  Once the reaction was complete (ca. 30 min), the flask 
was transferred to a rotary evaporator, and removal of the solvent in vacuo gave a crude 
oil.  The oil was purified by flash column chromatography (15 cm x 1 cm; silica) with 
100% EtOAc (150 mL) to afford 24 mg (97%) of 1.80 as a white solid.  An analytically 
pure sample of 1.80 could be obtained as small colorless needles by recrystallization from 
a cold (-25 °C) mixture of Et2O and EtOAc: mp 201-203 ºC (lit. mp 212-213 ºC3f and 
211-213 ºC3g); 1H NMR (400 MHz, CDCl3) δ 7.95 (s, 1H), 7.47 (d, J = 7.6 Hz, 1H), 6.99 
(d, J = 7.6Hz, 1H), 4.03 (q, J = 7.0 Hz, 2H), 3.91 (q, J = 7.0 Hz, 2H), 2.66 (s, 3H), 2.33 
(s, 3H), 1.49-1.44 (m, 6H); 13C NMR (100 MHz, CDCl3) δ 146.4, 144.1, 141.3, 136.6, 
125.2, 122.5, 122.4, 118.8, 117.7, 112.3, 107.9, 70.0, 69.4, 15.8, 15.7, 12.5, 10.3; IR 
(neat) ν 2922, 1599, 1474, 1381, 1304, 1130, 1073 cm-1; HRMS (ESI) calcd for 
C17H21N2O3 (MH+) 301.1552, found 301.1551;  Anal. Calcd for C17H20N2O3: C, 67.98; 
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H, 6.71; N, 9.33.  Found: C, 67.91; H, 6.80; N, 9.19.  The spectra of 1.80 are in 
agreement with those previously reported.3f,3g 
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3,8-Dimethyl-9-ethoxyimidazo[5,1-a]isoquinoline-7,10-dione (Cribrostatin 6, 1.1).  
To a 5 mL round-bottomed flask were added 1.80 (20 mg, 0.067 mmol) and a stir bar.  
The flask was placed in an ice (0 °C) bath and to this was added 14 M HNO3 [made by 
mixing 130 µL of fuming HNO3 (purchased from Fisher, catalog number A202-212) and 
70 µL of H2O] dropwise over 1 min.  The red mixture was stirred in the ice bath for 1.5 h 
and then the flask was removed from the ice bath and the reaction was neutralized (ca. 
pH = 7) with sat. NaHCO3 (ca. 10 mL).  The mixture was transferred to a separatory 
funnel, the layers were separated, and the aqueous layer was extracted with chloroform (3 
x 15 mL).  The organic phases were pooled, washed with saturated NaCl solution (1 x 25 
mL), dried with MgSO4, and filtered.  Removal of the solvent in vacuo gave a blue 
residue.  The residue was purified by flash column chromatography (8 cm x 1 cm; silica) 
with 100% EtOAc (50 mL) to afford 9.0 mg (45%) of 1.1 as a blue solid (Rf = 0.3; 5% 
MeOH in DCM; silica).  Recrystallization of the blue solid from cold (-25 °C) acetone 
gave 1.1 as blue needles: mp 165-167 ºC (lit. mp 169-171 ºC1 and 171-172 ºC3e,3f); 1H 
NMR (400 MHz, CDCl3) δ 8.30 (s, 1H), 7.90 (d, J = 7.6 Hz, 1H), 7.26 (d, J = 7.6 Hz, 
1H), 4.41 (q, J = 6.8 Hz, 2H), 2.74 (s, 3H), 2.08 (s, 3H), 1.43 (t, J = 6.8 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) δ 184.8, 180.5, 156.2, 137.5, 130.1, 125.3, 125.2, 124.7, 123.9, 
123.6, 108.0, 69.7, 16.1, 12.6, 9.3; IR (neat) ν 2921, 1661, 1625, 1610, 1526, 1170 cm-1; 
HRMS (ESI) calcd for C15H15N2O3 (MH+) 271.1083, found 271.1087.          
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When this oxidation was run at room temperature with 15 mg of 1.80 then an ca. 1:1 
mixture of 1.1 and a product tentatively identified as: 3,8-dimethyl-7-
ethoxyimidazo[5,1-a]isoquinoline-9,10-dionone (1.81) was obtained.  Compound 1.81 
(Rf = 0.6; 10% methanol in CH2Cl2; silica) was isolated from the column conditions 
described above after washing the column with 10% MeOH in CH2Cl2 (60 mL) as a 
green solid: 1H NMR (400 MHz, CDCl3) δ 8.13 (s, 1H), 7.95 (d, J = 7.6 Hz, 1H), 6.98 (d, 
J = 7.6 Hz, 1H), 4.22 (q, J = 6.8 Hz, 2H), 2.70 (s, 3H), 2.05 (s, 3H), 1.52 (t, J = 6.8 Hz, 
3H); IR (KBr) ν 2921, 1649, 1611, 1512, 1492, 1250 cm-1; HRMS (ESI) calcd for 
C15H15N2O3 (MH+) 271.1083, found 271.1080. 
 
 
 
 
 
 
 
 
 61
OEt
Me
EtO
OEt
Me
EtO
1.69 1.85
Br
 
3-Bromo-2,6-diethoxytoluene (1.85).  A 250 mL round-bottomed flask was charged 
with 1.69 (13.2 g, 73.3 mmol), Et2O (100 mL, ACS reagent grade), and a stir bar.  The 
solution was stirred and the flask was placed in a 0 °C bath.  To a separate 100 mL pear-
shaped flask were added bromine-1,4-dioxane (see preparation of 1.71, 19.1 g, 77.0 
mmol) and Et2O (50 mL, ACS reagent grade).  The pear-shaped flask was shaken and the 
resulting brown solution was added to the flask containing 1.69 by dropwise addition 
over 15 min.  The solution was stirred for an additional 15 min at 0 °C, the flask was 
removed from the cooling bath, stirred for 30 min at room temperature, and then 
quenched with H2O (100 mL).  The biphasic mixture was transferred to a separatory 
funnel, the aqueous layer was separated and the organic layer was washed with H2O (2 x 
75 mL) and saturated NaCl solution (1 x 75 mL), dried with MgSO4, and filtered.  
Removal of the solvent in vacuo gave a tan oil.  The oil was purified by fractional 
vacuum distillation to afford 17.9 g (94%) of 1.85 as a colorless oil: bp 112-114 ºC (0.05 
torr); 1H NMR (400 MHz, CDCl3) δ 7.28 (d, J = 8.8 Hz, 1H), 6.49 (d, J = 8.8 Hz, 1H), 
3.98 (q, J = 6.4 Hz, 2H), 3.93 (q, J = 6.4 Hz, 2H), 2.18 (s, 3H), 1.44 (t, J = 6.4 Hz, 3H), 
1.41 (t, J = 6.4 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 157.3, 154.7, 129.5, 122.2, 
108.2, 108.1, 68.8, 64.0, 15.5, 14.8, 9.9; IR (neat) ν 2979, 2929, 2881, 1582, 1463 cm-1; 
HRMS (ESI) calcd for C11H16BrO2 (MH+) 259.0334, found 259.0328; Anal. Calcd for 
C11H15BrO2: C, 50.98; H, 5.83; Br, 30.83.  Found: C, 51.20; H, 5.99; Br, 31.09.    
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3,5-Diethoxy-4-methylbenzenamine (1.86).  For a related procedure, see: Roth, B.; Aig, 
E.; Rauckman, B. S.; Strelitz, J. Z.; Phillips, A. P.; Ferone, R.; Bushby, S. R. M.; Sigel, 
C. W. J. Med. Chem. 1981, 24, 933–941.  To a 500 mL two-neck round-bottomed flask, 
equipped with a stir bar, were attached an oven-dried 350 x 75 [depth x cold finger o.d. 
(mm)] 24/40 dry ice condenser (Chemglass, catalog number CG-1209-A-28), rubber 
septum, and an Ar balloon.  The flask was placed in a -78 °C bath (dry ice and acetone) 
and the top of the condenser was filled with dry ice and acetone.  The flask was charged 
with liquid ammonia (ca. 250 mL) by replacing the Ar balloon inlet with a gaseous 
ammonia inlet and condensing the gas by passage of the gas into the flask.  Once 
complete, the ammonia inlet was replaced with an Ar balloon and the colorless solvent 
was stirred.  To the flask was added solid potassium (ca. 0.5 g, 10 mmol) producing a 
bright blue mixture followed by iron (III) nitrate nonahydrate (256 mg, 0.634 mmol, 
purchased from Aldrich, catalog number 21,682-8) in one portion producing a brown 
mixture.  Then potassium (7.49 g, 192 mmol) was added in small pieces (ca. 0.5 g) at a 
rate such that the blue color was discharged prior to each addition.  Once all of the 
potassium was added (ca. 35 minutes), the brown mixture was stirred for 15 min and then 
1.85 (25.0 g, 96.9 mmol) was added dropwise.  The flask was removed from the -78 °C 
bath and allowed to warm to reflux (-33 °C, maintained by continuously adding dry ice to 
the top of the condenser).  After stirring for 3 h, NH4Cl (7.76 g) was added over a period 
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of 25 minutes followed by benzene (50 mL) in one portion.  The condenser was removed, 
the ammonia was evaporated in a stream of air, and a mixture of H2O (150 mL) and 
benzene (100 mL) was added to the flask.  The flask was placed in an oil bath, the oil 
bath was heated at 50 °C, and the mixture was stirred.  Once all of the solid had dissolved 
(ca. 45 min), the flask was removed from the oil bath, allowed to cool to room 
temperature, and the mixture was transferred to a separatory funnel.  The benzene layer 
was separated, washed with H2O (2 x 50 mL), and transferred to a 500 mL flask 
containing 6 M HCl (50 mL) producing a white precipitate.  The white precipitate was 
collected by suction filtration, washed with Et2O (1 x 50 mL), and transferred to a 250 
mL flask containing 10 M NaOH (60 mL).  The resulting slurry was stirred for 1 h and 
then the white solid was collected by suction filtration, washed with H2O (1 x 50 mL), 
and dried in vacuo.  The crude white solid (Rf = 0.2, 40% EtOAc in hexanes; silica) was 
purified in a 50 mL sublimation apparatus (Chemglass, catalog number CG-3036-02) 
under reduced pressure (ca. 0.05 torr) in a sand bath heated at 110 °C to give 1.86 (8.25 
g, 60%) as colorless needles: mp 79-81 ºC; 1H NMR (400 MHz, DMSO) δ 5.84 (s, 2H), 
4.85 (s, 2H), 3.86 (q, J = 6.8 Hz, 4H), 1.83 (s, 3H), 1.29 (t, J = 6.8 Hz, 6H); 13C NMR 
(100 MHz, DMSO) δ 157.4, 147.3, 100.5, 91.4, 62.8, 14.8, 7.8; IR (KBr) ν 3364, 3286, 
2986, 2916, 1600 cm-1; HRMS (ESI) calcd for C11H18NO2 (MH+) 196.1338, found 
196.1338; Anal. Calcd for C11H17NO2: C, 67.66; H, 8.78; N, 7.17.  Found: C, 67.56; H, 
8.82; N, 7.18.     
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3,5-Diethoxy-4-methylphenol (1.87).  To a 250 mL round-bottomed flask, open to the 
air, were added 1.86 (1.00 g, 5.13 mmol), an HCl solution (10 mL of conc. HCl and 90 
mL of H2O), and a stir bar.  The mixture was stirred and the flask was placed in a 0 °C 
bath.  In a separate 25 mL pear-shaped flask was dissolved sodium nitrite (354 mg, 5.13 
mmol) in H2O (10 mL) and the flask was also placed in a 0 °C bath and allowed to cool 
for 15 min.  To the flask containing 1.86 was added a few chips of cracked ice followed 
by dropwise addition of the sodium nitrite solution over a period of 10 minutes (cracked 
ice was added a rate such that it was always present during the addition of the sodium 
nitrite solution).  The mixture was stirred in the 0 °C bath, open to the air, and both the 
flask and ice bath were allowed to warm on their own to room temperature.  After stirring 
for 20 h, EtOAc (75 mL) was added to the flask and the biphasic mixture was transferred 
to a separatory funnel.  The organic layer was separated and the aqueous layer was 
extracted with EtOAc (2 x 75 mL).  The organic layer and extracts were combined, 
washed with H2O (2 x 75 mL) and saturated NaCl solution (1 x 75 mL), dried with 
MgSO4, and filtered.  Removal of the solvent in vacuo gave a crude orange solid.  The 
orange solid was purified by flash column chromatography (20 cm x 4 cm; silica) with 
20% Et2O in hexanes (1 L) to afford 710 mg (71%) of 1.87 (Rf = 0.2, 20% Et2O in 
hexanes; silica) as a white solid: mp 112-114 °C; 1H NMR (400 MHz, CDCl3) δ 6.03 (s, 
2H), 4.52 (s, 1H), 3.97 (q, J = 6.8 Hz, 4H), 2.01 (s, 3H), 1.40 (t, J = 6.8 Hz, 6H); 13C 
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NMR (100 MHz, CDCl3) δ 158.2, 154.3, 107.3, 93.0, 64.0, 14.9, 7.9; IR (KBr) ν 3271, 
2977, 2927, 1615, 1506, 1455 cm-1; HRMS (ESI) calcd for C11H17O3 (MH+) 197.1178, 
found 197.1185; Anal. Calcd for C11H16O3: C, 67.32; H, 8.22.  Found: C, 66.96; H, 8.17.      
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3,5-Diethoxy-4-methylphenyl trifluoromethanesulfonate (1.88).  A 100 mL round-
bottomed flask was charged with 1.87 (1.18 g, 6.02 mmol) and a stir bar.  The flask and 
its contents were evacuated under vacuum and back-filled with Ar.  To the flask were 
added anhydrous CH2Cl2 (30 mL) and pyridine (720 µL, 8.9 mmol, see general 
experimental remarks) and the flask was placed in a 0 °C bath.  To the orange solution 
was added distilled (see general experimental remarks) trifluoromethanesulfonic 
anhydride (1.00 mL, 5.94 mmol) by dropwise addition over 10 min.  The solution was 
stirred for 15 min at 0 °C, then the flask was removed from the bath, allowed to warm on 
its own to room temperature, and the progress of the reaction was monitored by TLC (Rf 
of 1.88 = 0.5; 10% Et2O in hexanes; silica).  Once the reaction was complete (ca. 1 h), the 
solution was quenched with sat. NaHCO3 (25 mL) and the biphasic mixture was 
transferred to a separatory funnel.  The organic layer was separated and the aqueous layer 
was extracted with CH2Cl2 (2 x 25 mL).  The organic layer and extracts were combined, 
washed with 1 M HCl (2 x 25 mL), H2O (1 x 25 mL) and saturated NaCl solution (1 x 25 
mL), dried over MgSO4, and filtered.  The solvent was removed in vacuo to give a white 
solid.  This solid was purified by flash column chromatography (2 cm x 15 cm; silica) 
with 5% Et2O in hexanes (200 mL) to give 1.70 g (87%) of 1.88 as a white solid: mp 56-
58 °C; 1H NMR (400 MHz, CDCl3) δ 6.39 (s, 2H), 4.00 (q, J = 6.8 Hz, 4H), 2.07 (s, 3H), 
1.43 (t, J = 6.8 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 157.9, 148.1, 118.7 (q, J = 318 
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Hz), 115.2, 98.0, 64.4, 14.7, 8.3; IR (KBr) ν 3129, 2987, 2936, 1614, 1428 cm-1; HRMS 
(ESI) calcd for C12H16F3O5S (MH+) 329.0671, found 329.0685; Anal. Calcd for 
C12H15F3O5S: C, 43.90; H, 4.61.  Found: C, 43.91; H, 4.61.        
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5-(3,5-Diethoxy-4-methylphenyl)-2-methyl-1-[[2-(trimethylsilyl)ethoxy]methyl]-1H-
imidazole (1.92).  This reaction was set up in a glove box under an atmosphere of N2.  
Prior to use, distilled (see general experimental remarks) 1,4-dioxane was freeze-pump-
thaw-degassed four times.  A 25 x 95 mm screw-thread vial (purchased from Fisher, 
catalog number 03-339-21H) was charged with 1.88 (639 mg, 1.95 mmol), 1.67 (987 mg, 
1.97 mmol), lithium chloride (251 mg, 5.92 mmol, purchased from Aldrich, catalog 
number 310468), tetrakis(triphenylphosphine)palladium(0) (192 mg, 0.166 mmol, 
purchased from Strem, catalog number 46-2150), degassed 1,4-dioxane (9 mL), and a stir 
bar.  The vial was tightly capped in the glove box, transferred to a fume hood, and placed 
in an oil bath.  The oil bath was heated at 110 °C and the reaction mixture was stirred 
behind a blast shield.  After stirring for 17 h, the mixture was cooled to room temperature 
and filtered through a pad of Celite.  The Celite was rinsed with Et2O, and the volatiles in 
the combined filtrate and rinse were removed in vacuo to give an orange oil.  The oil was 
purified by flash column chromatography (18 cm x 2 cm; silica) with 75% Et2O in 
hexanes (500 mL) to give 735 mg (96%) of 1.92 (Rf = 0.25; 70% Et2O in hexanes; silica) 
as a white solid: mp 56-58 °C; 1H NMR (400 MHz, CDCl3) δ 6.93 (s, 1H), 6.60 (s, 2H), 
5.17 (s, 2H), 4.03 (q, J = 6.8 Hz, 4H), 3.45 (t, J = 8.4 Hz, 2H), 2.51 (s, 3H), 2.13 (s, 3H), 
1.42 (t, J = 6.8 Hz, 6H), 0.88 (t, J =  8.4 Hz, 2H), -0.02 (s, 9H); 13C NMR (100 MHz, 
CDCl3) δ 157.6, 146.2, 134.4, 127.9, 125.5, 114.9, 105.3, 72.5, 65.6, 63.9, 17.9, 14.9, 
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13.6, 8.3, -1.5; IR (KBr) ν 2932, 1585, 1434 cm-1; HRMS (ESI) calcd for C21H35N2O3Si 
(MH+) 391.2417, found 391.2419; Anal. Calcd for C21H34N2O3Si: C, 64.58; H, 8.77; N, 
7.17.  Found: C, 64.67; H, 8.84; N, 7.08. 
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5-(2-Bromo-3,5-diethoxy-4-methylphenyl)-2-methyl-1-[[2-
(trimethylsilyl)ethoxy]methyl]-1H-imidazole (1.93).  A 250 mL round-bottomed flask 
was charged with 1.92 (2.05 g, 5.26 mmol), reagent grade (see general experimental 
remarks) chloroform (80 mL), and a stir bar.  The solution was stirred open to the air at 
room temperature and distilled (see general experimental remarks) trifluoroacetic acid 
(1.57 mL, 21.0 mmol) was added dropwise.  To a separate 50 mL pear-shaped flask were 
added bromine-1,4-dioxane (1.30 g, 5.26 mmol, see preparation of 1.71) and reagent 
grade chloroform (20 mL).  The pear-shaped flask was shaken and the brown solution 
was added to the flask containing 1.92 by dropwise addition over a period of ca. 15 min.  
The orange solution was stirred for 20 min and then quenched with sat. NaHCO3 (50 
mL).  The biphasic mixture was transferred to a separatory funnel, the organic layer was 
removed, and the aqueous layer was extracted with chloroform (2 x 50 mL).  The organic 
layer and extracts were combined, washed with H2O (1 x 75 mL) and saturated NaCl 
solution (1 x 75 mL), dried with MgSO4, and filtered.  Removal of the solvent in vacuo 
gave a tan oil.  The tan oil was purified by flash column chromatography (18 cm x 4 cm; 
silica) with 75% Et2O in hexanes (1.5 L) to give 2.11 g (86%) of 1.93 (Rf = 0.3; 75% 
Et2O in hexanes; silica) as an oil: 1H NMR (400 MHz, CDCl3) δ 6.87 (s, 1H), 6.61 (s, 
1H), 5.04 (s, 2H), 3.98-3.92 (m, 4H), 3.19 (t, J = 8.4 Hz, 2H), 2.49 (s, 3H), 2.22 (s, 3H), 
1.45 (t, J = 6.8 Hz, 3H), 1.40 (t, J = 6.8 Hz, 3H), 0.72 (t, J = 8.4 Hz, 2H), -0.10 (s, 9H); 
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13C NMR (100 MHz, CDCl3) δ 156.5, 154.9, 145.7, 131.7, 129.1, 126.2, 122.4, 111.4, 
111.1, 72.8, 68.6, 65.5, 63.8, 17.5, 15.2, 14.5, 13.3, 9.8, -1.8; IR (NaCl, neat) ν 3286, 
2954, 1600, 1557, 1512 cm-1; HRMS (ESI) calcd for C21H34BrN2O3Si (MH+) 469.1522, 
found 469.1524; Anal. Calcd for C21H33BrN2O3Si: C, 53.72; H, 7.08; N, 5.97.  Found: C, 
53.70; H, 7.21; N, 5.85. 
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4-Bromo-5-(3,5-diethoxy-4-methylphenyl)-2-methyl-1-[[2-
(trimethylsilyl)ethoxy]methyl]-1H-imidazole (1.99).  A 15 mL round-bottomed flask 
was charged with 1.92 (112 mg, 0.287 mmol), reagent grade (see general experimental 
remarks) chloroform (4 mL), and a stir bar.  The solution was stirred open to the air at 
room temperature.  In a separate 5 mL pear-shaped flask were added bromine-1,4-
dioxane (see preparation of 1.71, 71 mg, 0.29 mmol) and reagent grade chloroform (1 
mL).  The pear-shaped flask was shaken and the brown solution was added to the flask 
containing 1.92 dropwise over a period of ca. 2 min.  The orange solution was stirred for 
10 min and then quenched with sat. NaHCO3 (5 mL).  The biphasic mixture was 
transferred to a separatory funnel, the organic layer was removed, and the aqueous layer 
was extracted with chloroform (2 x 5 mL).  The organic layer and extracts were 
combined, washed with H2O (1 x 5 mL) and saturated NaCl solution (1 x 5 mL), dried 
with MgSO4, and filtered.  Removal of the solvent in vacuo gave a tan oil.  The tan oil 
was purified by flash column chromatography (18 cm x 2 cm; silica) with 50% Et2O in 
hexanes (500 mL) to give 64 mg (47%) of 1.99 (Rf = 0.25; 50% Et2O in hexanes; silica) 
as an oil: 1H NMR (400 MHz, CDCl3) δ 6.57 (s, 2H), 5.10 (s, 2H), 4.02 (q, J = 6.8 Hz, 
4H), 3.38 (t, J = 8.4 Hz, 2H), 2.48 (s, 3H), 2.13 (s, 3H), 1.41 (t, J = 6.8 Hz, 6H), 0.83 (t, J 
= 8.4 Hz, 2H), -0.04 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 157.5, 145.5, 130.6, 126.0, 
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115.7, 112.8, 106.6, 73.0, 66.0, 64.0, 17.9, 14.9, 13.5, 8.4, -1.5; IR (NaCl, neat) ν 2952, 
1608, 1581 cm-1; HRMS (ESI) calcd for C21H34BrN2O3Si (MH+) 469.1522, found 
469.1524. 
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5-[3,5-Diethoxy-4-methyl-2-(2-propen-1-yl)phenyl]-2-methyl-1-[[2-
(trimethylsilyl)ethoxy]methyl]-1H-imidazole (1.94).  This reaction was set up in a 
glove box under an atmosphere of N2.  Prior to use, distilled (see general experimental 
remarks) DMF was freeze-pump-thaw-degassed four times.  A 25 x 95 mm screw-thread 
vial (purchased from Fisher, catalog number 03-339-21H) was charged with 1.92 (800 
mg, 1.71 mmol), allyltributylstannane (800 μL, 2.61 mmol), 
tetrakis(triphenylphosphine)palladium(0) (100 mg, 0.087 mmol, purchased from Strem, 
catalog number 46-2150), degassed DMF (9 mL), and a stir bar.  The vial was tightly 
capped in the glove box, transferred to a fume hood, and placed in an oil bath.  The oil 
bath was heated at 110 °C and the reaction solution was stirred behind a blast shield.  
After stirring for 17 h, the solution was cooled to room temperature, filtered through a 
pad of Celite, and the Celite was rinsed with Et2O.  The combined filtrate and rinse were 
transferred to a separatory funnel, H2O (25 mL) was added, the layers were shaken and 
then separated, and the aqueous layer was extracted with Et2O (2 x 20 mL).  The organic 
layer and extracts were pooled, washed with H2O (2 x 25 mL) and saturated NaCl 
solution (1 x 25 mL), dried with MgSO4, and filtered.  Removal of the solvent in vacuo 
gave an oil.  The oil was purified by flash column chromatography (20 cm x 3 cm; silica) 
with 75% Et2O in hexanes (1 L) to afford 630 mg (86%) of 1.94 (Rf = 0.35; 75% Et2O in 
hexanes; silica) as a colorless oil: 1H NMR (400 MHz, CDCl3) δ 6.83 (s, 1H), 6.53 (s, 
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1H), 5.85-5.76 (m, 1H), 4.91 (s, 2H), 4.86 (dd, J = 10.0, 1.6 Hz, 1H),  4.72 (dd, J = 17.0, 
1.6 Hz, 1H), 3.95 (q, J = 6.8 Hz, 2H), 3.84 (q, J = 6.8 Hz, 2H), 3.28 (t, J = 8.4 Hz, 2H), 
3.19 (d, J = 6.0 Hz, 2H), 2.48 (s, 3H), 2.19 (s, 3H), 1.40 (t, J = 6.8 Hz, 3H), 1.39 (t, J = 
6.8 Hz, 3H), 0.78 (t, J = 8.4 Hz, 2H), -0.06 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 156.9, 
155.9, 145.5, 137.8, 131.5, 127.8, 126.3, 125.9, 121.0, 114.4, 110.6, 72.7, 68.8, 65.7, 
63.8, 32.0, 18.0, 15.6, 14.9, 13.6, 9.7, -1.5; IR (neat) ν 2952, 1605, 1569, 1468, 1383, 
1249, 1124, 1081, 836 cm-1; HRMS (ESI) calcd for C24H39N2O3Si (MH+) 431.2730, 
found 431.2741. 
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5-[3,5-Diethoxy-4-methyl-2-(2-propen-1-yl)phenyl]-2-methyl-1H-imidazole (1.95).  
To a 50 mL round-bottomed flask was added 1.94 (630 mg, 1.47 mmol), distilled (see 
general experimental remarks) trifluoroacetic acid (20 mL), and a stir bar.  The colorless 
solution was stirred open to the air at room temperature for 12 h and the remaining 
solvent was removed in vacuo.  The residue was dissolved in a mixture of 1 M NaOH (20 
mL) and Et2O (20 mL) and transferred to a separatory funnel.  The layers were separated 
and the aqueous layer was extracted with Et2O (2 x 10 mL).  The organic layer and 
extracts were pooled, washed with H2O (1 x 25 mL) and saturated NaCl solution (1 x 30 
mL), dried with MgSO4, and filtered.  Removal of the solvent in vacuo gave a solid.  The 
solid was purified by flash column chromatography (16 cm x 3 cm; neutral aluminum 
oxide) with 40% Et2O in hexanes (750 mL) to afford 361 mg (82%) of 1.95 (Rf = 0.14; 
100% EtOAc; silica) as a white solid: mp 136-138 °C; 1H NMR (400 MHz, CDCl3) δ 
6.99 (s, 1H), 6.81 (s, 1H), 6.18-6.09 (m, 1H), 5.09 (dd, J = 10.2, 2.0 Hz, 1H), 4.88 (dd, J 
= 17.4, 2.0 Hz, 1H), 4.01 (q, J = 6.8 Hz, 2H), 3.83 (q, J = 7.0 Hz, 2H), 3.45 (d, J = 4.8 
Hz, 2H), 2.41 (s, 3H), 2.18 (s, 3H), 1.43-1.38 (m, 6H); 13C NMR (100 MHz, CDCl3) δ 
157.1, 156.4, 143.8, 139.6, 134.4, 130.4, 122.1, 120.7, 119.5, 115.0, 108.2, 68.9, 63.8, 
31.5, 15.6, 15.0, 14.1, 9.7; IR (neat) ν 2973, 2928, 2594, 1607, 1418, 1380, 1121, 1104, 
1027 cm-1; HRMS (ESI) calcd for C18H25N2O2 (MH+) 301.1916, found 301.1913. 
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7,9-Diethoxy-5,6-dihydro-3,8-dimethylimidazo[5,1-a]isoquinolin-5-ol (1.96).  To a 25 
mL round-bottomed flask were added 1.95 (35 mg, 0.12 mmol), THF (5 mL), tert-
butanol (2.5 mL), H2O (2.5 mL), OsO4 (70 μL, ca. 0.011 mmol, 4 wt% in H2O, purchased 
from Strem, catalog number 76-2952), NaIO4 (83 mg, 0.39 mmol), and a stir bar.  The 
solution was stirred open to the air at room temperature and the progress of the reaction 
was monitored by TLC (Rf of 1.96 = 0.35; 100% EtOAc; neutral aluminum oxide).  Once 
the reaction was complete (ca. 24 h), the mixture (as the reaction progresses a white 
precipitate forms) was transferred to a separatory funnel, and to the funnel was added a 
mixture of H2O (20 mL) and Et2O (10 mL).  The layers were separated and the aqueous 
layer was extracted with Et2O (2 x 10 mL).  The organic layer and extracts were pooled, 
washed with H2O (1 x 20 mL) and saturated NaCl solution (1 x 20 mL), dried with 
MgSO4, and filtered.  Removal of the solvent in vacuo gave a crude yellow solid.  The 
solid was purified by flash column chromatography (12 cm x 2 cm; neutral aluminum 
oxide) with 100% EtOAc (100 mL) followed by 5% MeOH in CH2Cl2 (150 mL) to afford 
8 mg (22%) of 1.96 as a white solid: mp 196-198 °C; 1H NMR (400 MHz, CDCl3) δ 6.99 
(s, 1H), 6.73 (s, 1H), 5.77 (d, J = 2.4 Hz, 1H), 4.05-3.99 (m, 2H), 3.84 (q, J = 6.8 Hz, 
2H), 3.50 (d, J = 14.8 Hz, 1H), 2.93 (dd, J = 16.2, 4.0 Hz, 1H), 2.30 (s, 3H), 2.15 (s, 3H), 
1.43 (t, J = 6.8 Hz, 3H), 1.42 (t, J = 6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 157.1, 
156.6, 143.6, 127.6, 124.9, 121.0, 119.1, 112.7, 101.4, 73.1, 68.8, 64.0, 30.9, 15.7, 14.9, 
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12.1, 9.4; IR (neat) ν 2974, 1611, 1459, 1228, 1126 cm-1; HRMS (ESI) calcd for 
C17H23N2O3 (MH+) 303.1709, found 303.1713. 
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7,9-Diethoxy-3,8-dimethylimidazo[5,1-a]isoquinoline (1.97).  To a 15 mL round-
bottomed flask were added 1.96 (22 mg, 0.047 mmol), anhydrous CH2Cl2 (4 mL), 
distilled (see general experimental remarks) NEt3 (33 μL, 0.24 mmol), and a stir bar.  The 
solution was stirred, placed in an ice bath (0 °C), and to it was added distilled (see 
general experimental remarks) methanesulfonyl chloride (6 μL, 0.07 mmol).  The 
solution was stirred at 0 °C and the progress of the reaction was monitored by TLC (Rf of 
1.97 = 0.2; 100% EtOAc; silica).  Once the reaction was complete (ca. 2 h), the solution 
was transferred to a separatory funnel.  To the separatory funnel was added H2O (10 mL), 
the organic layer was separated, and the aqueous layer was extracted with CH2Cl2 (3 x 5 
mL).  The organic layer and extracts were pooled, washed with H2O (1 x 10 mL) and 
saturated NaCl solution (1 x 15 mL), dried with MgSO4, and filtered.  Removal of the 
solvent in vacuo gave a crude solid.  The solid was purified by flash column 
chromatography (2 cm x 12 cm; silica) with 100% EtOAc (350 mL) to afford 10 mg 
(74%) of 1.97 as a white solid: mp 164-166 °C; 1H NMR (400 MHz, CDCl3) δ 7.62 (s, 
1H), 7.44 (d, J = 7.6 Hz, 1H), 7.12 (s, 1H), 7.04 (d, J = 7.6 Hz, 1H), 4.17 (q, J = 6.8 Hz, 
2H), 3.97 (q, J = 6.8 Hz, 2H), 2.65 (s, 3H), 2.25 (s, 3H), 1.50 (t, J = 6.8 Hz, 3H), 1.49 (t, 
J = 6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 158.3, 154.1, 137.2, 128.3. 124.3, 119.2, 
118.0, 117.2, 114.6. 108.0, 99.0, 69.9, 64.0, 15.7, 14.8, 12.8, 9.6; IR (neat) ν 2924, 1605, 
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1460, 1382, 1248, 1122 cm-1; HRMS (ESI) calcd for C17H21N2O2 (MH+) 285.1603, found 
285.1602. 
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3,8-Dimethyl-9-ethoxy-7-hydroxyimidazo[5,1-a]isoquinoline (1.98).  To a 15 x 45 mm 
screw thread vial (purchased from Fisher, catalog number 03-339-25B) were added 1.97 
(7 mg, 0.02 mmol), sodium thiomethoxide (6 mg, 0.09 mmol, purchased from Aldrich, 
catalog number 281018), distilled (see general experimental remarks) DMF (750 µL), 
and a stir bar.  The vial was sealed and then placed in an oil bath behind a blast shield.  
The oil bath was heated at 170 °C and the mixture was stirred.  After stirring for 2 h the 
vial was cooled to room temperature and quenched with H2O (1 mL).  The solution was 
transferred to a separatory funnel, diluted with H2O (5 mL), neutralized (ca. pH = 6) with 
1 M HCl (ca. 50 µL), and extracted with EtOAc (3 x 3 mL).  The combined organic 
extracts were washed with H2O (2 x 3 mL) and extracted with 1 M NaOH (4 x 3 mL).  
The combined 1 M NaOH extracts were neutralized (ca. pH = 7) with 1 M HCl (ca. 12 
mL) and then extracted with EtOAc (3 x 4 mL).  The combined organic extracts were 
washed with H2O (1 x 5 mL) and saturated NaCl solution (1 x 5 mL), dried with MgSO4, 
and filtered.  Removal of the solvent in vacuo gave 3 mg (50%) of 1.98 (Rf = 0.2; 100% 
EtOAc; silica) as a white solid: mp 221-225 °C; 1H NMR (400 MHz, DMSO) δ 9.14 (s, 
1H), 7.78 (d, J = 7.6 Hz, 1H), 7.71 (s, 1H), 7.16 (d, J = 7.6 Hz, 1H), 7.14 (s, 1H), 4.15 (q, 
J = 6.8 Hz, 2H), 2.57 (s, 3H), 2.13 (s, 3H), 1.40 (t, J = 6.8 Hz, 3H); HRMS (ESI) calcd 
for C15H17N2O2 (MH+) 257.1290, found 257.1292. 
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Introduction 
Santiagonamine: Isolation and Structure Determination 
 In 1984, Shamma and colleagues reported1 the isolation and structure 
determination of santiagonamine (2.1).  Santiagonamine, which was extracted from the 
stems and branches of the South American shrub Berberis darwinii Hook and shows2 
wound-healing properties, is the only known example–naturally occurring or otherwise–
of the 10H-[1]benzopyrano[5,4,3-hij]isoquinoline ring system.     
2.1
santiagonamine
N
O
O
MeO N
Me
Me
 
 
Biosynthesis of Aporphine Alkaloids 
 Although santiagonamine contains a novel ring system, this natural product is 
related to and derived from the well-known aporphine3 alkaloids.  The aporphines, 
generally represented by the tetracyclic ring structure 2.2 (Figure 2.1), are one of the 
largest groups4 of isoquinoline alkaloids.  Glaucine (2.3) and bulbocapnine (2.4) were 
                                                 
(1) Valencia, E.; Patra, A.; Freyer, A. J.; Shamma, M.; Fajardo, V. Tetrahedron Lett. 1984, 25, 3163–
3166. 
(2) Lewis, W. H.; Stonard, R. J.; Porras-Reyes, B.; Mustoe, T. A.; Thomas, A. Wound-healing 
composition. U.S. Patent 5,156,847, 1992.  
(3) Guinaudeau, H.; Leboeuf, M.; Cavé, A. Lloydia 1975, 38, 275–338. 
(4) (a) Cordell, G. A. Introduction to Alkaloids; John Wiley & Sons: New York, 1981; pp 388–410.  (b) 
Manske, R. H. F. The Aporphine Alkaloids.  In The Alkaloids. Chemistry and Pharmacology; Manske, R. 
H. F., Holmes, H. L., Eds.; Academic Press: New York, 1954; Vol. 4, pp 119–145.   
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Figure 2.1 Aporphine alkaloids.  
among the first naturally occuring aporphine alkaloids to have their structures 
elucidated.5  The aporphines are commonly found in plants, usually optically active, and 
always oxygenated. 
 The biosynthetic origins of the aporphine alkaloids can be traced6 to the amino 
acid tyrosine (2.5).  As shown in Scheme 2.1, tyrosine (2.5) can be transformed into 
dopamine (2.6) and a functionalized aldehyde 2.7.  A Pictet-Spengler reaction7 between 
2.6 and aldehyde 2.7 then gives the benzylisoquinoline derivative 2.9 through the  
HO
2.5
CO2H
NH2HO
2.6
NH2HO
HO
O
2.7
NR1
R1O
HO
2.9 R1=H
2.10 R1=Me
N
HO
2.8
-H2O
Scheme 2.1
HO
HO R1O
HO HOHO
                                                 
(5) Neumeyer, J. L.  In The Chemistry and Biology of Isoquinoline Alkaloids;  Phillipson, J. D., Roberts, 
M. F., Zenk, M. H., Eds.; Springer-Verlag: Berlin, 1985; p 146. 
(6) (a) Herbert, R. B. The Biosynthesis of Isoquinoline Alkaloids. In The Chemistry and Biology of 
Isoquinoline Alkaloids; Phillipson, J. D., Roberts, M. F., Zenk, M. H., Eds.; Springer-Verlag: Berlin, 1985; 
pp 213–228. (b) Shamma, M.; Guinaudeau, H. Tetrahedron 1984, 23, 4795–4822. 
(7) Kürti, L.; Czakó, B. Strategic Applications of Named Reactions in Organic Synthesis; Elsevier: 
Amsterdam, 2005; pp 348–349. 
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intermediacy of a Schiff base (2.8).  Methylation of 2.9 gives the benzylisoquinoline 2.10 
and sets the stage for the formation of the single bond between the two aromatic rings.   
 In 1957, Barton and Cohen first proposed8 a phenolic oxidative coupling 
mechanism to account for the formation of the central bond of the aporphines.  In 
principle, a phenolic oxidative coupling reaction (Scheme 2.2) occurs when a phenoxide 
anion (2.11) is oxidized to a mesomeric phenoxyl radical (2.12a – 2.12d).  This radical 
(2.12b) can then react with another phenoxyl radical (2.12d), either ortho or para to the 
original phenolic group, to form a biaryl bond (2.14) after tautomerization. 
2.11
Scheme 2.2
O O O O O
O O O O
H H
OH OH
2.12a 2.12b 2.12c 2.12d
2.12b 2.12d 2.13 2.14
[O]
                                                
~H+
 
 Formation of the central bond of the aporphines continues (Scheme 2.3) with a 
one-electron oxidation of the two phenolic nuclei on the benzylisoquinoline 2.15 to give 
the diradical 2.16.  Diradical 2.16 could then couple intramolecularly to form the 
proaporphine derivative 2.17.  Proaporphine 2.17 can tautomerize to 2.18 and then 
undergo a dienone-phenol rearrangement (2.18 → 2.20) to give the aporphine ring system 
(2.20). 
 
(8) Barton, D. H. R.; Cohen, T. Festschrift Arthur Stoll 1957, 117–143. 
 86
NMe
MeO
HO
2.15
HO
RO
NMe
MeO
O
2.16
O
RO
NMe
MeO
O
2.17
O
RO
NMe
MeO
HO
2.18
O
RO
H
NMe
MeO
HO
2.19
O
RO H
NMe
MeO
HO
2.20
HO
RO
Scheme 2.3
[O]
 
Biosynthesis of Santiagonamine from the Aporphine Skeleton 
 Aporphine alkaloids are known9 to undergo degradation to several different 
alkaloids by way of a phenanthrene skeleton (2.22, Figure 2.2).  Hofmann elimination9 of 
the quaternized ammonium salt 2.21, generated by methylation of an aporphine alkaloid 
(2.20), would lead to a phenanthrene alkaloid (2.22).  Such a phenanthrene alkaloid can 
then suffer oxidative cleavage9 of either the C-9,10 double bond, C-5,6 double bond, or 
C-6,7 double bond.  These transformations can eventually lead to alkaloids like taspine10 
(2.23), chiloenamine11 (2.24), or santiagonamine1 (2.1) respectively. 
                                                 
(9) Shamma, M. Natural Degradative Routes for the Aporphines. In The Chemistry and Biology of 
Isoquinoline Alkaloids; Phillipson, J. D., Roberts, M. F., Zenk, M. H., Eds.; Springer-Verlag: Berlin, 1985; 
pp 142–145. 
(10) Kelly, T. R.; Xie, R. L. J. Org. Chem. 1998, 63, 8045–8048. 
(11) Shamma, M.; Lan, H.-Y.; Freyer, A. J.; Leet, J. E.; Urzúa, A.; Fajardo, V. J. Chem. Soc., Chem. 
Commun. 1983, 799–800. 
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Figure 2.2. Possible degradation pathways for aporphine 2.21  
 Shamma et al. have proposed1 (Figure 2.3) that santiagonamine is derived from a 
phenanthrene derivative with structure 2.26.  Phenanthrene derivative 2.26, which is 
possibly related to the known aporphine (+)-corydine12 (2.25), can suffer distal extradiol 
cleavage by a catechol dioxygenase13 to produce the aldehydo acid 2.27.  Aldehydo acid 
2.27 can then lactonize to aldehyde 2.28, trap ammonia (to give 2.29), and finally 
undergo a dehydrative cyclization to give the natural product (2.1). 
                                                 
(12) Arumugam, N.; Govindachari, T. R.; Nagarajan, K.; Rao, U. R. Chem. Ber. 1958, 91, 40–45. 
(13) For reviews on the dioxygenases, see: (a) Nozaki, M. In Topics in Current Chemistry; Boschke, F. 
L., Ed.; Springer-Verlag: Berlin, 1979; pp 145–186; (b) Nozaki, M. Nonheme Iron Dioxygenase. In 
Molecular Mechanisms of Oxygen Activation; Hayaishi, O., Ed.; Academic Press: New York, 1974; pp 
135–165. 
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 Shamma et al. considered1 the possibility that the trapping of ammonia and the 
subsequent dehydrative cyclization (2.29→2.1) could have occurred during the isolation 
process, since the plant extracts were treated with ammonium hydroxide during initial 
fractionation.  If this were to be the case, then the true natural product would be the 
lactone 2.28.   
 Fortunately, a similar problem with regards to the true origin of an alkaloid was 
previously dealt with by Dagne and Steglich during the isolation14 of erymelanthine 
(2.33).  Erymelanthine was recognized14 (Figure 2.4) as the product of an extradiol 
cleavage of the accompanying alkaloid erysovine (2.31), through the intermediacy of the 
aldehydo ketoester 2.32.  To rule out the possibility that erymelanthine (2.33) was an 
artifact formed from 2.32 during the ammonia extraction of the seeds of E. 
melanacantha, Dagne and Steglich omitted ammonia during a second extraction of the  
                                                 
(14) Dagne, E.; Steglich, W. Tetrahedron Lett. 1983, 24, 5067–5070. 
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Figure 2.4 Proposed biosynthesis of erymelanthine (2.33).
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natural source and also received erymelanthine (2.33).  Given the complexity of the crude 
ethanolic extracts from B. darwinii, Shamma et al. could not reisolate santiagonamine 
without an ammonia work-up and therefore assumed,1 by analogy to the erymelanthine 
isolation (Figure 2.4), that santiagonamine is also a true natural product and not an 
artifact formed from 2.28 during the work-up with ammonia. 
 
Biological Activity of Santiagonamine 
 There have been no studies related to the biological activity of santiagonamine; 
however, studies15 have been performed on a similar alkaloid, taspine (2.23, Figure 2.2).  
Taspine has been shown15 to be both an anti-inflammatory agent and enhancer of wound-
healing.  Taspine’s biological activity as an enhancer of wound-healing is related15b to its 
ability to stimulate the chemotaxis of fibroblasts that migrate into the wound from the 
local tissue.  Both taspine and santiagonamine are found2 in the formulation of the 
wound-healing composition reported in U.S. patent 5,156,847, but the authors of this 
patent make no mention about santiagonamine’s specific role as a wound-healer. 
                                                 
(15) (a) Vaisberg, A. J.; Milla, M.; Planas, M. C.; Cordova, J. L.; de Agusti, E. R.; Ferreyra, R.; Mustiga, 
M. C.; Carlin, L.; Hammond, G. B. Planta Medica 1989, 55, 140–143. (b) Porras-Reyes, B. H.; Lewis, W. 
H.; Roman, J.; Simchowitz, L.; Mustoe, T. A. Proc. Soc. Exp. Biol. Med. 1993, 203, 18–25. 
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Synthetic Approaches to the 10H-[1]Benzopyrano[5,4,3-hij]isoquinoline Ring  
 The unique ring system contained within santiagonamine has stimulated synthetic 
studies16 from other research groups.  In 1991, Castedo et al. described16a a synthetic 
approach to the azaphenanthrene backbone (2.40) found in santiagonamine based on a 
biaryl coupling reaction and photocyclization.  Their synthetic approach, shown in 
Scheme 2.4, begins with reaction of oxazoline 2.34 with a pyridyl anion generated from 
3-bromopyridine and butyllithium (n-BuLi) to give oxazoline 2.35.  Hydrolysis of 
oxazoline 2.35 followed by treatment with thionyl chloride (SOCl2) and ethanol (EtOH)  
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N
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2.402.41
a.) 3-Bromopyridine/ n-BuLi; b.) NaOCl, NaOH, MeOH; c.) (i) SOCl2; (ii) EtOH; d.) LAH;
e.) (COCl)2, NEt3, DMSO; f.) X=H: Ph3P+CH3I-, n-BuLi; X=Br: Ph3P+CH2BrBr-, NaN(TMS)2;
g.) X=H: hν , pyrex, I2/O2; X=Br: hν , quartz.
a b,c
d,e
f
g
Scheme 2.4
                                                 
(16) (a) Castedo, L.; Cid, M. M.; Seijas, J. A.; Villaverde, M. C. Tetrahedron Lett. 1991, 32, 3871–3872.  
(b) Pavé, G.; Chalard, P.; Viaud-Massuard, M.-C.; Troin, Y.; Guillaumet, G. Synlett 2003, 987–990. 
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gave ester 2.36.  Ester 2.36 was reduced with lithium aluminum hydride (LAH) and 
oxidized to aldehyde 2.37 employing Swern conditions.  Aldehyde 2.37 was transformed 
into the styrenes 2.38 and 2.39 by a Wittig reaction with the appropriate ylides.  
Photocyclization of styrenes 2.38 and 2.39 gave a ca. 1:1 mixture of azaphenanthrenes 
2.40 and 2.41. 
        In 2003, Pavé et al. were interested16b in synthesizing santiagonamine and some 
non-natural analogs of the pyrido[2,3-c]coumarin skeleton17 (2.46) found in 
santiagonamine.  They reported16b (Scheme 2.5) condensation of different 3- 
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(17) For syntheses of the pyrido[2,3-c]coumarin ring system, see: (a) Khan, M. A.; Gemal, A. L. J. 
Heterocyclic Chem. 1977, 14, 1009–1012. (b) Tabakovic, K.; Tabakovic, I.; Trkovnik, M.; Juric, A.; 
Trinajstic, N. J. Heterocyclic Chem. 1980, 17, 801–803. (c) Sagi, M.; Wada, K.; Konno, S.; Yamanaka, H. 
Heterocycles 1990, 30, 1009–1021. (d) Majumdar, K. C.; Chattopadhyay, B.; Taher, A. Synthesis 2007, 
3647–3652. 
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hydroxycoumarins 2.42 with various amines 2.43 with a catalytic amount of  
camphorsulfonic acid (CSA) in toluene gave aminocoumarins 2.44.  Subsequent addition 
of boron trifluoride•diethyl etherate complex (BF3•OEt2) to the reaction mixture induced 
cyclization of 2.44 to give dihydropyrido[2,3-c]coumarins 2.45, which were oxidized 
with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) to the pyrido[2,3-c]coumarins 
2.46. 
 
Purpose of Research 
 Because of santiagonamine’s structural novelty and the absence of any 
independent confirmation of the structure determination, the synthesis18 of this alkaloid 
was undertaken.  Herein is an account of the first synthesis of santiagonamine and the 
verification of the original structure assignment. 
 
 
 
 
 
 
 
 
 
                                                 
(18) Markey, M. D.; Fu, Y.; Kelly, T. R. Org. Lett. 2007, 9, 3255–3257. 
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Results and Discussion 
 Retrosynthetic analysis (Figure 2.5) suggested that attachment of a side-chain 
equivalent (2.48) to intermediate 2.47 would lead to santiagonamine (2.1).  Intermediate 
2.47 was envisioned to originate from manipulation of biaryl 2.49, with the latter being 
secured from an Ullmann cross-coupling reaction19 between monocycles 2.50 and 2.51.  
Both 2.50 and 2.51 should be derivable from commercially available material. 
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Figure 2.5 Retrosynthetic analysis of santiagonamine (2.1).
 
 Since its discovery20 in 1901, the Ullmann reaction has become a general method 
for the synthesis of symmetrical and unsymmetrical biaryl compounds.  The traditional 
Ullmann reaction is the homocoupling of aromatic (or heteroaromatic) halides mediated 
by copper at elevated temperatures (eq 2.1).19a Usually, copper bronze21 (a copper-tin  
                                                 
(19) For some leading reviews on the Ullmann reaction, see: (a) Nelson, T. D.; Crouch, R. D. Cu, Ni, and 
Pd Mediated Homocoupling Reactions in Biaryl Synthesis: The Ullmann Reaction. In Organic Reactions; 
Overman, L. E. Ed.; Wiley: Hoboken, New Jersey, 2004; Vol. 63, pp 265–555. (b) Fanta, P. E. Synthesis 
1974, 9–21. (c) Goshaev, M.; Otroshchenko, O. S.; Sadykov, A. S. Russ. Chem. Rev. 1972, 41, 1046–1059. 
(d) ref 7. 
(20)  Ullmann, F.; Bielecki, J. Chem. Ber. 1901, 34, 2174–2185. 
(21) Parish, E. J.; Kizito, S. A. In Encyclopedia of Reagents for Organic Synthesis; Paquette, L. A., Ed.; 
John Wiley: Chichester, UL, 1995; Vol. 2, pp 1320–1321. 
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2 ArX
Cu0
X = I, Br, or Cl
Ar-Ar (2.1)
heat
 
alloy)22 is used as the source23 of copper(0) for this transformation and it is often 
activated24 prior to use.  The purpose for activating the copper bronze prior to use is to 
remove copper oxide,25 the primary surface impurity.   
 Although the Ullmann reaction is often reported19 to be erratic with regards to 
yield, reproducibility, and substrate scope, the best results have been obtained when the 
coupling substrates contain: (i) an iodine atom (reactivity order being I > Br >> Cl); (ii) 
an electron-withdrawing group (e.g., NO2, CO2Me, CHO); and (iii) a functional group in 
the ortho position which has a lone pair of electrons.  The reaction tends to be sensitive 
to: (i) bulky groups located ortho to the halogen; (ii) substrates that are very electron rich 
(e.g., multiple alkyl or alkoxy groups); and (iii) some unprotected functional groups (e.g., 
OH, NH2, CO2H, SO2NH2). 
 The exact mechanism of the Ullmann reaction is not know, however the two most 
likely pathways19a,26 by which the coupling may occur involve either formation of aryl 
radicals or the formation of discrete aryl-copper species.  Although neither mechanism 
                                                 
(22) Shaikh, N. S.; Parkin, S.; Lehmler, H.-J. Organometallics 2006, 25, 4207–4214. 
(23) There have been some modifications to the Ullmann reaction particularly dealing with the sources of 
copper.  For example, see: (a) Stark, L. M.; Lin, X.-F., Flippin, L. A. J. Org. Chem. 2000, 65, 3227–3230. 
(b) Zhang, S.; Zhang, D.; Liebeskind, L. S. J. Org. Chem. 1997, 62, 2312–2313. (c) Ziegler, F. E.; 
Chliwner, I.; Fowler, K. W.; Kanfer, S. J.; Kuo, S. J.; Sinha, N. D. J. Am. Chem. Soc. 1980, 102, 790–798. 
(24) Kleiderer, E. C.; Adams, R. J. Am. Chem. Soc. 1933, 55, 4219–4225. 
(25) Paine has positively identified by transmission electron microscopy (TEM), that copper oxide is in 
the surface oxide layer of copper powder, see: Paine, A. J. J. Am. Chem. Soc. 1987, 109, 1496–1502. 
(26) van Allen, D. Methodology and Mechanism: Reinvestigating the Ullmann Reaction. Ph. D. Thesis, 
University of Massachusetts, Amherst, MA, 2004. 
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has been entirely ruled out, Nelson and Crouch report19a the most widely accepted 
mechanism, shown in Scheme 2.6, involves the formation of an aryl copper intermediate.   
ArX + Cu0 ArCu(II)X
ArCu(II)X + Cu0 ArCu(I) + Cu(I)X
ArCu(I) + ArX ArCu(III)XAr
ArCu(III)XAr Ar-Ar + Cu(I)X
Scheme 2.6
2.52 2.53 2.54
2.562.552.532.54
2.55 2.52 2.57
2.57 2.58 2.56  
 Initially, oxidative addition (Scheme 2.6) of copper(0) (2.53) into an aryl halogen 
bond (2.52) would produce an arylcopper(II) complex (2.54).   Disproportionation of the 
arylcopper(II) complex (2.54) with copper(0) (2.53) would then give an arylcopper(I) 
compound (2.55) and copper(I) halide (2.56).  The arylcopper(I) compound (2.56) could 
then undergo an oxidative addition into another aryl halogen bond (2.52) to form a 
diarylcopper(III) complex (2.57).  Reductive elimination from complex 2.57 would 
afford biaryl compound 2.58 and another equivalent of copper(I) halide (2.56).   
 Despite the uncertainty of the mechanism for this reaction, the utility of this 
method to synthesize symmetrical biaryl ring systems has been well established.19  To a 
lesser extent, the Ullmann reaction has also been employed for the synthesis of 
unsymmetrical biaryl ring systems, although a large excess of one of the two components 
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is usually required.  In some cases the yield of forming the unsymmetrical biaryl product 
has been improved with the addition27,28 of catalytic quantities of palladium.  
 For example, Thompson and Gaudino found27a (eq 2.2) that the addition of 
palladium to the reaction mixture of 2.59, 2.60, and excess copper bronze gave the 
desired product 2.61 in 20% yield.  In the absence of either palladium or copper, the 
reaction failed to produce any of the desired biaryl product (2.61).  Also, they discovered 
that copper bronze reacted faster with the pyridine derivative 2.59 than it did with the 
aromatic derivative 2.60. 
N
H3CO2C Br
NO2Br
+
2.59 2.60
Cu0, "Pd",
N
H3CO2C NO2
2.61
(2.2)
DMF, 180 °C
(20%)
 
 Based on these observations, they proposed27a (Scheme 2.7) that 2.59 reacted with 
copper to eventually form a pyridylcopper(I) intermediate (2.62) and that 2.60 reacted 
with palladium to give an arylpalladium(II) bromide (2.63).  Reaction between the 
postulated pyridylcopper(I) intermediate (2.62) and the arylpalladium(II) bromide (2.63) 
then lead to an arylpyridylpalladium(II) complex (2.64) from which reductive elimination 
produced the desired biaryl compound 2.61.   
                                                 
(27) (a) Thompson, W. J.; Gaudino, J. J. Org. Chem. 1984, 49, 5237–5243. (b) Shimizu, N.; Kitamura, 
T.; Watanabe, K.; Yamaguchi, T.; Shigyo, H.; Ohta, T. Tetrahedron Lett. 1993, 34, 3421–3424. (c) 
Banwell, M. G.; Lupton, D. W.; Ma, X.; Renner, J.; Sydnes, M. O. Org. Lett. 2004, 6, 2741–2744. (d) 
Some, S.; Dutta, B.; Ray, J. K. Tetrahedron Lett. 2006, 47, 1221–1224. 
(28) For examples of palladium-catalyzed Ullmann-type coupling reactions, see: (a) Liang. Y.; Li, J.-H. 
Youji Huaxue 2005, 25, 147–151. (b) ref 19a. 
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 In order to apply an Ullmann reaction to our synthesis18 we first set out to 
synthesize aromatic halides 2.67 and 2.71. Accordingly (Scheme 2.8), conversion of 
picolinic acid (2.65) into the known29 secondary amide 2.66 was accomplished under 
standard conditions.  Ortho-lithiation of 2.66 with two equivalents of n-butyllithium 
(nBuLi) and subsequent quenching of the dilithiated intermediate with iodine supplied the 
desired specific embodiment (2.67)30 of 2.51. 
N
HO2C
oxalyl chloride,
DMF (1 mole %),
NEt3, DCM, 0 °C;
aniline, 0 °C - rt
(74%)
nBuLi; I2,
THF, -78 °C
(63%)
N
O
PhHN
N
O
PhHN
2.65 2.66 2.67
I
Scheme 2.8
 
 Preparation of the unit corresponding to 2.50, commenced (Scheme 2.9) with 
transformation of isovanillic acid (2.68) into its N-propylamide (2.69) employing a two-
step, one-pot procedure.10  Protection of the hydroxyl group as its methoxymethyl  
                                                 
(29) (a) Jóźwiak, A.; Brzeziński, J. Z.; Płotka, M. W.; Szcześniak, A. K.; Malinowski, Z.; Epsztajn, J. 
Eur. J. Org. Chem. 2004, 3254–3261. (b) Brunner, H.; Nuber, B.; Prommesberger, M. J. Organomet. 
Chem. 1996, 523, 179–185. 
(30) Epsztajn, J.; Płotka, M. W.; Grabowska, A. Synth. Commun. 1997, 27, 1075–1086. 
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(MOM) ether afforded 2.70.10  Ortho-lithiation of 2.70 with two equivalents of nBuLi and 
subsequent quenching of the dilithiated intermediate with iodine generated the desired 2-
iodo-N-propylbenzamide 2.71.10 
 Formation of the hindered biaryl bond in 2.49 was achieved with a palladium-
catalyzed Ullmann cross-coupling reaction between the two functionalized iodo 
monocycles 2.67 and 2.71 with the conditions shown in eq 2.3.31  For an optimal set-up, 
monocycle 2.71 and 2.67 were stirred with 8 equivalents of activated copper bronze and 
10 mole percent palladium to afford a 28% yield of the desired cross-coupled 
 
Pd2(dba)3 (10 mole %),
Cu0, DMF, 90 °C
(28%)
MeOI
N
PhHNOC
MOMO CONHPr
2.74
(2.3)+
MeO
MOMO CONHPr
2.71
I
N
PhHNOC
2.67
                                                 
(31) Reaction was initially performed by Ying Fu. 
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product 2.7432 along with reduced monocycles 2.70 (16%) and 2.66 (8%) and 
homodimers 2.10310 (40%) and 2.104 (50%).33   
PrHNOC
MOMO
MeO
CONHPr
2.103
N
N
PhHNOC
CONHPh
2.104
OMOM
OMe
 
 A decreased production of 2.74 was generally observed if this reaction (eq 2.3) 
was run either at temperatures below 90 °C or with less than an excess of activated 
copper bronze.  Also, if palladium was omitted from the conditions shown in eq 2.3, then 
the desired product 2.74 was obtained in an 11% yield along with 2.70 (14%), 2.104 
(54%), and 2.103 (60%).  Furthermore, when 2.71 was stirred at room temperature with 
activated copper bronze there was no reaction.  However, when 2.67 was subjected to 
these same conditions, 2.67 was completely consumed to give homodimer 2.104 as the 
major isolated product.   
 These observation suggest that, in the absence of palladium (from eq 2.3), the 
major arylcopper(I) intermediate present during the reaction (Scheme 2.10) is  
                                                 
(32) Other attempts to make biaryl 2.74, particularly palladium-catalyzed cross-coupling strategies 
involving the reaction between 2.67 and 2.72 (see Experimental Section; prepared by reaction of 2.70 with 
BuLi then Bu3SnCl) or between 2.67 and 2.73 (see Experimental Section; prepared by reaction of 2.66 with 
BuLi then Bu3SnCl), were not successful, perhaps because of severe steric hinderance. 
MeO
MOMO CONHPr
2.72
SnBu3
N
PhHNOC
SnBu3
2.73  
(33) All yields are based on their respective starting monocycles. 
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intermediate 2.105 (and not arylcopper(I) intermediate 2.108).  Based on the yields 
observed when palladium is not added to the conditions in equation 2.3 (vide supra), 
reaction between arylcopper(I) intermediate 2.105 and 2.67 (to produce homodimer 
2.104) is favored (although not exclusively) over reaction between 2.105 and 2.71 (to 
produce biaryl 2.74).  However, when palladium is added to the conditions in equation 
2.3, then the series of events proposed in Scheme 2.10 can run concurrent with those 
suggested above.  Now pyridylcopper(I) intermediate 2.105 can react with both 2.71 and 
2.106 to form 2.74.  This may explain why the yield to form biaryl 2.74 is improved 
when palladium is present in the reaction (eq 2.3).  
CONHPr
2.108
MeO
MOMO
Cu(I)
 
 Despite the poor yield to form biaryl 2.74, this reaction can be run on a large 
enough scale so as to produce a sufficient quantity of 2.74 to carry on with the synthesis.  
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Therefore (Scheme 2.11), a sequential two-step deprotection and cyclization were 
performed in the same pot when 2.74 was exposed to acetic acid in THF to give lactone 
2.75.  To facilitate the hydrolysis of the secondary amide,34 2.75 was converted into  
N
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MeO
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N
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MeO
O
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N
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O
O
N
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N
HO
MeO
HO2C
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(35% from 2.76)
N
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O
NHPr
O
NHPr
O
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O
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O
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2.76
2.75
2.77
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O
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O
2.1
X NMe2
THF
                                                 
(34) Flynn, D. L.; Zelle, R. E.; Grieco, P. A. J. Org. Chem. 1983, 48, 2424–2426. 
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carbamate 2.76 with triethylamine and BOC anhydride.  Hydrolysis of carbamate 2.76 at 
room temperature with 1 M LiOH in THF gave the unexpected carboxylic acid 2.83 
instead of the desired carboxylic acid 2.78.  If the temperature was raised to 80 °C then 
dicarboxylic acid 2.77 could be obtained.  Efforts to purify diacid 2.77 were unsuccessful 
but this material could be carried on crude and the lactone re-formed.  Stirring diacid 2.77 
with neat trifluoroacetic acid gave the lactone carboxylic acid 2.78 which also proved to 
be very difficult to purify.   
N
HO
MeO
HO2C
N
O
2.83
Pr
Boc
 
 In order to complete the synthesis of santiagonamine (2.1) from lactone 2.78 it 
was necessary (Scheme 2.11) to: (i) add a handle onto the ring system of 2.78 (to attach 
the side chain); (ii) selectively reduce the carboxylic acid in lactone 2.78 to benzyl 
alcohol 2.79; (iii) transform benzyl alcohol 2.79 into styrene 2.81; (iv) photocyclize 
styrene 2.81 to ring system 2.82; and (v) attach an appropriate side-chain to 2.82.   
 We planned to add a halogen atom para to the hydroxyl group (vide infra) of 2.77 
(or an equivalent derivative) to provide a handle for the incorporation of the side-chain at 
a later point in the synthesis.  Also, it was anticipated that borane reagents35 would 
selectively reduce the carboxylic acid in 2.78 over the lactone.  Unfortunately all attempts 
to reduce the carboxylic acid in 2.78 with either borane•tetrahydrofuran or 
                                                 
(35) (a) Lane, C. F. Chem. Rev. 1976, 76, 773–798. (b) Brown, H. C.; Stocky, T. P. J. Am. Chem. Soc. 
1977, 99, 8218–8226 and referenences therein. 
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borane•dimethyl sulfide complexes or a combination of these complexes with either 
trimethyl borate36 or boron trifluoride•diethyl etherate37 were unsuccessful.  
 In order to avoid the complications met with attempts to selectively reduce 2.78, 
the synthetic route was modified as shown in Figure 2.6.  The same approach to the 
natural product was maintained; however, instead of using amide 2.50 as a precursor to 
biaryl 2.49 (Figure 2.5) the new approach would use aldehyde 2.85 as a precursor for the 
cross-coupling reaction.  The hope was that this modification would avoid the problems 
met while trying to change the oxidation state of a secondary amide into an aldehyde.  
N
O
O
MeO X
Z
Y
N
R2OC
R1O
MeO
X
R1O
MeO
N
R2OC
X
+
N
O
O
MeO NMe2
2.1
santiagonamine
2.47
2.48
2.84
2.51
2.85
+
Figure 2.6. Revised retrosynthetic analysis of santiagonamine (2.1).
O
O
 
 Therefore, preparation of the unit (2.88) corresponding to 2.85 commenced 
(Scheme 2.12) with a previously described38 procedure for the iodination of isovanillin 
(2.86) to give iodide 2.87.  Protection of the hydroxyl group as its methoxymethyl 
(MOM) ether gave the known aldehyde 2.88, which had also been prepared from 2.86 by 
a 4-step route.39 
                                                 
(36) Lane, C. F.; Myatt, H. L.; Daniels, J.; Hopps, H. B. J. Org. Chem. 1974, 39, 3052–3054. 
(37) Boron trifluoride•diethyl etherate was used to complex with the pyridine nitrogen and prevent it 
from directing the reduction to the lactone carbonyl in 2.78. 
(38) Markovich, K. M.; Tantishaiyakul, V.; Hamada, A; Miller, D. D.; Romstedt, K. J.; Shams, G.; Shin, 
Y.; Fraundorfer, P. F.; Doyle, K.; Feller, D. R. J. Med. Chem. 1992, 35, 466–479. 
(39) Uchida, K.; Yokoshima, S.; Kan, T.; Fukuyama, T. Org. Lett. 2006, 8, 5311–5313. 
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DCM, 0 °C
NaH, MOMCl,
DMF, 0 °C
(67% from 2.86)
2.872.86
MeO
HO
O
MeO
HO
I O
MeO
MOMO
I O
Scheme 2.12
  
 It was found that exposure of 2.88 and 2.67 to palladium and activated copper 
bronze at 145 °C did give the desired product 2.89, albeit in only 7% yield (eq 2.4).  An 
even lower production of 2.89 was generally observed if this reaction (eq 2.4) was run 
either at temperatures below 145 °C or with no palladium present.  Furthermore, when 
2.88 was stirred at room temperature with activated copper bronze there was no reaction.  
The question then became, why does the postulated pyridylcopper(I) intermediate 2.105 
(Scheme 2.10) undergo a higher yielding cross-coupling reaction with 2.71 (eq 2.5) than 
it does with 2.88 (eq 2.6)?   
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 We reasoned that the nitrogen atom of the propyl amide in 2.71 may have played 
an important role in promoting the desired cross-coupling reaction.  If this were the case, 
then a simple solution to improve the reactivity of 2.88 would be to convert the aldehyde 
into an imine.  Imines (i) possess a history of success in Ullmann reactions;40 (ii) contain 
a coordinating lone pair of electrons,41 and (iii) preserve the benzylic carbon’s oxidation 
state. 
 Consequently, condensation (Scheme 2.13) of 2.88 with cyclohexylamine gave 
imine 2.90.  Without purification, 2.90 was coupled with 2.67 at 100 °C to afford, after 
                                                 
(40) (a) Büttner, F.; Bergemann, S.; Guénard, D.; Gust, R.; Seitz, G.; Thoret, S. Bioorg. Med. Chem. 
2005, 13, 3497–3511. (b) Gies, A.-E.; Pfeffer, M. J. Org. Chem. 1999, 64, 3650–3654. (c) Ziegler, F. E.; 
Fowler, K. W.; Kanfer, S. J. Am. Chem. Soc. 1976, 98, 8282–8283. 
(41) (a) Ziegler, F. E.; Fowler, K. W. J. Org. Chem. 1976, 41, 1564–1566. (b) van Koten, G.; Leusink, A. 
J.; Noltes, J. G. J. Chem. Soc. D 1970, 1107–1108. 
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an aqueous workup, biaryl 2.89 in 39% yield.  Here too, a decreased production of 2.89 
was generally observed if this reaction was run either at temperatures below 100 °C, with 
less than an excess of activated copper bronze, or with no palladium present.   
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MeO
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MeO
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Furthermore, when 2.90 was stirred at room temperature with activated copper bronze 
there was no reaction.   
 With a sufficient amount of 2.89 in hand, the synthesis (Scheme 2.13) continued 
with a Wittig reaction between 2.89 and methylenetriphenylphosphorane to produce 
styrene 2.91.  Subjection of styrene 2.91 to standard photocyclization42 conditions gave 
compound 2.92 instead of the expected product 2.93.  Assignment of the structure for 
compound 2.92 was based on HRMS,43 1H,44 and 13C45 NMR spectra (see Experimental 
                                                 
(42) For a leading reference on photocyclizations, see: (a) Mallory, F. B.; Mallory, C. W. Org. React. 
1984, 30, 1–456. For related applications on similar ring systems, see: (b) ref 16a. (c) Veeramani, K.; 
Paramasivam, K.; Ramakrishnasubramanian, S.; Shanmugam, P. Synthesis 1978, 855–857. (d) Kende, A. 
S.; Curran, D. P. J. Am. Chem. Soc. 1979, 101, 1857–1864. (e) McDonald, E.; Martin, R. T. Tetrahedron 
Lett. 1978, 19, 4723–4726. (f) Padwa, A.; Doubleday, C.; Mazzu, A. J. Org. Chem. 1977, 42, 3271–3279. 
(43) A mass of 270.1125 corresponding to a molecular formula of C16H16NO3 (MH+) was found by 
HRMS for compound 2.92. 
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Section). Also, the spectra of 2.92 were in agreement with those reported for the known 
compound16a 2.40 and not in agreement with those reported for the known16a compound 
2.41.  
N
PhHNOC
MOMO
MeO
2.93
N
MeO
MeO
2.40
N
MeO
MeO
2.41  
 In order to overcome this unexpected outcome, the route was modified and 2.89 
was first deprotected (Scheme 2.14) with TMSBr to give phenol 2.94.  Phenol 2.94 then 
underwent a Wittig reaction with methylenetriphenylphosphorane to afford styrene 2.95.   
                                                                                                                                                 
(44) A total of fifteen protons were found for compound 2.92: six aromatic doublets (each intergrates to 
one proton), one aromatic doublet of doublets (integrates to one proton), and one singlet at 5.3 ppm 
(intergrates to two protons) and two singlets between 3.5 and 4.5 ppm (each intergrates to three protons). 
(45) A total of sixteen carbons were found for compound 2.92: thirteen aromatic (between 151.0-113.7 
ppm) and 3 non-aromatic (between 56.5 and 99.4 ppm). 
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Bromination of 2.95 at -78 °C with a mixture of triethylamine46 and bromine–1,4-
dioxane47 gave bromide 2.96.48  Cyclization of 2.96 with trifluoracetic acid in THF gave 
styrene lactone 2.97.  The latter underwent smooth and rapid photocyclization to give 
                                                 
(46) When this reaction was performed at room temperature or in the absence of base there was 
competing addition of bromine to the vinyl group.  We believe the triethylamine accelerates the rate of ring 
bromination by deprotonation of 2.95 to the corresponding phenoxide.   
(47) Finklestein, B. L. In Encyclopedia of Reagents for Organic Synthesis; Paquette, L. A., Ed.; John 
Wiley: Chichester, UL, 1995; Vol. 1, pp 686–687. 
(48) The regioselectivity of the bromination was later proven by an X-ray crystallographic 
characterization of 2.98 (see Figure 2.7). 
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bromolactone 2.98.  Fortunately, X-ray quality crystals of 2.98 were grown from 
chloroform and the crystal structure of 2.98 is shown in Figure 2.7. 
Figure 2.7.   ORTEP diagram of compound 2.98.  Compound 2.98 crystallized with a 
molecule of chloroform.  Chloroform is omitted for clarity.  
 Completion of the synthesis began with the side-chain installation employing a 
Stille coupling between 2.98 and allyltributyltin to generate allyl lactone 2.99.  Allyl 
lactone 2.99 was transformed into aldehyde 2.100 by the action of osmium tetroxide and 
sodium periodate.  Reductive amination49 of 2.100 with dimethylamine and sodium 
triacetoxyborohydride secured santiagonamine (2.1).  The spectra of synthetic 2.1 are in 
                                                 
(49) Abdel-Magid, A. F.; Carson, K. G.; Harris, B. D.; Maryanoff, C. A.; Shah, R. D. J. Org. Chem. 
1996, 61, 3849–3862. 
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excellent agreement with those reported1 for the natural product.  The synthesis thus 
affirms the original structure assignment. 
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Experimental Section 
For general experimental remarks on pages iii-vi. 
 
N
HO2C
2.65
N
O
PhHN
2.66  
N-Phenyl-2-pyridinecarboxamide (2.66).  A 1 L round-bottomed flask fitted with a 
mineral oil bubbler and immersed in a 0 ºC bath (ice and water) was charged with 
picolinic acid (2.65, 25.0 g, 203 mmol, purchased from Aldrich, catalog number P42800), 
anhydrous CH2Cl2 (400 mL), and a stir bar.  To the stirred suspension was added oxalyl 
chloride (19.0 mL, 223 mmol) dropwise over a 15 minute period followed by addition of 
distilled (see general experimental remarks) DMF (1-2 mL, catalytic amount) in one 
portion, producing a rust-red color and the evolution of a gas.  The mixture was kept in 
the cooling bath for 1 h and then allowed to warm to room temperature.  After gas 
evolution ceased (ca. 8 h), the mixture was again cooled to 0 ºC and distilled (see general 
experimental remarks) NEt3 (56.6 mL, 406 mmol) was added dropwise over a 15 minute 
period followed by aniline (20.3 mL, 223 mmol) added dropwise over a 15 minute 
period.  The brown mixture was left in the cooling bath for 30 minutes and then allowed 
to warm to room temperature. Stirring was continued at room temperature for 2 h and 
then the precipitate which had formed was collected by gravity filtration through 
Fisherbrand® qualitative P8 filter paper (purchased from Fisher, catalog number 09-
795F).  The precipitate was washed with THF (2 x 75 mL) and the filtrate and washes 
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were combined.  Removal of the solvents in vacuo gave a crude brown solid.  This solid 
was recrystallized from hexanes to give 29.6 g (74%) of 2.66 (Rf = 0.4; 25% EtOAc in 
hexanes; silica) as yellow needles: mp 74-76 ºC (lit.29 mp 74-76 ºC); 1H NMR (400 MHz, 
DMSO-d6) δ 10.63 (s, 1H), 8.75 (ddd, J = 4.8, 1.6, 1.0 Hz, 1H), 8.17 (dt, J = 8.0, 1.0 Hz, 
1H), 8.08 (td, J = 7.6, 1.6 Hz, 1H), 7.92-7.89 (m, 2H), 7.69 (ddd, J = 7.6, 4.8, 1.6 Hz, 
1H), 7.39-7.34 (m, 2H), 7.13 (t, J = 7.2 Hz, 1H); 13C NMR (100 MHz, DMSO-d6) δ 
162.3, 149.8, 148.3, 138.2, 138.0, 128.6, 126.8, 123.8, 122.3, 120.1; IR (KBr) ν 3336, 
1671, 1530, 1236 cm-1; HRMS (ESI) calcd for C12H10N2ONa (MNa+) 221.0691, found 
221.0697; Anal. Calcd for C12H10N2O: C, 72.71; H, 5.09; N, 14.13.  Found: C, 72.63; H, 
5.18; N, 13.98.  The spectra for 2.66 are in agreement with those reported in the 
literature.29 
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3-Iodo-N-phenyl-2-pyridinecarboxamide (2.67).  To a 250 mL round-bottomed flask 
were added 2.66 (6.00 g, 30.3 mmol), anhydrous THF (100 mL), and a stir bar.  The 
yellow solution was placed in a -78 ºC bath (dry ice and acetone) and nBuLi (27.8 mL, 
2.50 M solution in hexane, 66.7 mmol) was added over a 20 minute period. In a separate 
100 mL pear-shaped flask was placed iodine (9.25 g, 36.4 mmol) and anhydrous THF (80 
mL).  Two hours after the addition of nBuLi, the iodine solution was transferred under Ar 
via cannula over 25 minutes to the pyridyl dianion solution.  The resulting brown solution 
was left in the cooling bath for 45 minutes and then allowed to warm to room 
temperature.  The solution was kept at room temperature for two hours and then carefully 
(initially dropwise) quenched with H2O (90 mL).  The aqueous layer was separated and 
extracted with EtOAc (2 x 60 mL).  The organic layer and extracts were pooled, washed 
with saturated sodium thiosulfate solution (1 x 100 mL) and saturated NaCl solution (1 x 
100 mL), dried with MgSO4, and filtered.  Removal of the solvents in vacuo gave a solid 
which was purified by flash column chromatography (12 cm x 5 cm; silica) with 50% 
EtOAc in hexanes (1.1 L) to give a beige solid.  This solid was recrystallized from 33% 
EtOAc in hexanes to give (after three crops total) 6.20 g (63%) of 2.67 (Rf = 0.6; 40% 
EtOAc in hexanes; silica) as clear colorless prisms: mp 109-111 ºC (lit.30 106-107 ºC); 1H 
NMR (400 MHz, CDCl3) δ 10.09 (br s, 1H), 8.60 (d, J = 4.4 Hz, 1H), 8.42 (d, J = 8.4 Hz, 
1H), 7.76 (d, J = 8.4 Hz, 2H), 7.37 (t, J = 7.8 Hz, 2H), 7.16-7.11 (m, 2H); 13C NMR (100 
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MHz, CDCl3) δ 161.1, 151.2, 147.5, 146.9, 137.6, 128.9, 126.4, 124.3, 119.7, 89.3; IR 
(KBr) ν 3329, 1692 cm-1; HRMS (ESI) calcd for C12H10N2OI (MH+) 324.9838, found 
324.9854; Anal. Calcd for C12H9N2OI: C, 44.47; H, 2.80; N, 8.64.  Found: C, 44.45; H, 
2.78; N, 8.54.  The spectra for 2.67 are in agreement with those reported in the 
literature.30  
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N-Phenyl-3-(tributylstannyl)-2-pyridinecarboxamide (2.73). To a 50 mL round-
bottomed flask were added 2.66 (500 mg, 2.53 mmol), anhydrous THF (20 mL), and a 
stir bar.  The flask was placed in a -78 ºC bath (dry ice and acetone) and nBuLi (2.32 mL, 
2.50 M solution in hexane, 5.80 mmol) was added over a 20 minute period. The solution 
was allowed to stir for 1 h in the -78 °C bath and then tributyltin chloride (828 µL, 2.91 
mmol) was added dropwise over 5 minutes to the flask.  The solution was left in the 
cooling bath for 15 minutes and then allowed to warm to room temperature on its own.  
The solution was kept at room temperature for 30 minutes and then carefully (initially 
dropwise) quenched with H2O (25 mL).  The aqueous layer was separated and extracted 
with EtOAc (2 x 25 mL).  The organic layer and extracts were pooled, washed with H2O 
(1 x 25 mL) and saturated NaCl solution (1 x 25 mL), dried with MgSO4, and filtered.  
Removal of the solvents in vacuo gave an oil which was purified by flash column 
chromatography (4 cm x 14 cm; silica) with 10% EtOAc in hexanes (500 mL) to give 
1.05 g (85%) of 2.73 (Rf = 0.6; 20% Et2O in hexanes; silica) as a colorless oil: 1H NMR 
(400 MHz, CDCl3) δ 10.23 (br s, 1H), 8.54 (dd, J = 4.6, 1.8 Hz, 1H), 8.08-8.05 (m, 1H), 
7.78-7.76 (m, 2H), 7.42-7.37 (m, 3H), 7.16-7.12 (m, 1H), 1.55-0.84 (m, 27H); 13C NMR 
(100 MHz, CDCl3) δ 163.7, 153.0, 147.2, 146.0, 138.7, 137.9, 128.9, 125.6, 123.9, 119.5, 
29.3, 27.4, 13.8, 11.6; IR (KBr) ν 3331, 2954, 2870, 1678, 1602, 1532, 1447 cm-1; 
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HRMS (ESI) calcd for C24H37N2OSn (MH+) 485.1923, found 485.1923; Anal. Calcd for 
C24H36N2OSn: C, 59.16; H, 7.45; N, 5.75.  Found: C, 59.19; H, 7.42; N, 5.71.  
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3-Hydroxy-4-methoxy-N-propylbenzamide (2.69).10  A 2 L round-bottomed flask fitted 
with a reflux condenser and immersed in a 0 ºC bath (ice and water) was charged with 
isovanillic acid (2.68, 25.0 g, 148 mmol, purchased from Aldrich, catalog number 
220108), anhydrous THF (550 mL), anhydrous MeCN (150 mL), and a stir bar.  The 
solution was stirred and to the flask was added N,N’-dicyclohexylcarbodiimide (30.7 g, 
151 mmol, purchased from Aldrich, catalog number D80002) and N-hydroxysuccinimide 
(17.5 g, 152 mmol, purchased from Aldrich, catalog number 130672), each in one 
portion.  The flask was removed from the ice bath, allowed to stir at room temperature, 
and a white precipitate formed as the reaction progressed.  After stirring for ca. 13 h 
propylamine (16.5 mL, 201 mmol, purchased from Aldrich, catalog number 109819) was 
added to the flask in one portion and the flask was placed in an oil bath.  The oil bath was 
heated at 90 ºC bath for 2 h and then allowed to cool to room temperature.  The 
precipitate was removed by suction filtration and washed with CH2Cl2 (2 x 50 mL).  The 
filtrate and washes were combined, transferred to a separatory funnel, washed with H2O 
(2 x 150 mL) and saturated NaCl solution (1 x 150 mL), dried with MgSO4, and filtered.  
Removal of the solvent in vacuo gave a crude solid.  The solid was purified by flash 
column chromatography (10 cm x 20 cm; silica) with 75% EtOAc in hexanes (1.5 L) 
followed by 100% EtOAc (2 L) to give 25.3 g (82%) of 2.69 (Rf = 0.6; 100% EtOAc; 
silica) as a white solid: mp 106-109 ºC (lit.10 110-112 ºC); 1H NMR (400 MHz, CDCl3) δ 
7.35-7.33 (m, 2H), 6.87 (d, J = 8.4 Hz, 1H), 6.04 (br s, 1H), 5.81 (br s, 1H), 3.93 (s, 3H), 
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3.40 (q,  J = 6.8 Hz, 2H), 1.67-1.58 (m, 2H), 0.98 (t, J = 7.2 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ 167.1, 149.3, 145.5, 127.7, 119.3, 113.3, 110.2, 55.9, 41.8, 22.9, 11.4; 
HRMS (ESI) calcd for C11H16NO3 (MH+) 210.1130, found 210.1128.  The spectra for 
2.69 are in agreement with those reported in the literature.10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 119
MeO
HO CONHPr
2.69
MeO
MOMO CONHPr
2.70  
4-Methoxy-3-(methoxymethoxy)-N-propylbenzamide (2.70).10  A 2 L round-bottomed 
flask was charged with 2.69 (16.0 g, 76.6 mmol), CH2Cl2 (500 mL), and a stir bar.  In a 
separate 500 mL Erlenmeyer flask was dissolved sodium hydroxide (6.12 g, 153 mmol) 
in H2O (225 mL) and the resulting solution was added in one portion to the flask 
containing 2.69.  The biphasic mixture was stirred and to the mixture was added Adogen® 
464 (44 mL, 29.8 mmol, purchased from ACROS, catalog number 22755) in one portion.  
The mixture was stirred for 45 minutes at room temperature and then the flask was placed 
in a 0 ºC bath (ice and water) and to the flask was added chloromethyl methyl ether (21.3 
mL, 280 mmol) dropwise over a period of ca. 20 minutes.  The flask was removed from 
the ice bath, warmed to room temperature, and the progress of the reaction was monitored 
by TLC (Rf of 2.70 = 0.56; 50% Et2O in CH2Cl2; silica).  Once complete (ca. 1 h), the 
biphasic mixture was transferred to a separatory funnel, the organic layer was separated, 
and the aqueous layer was extracted with CH2Cl2 (2 x 75 mL).  The organic layer and 
extracts were pooled, dried over MgSO4, and filtered.  Removal of the solvent in vacuo 
gave a yellow oil.  The oil was purified by flash column chromatography (100 cm x 18 
cm; silica) with 50% Et2O in CH2Cl2 (3 L) to afford 19.3 g (99%) of 2.70 as a white 
solid: mp 82-84 ºC (lit.10 85-86 ºC); 1H NMR (400 MHz, CDCl3) δ 7.56 (d, J = 2.0 Hz, 
1H), 7.41 (dd,  J = 8.4, 2.0 Hz, 1H), 6.85 (d,  J = 8.4 Hz, 1H), 6.36 (br s, 1H), 5.21 (s, 
2H), 3.87 (s, 3H), 3.47 (s, 3H), 3.34 (q,  J = 7.2 Hz, 2H), 1.63-1.54 (m, 2H), 0.92 (t,  J = 
7.6 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 166.7, 152.2, 146.0, 127.4, 121.4, 115.2, 
 120
110.9, 95.4, 56.2, 55.9, 41.7, 22.9, 11.4; HRMS (ESI) calcd for C13H19NO4Na (MNa+) 
276.1212, found 276.1208.  The spectra for 2.70 are in agreement with those reported in 
the literature.10 
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2-Iodo-4-methoxy-3-(methoxymethoxy)-N-propylbenzamide (2.71).10  To a 1 L 
round-bottomed flask were added 2.70 (6.50 g, 25.7 mmol), anhydrous THF (500 mL), 
and a stir bar.  The solution was stirred and the flask was placed in a -78 °C bath (acetone 
and dry ice).  To the flask was added nBuLi (22.6 mL, 2.50 M solution in hexane, 56.5 
mmol) over a 25 minute period. In a separate 100 mL pear-shaped flask iodine (8.37 g, 
33.0 mmol) was dissolved in anhydrous THF (50 mL).  One hour after the addition of 
nBuLi to the flask containing 2.70, the iodine solution was transferred under Ar via 
cannula over 45 minutes to the aromatic dianion solution.  The flask was then removed 
from the cooling bath and allowed to warm to room temperature on its own.  The solution 
was kept at room temperature for two hours and then carefully (initially dropwise) 
quenched with H2O (25 mL).  The flask was then transferred to a rotary evaporator and 
the volatiles were removed.  To the flask was then added H2O (150 mL) and CH2Cl2 (150 
mL) and the biphasic mixture was transferred to a separatory funnel.  The organic layer 
was separated and the aqueous layer was extracted with CH2Cl2 (2 x 50 mL).  The 
organic layer and extracts were pooled, washed with saturated sodium thiosulfate solution 
(2 x 50 mL) and saturated NaCl solution (1 x 100 mL), dried with MgSO4, and filtered.  
Removal of the solvents in vacuo gave a solid which was purified by flash column 
chromatography (6 cm x 18 cm; silica) with 15% Et2O in CH2Cl2 (1 L) followed by 25% 
Et2O in CH2Cl2 (1 L) to produce 6.90 g (71%) of 2.71 (Rf = 0.63; 50% Et2O in CH2Cl2; 
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silica) as a white solid: mp 104-106 ºC (lit.10 94-95 ºC); 1H NMR (400 MHz, CDCl3) δ 
7.04 (d, J = 8.4, 1H), 6.83 (d, J = 8.4, 1H), 6.24 (br s, 1H), 5.12 (s, 2H), 3.84 (s, 3H), 3.66 
(s, 3H), 3.34 (q,  J = 6.8, 2H), 1.67-1.58 (m, 2H), 0.98 (t, J = 7.2, 3H); 13C NMR (100 
MHz, CDCl3) δ 169.0, 152.5, 145.5, 136.0, 123.9, 111.9, 98.5, 92.0, 58.3, 55.9, 41.6, 
22.5, 11.4; HRMS (ESI) calcd for C13H18NO4INa (MNa+) 402.0178, found 402.0188.  
The spectra for 2.71 are in agreement with those reported in the literature.10 
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4-Methoxy-3-(methoxymethoxy)-N-propyl-2-(tributylstannyl)benzamide (2.72).  To 
a 25 mL round-bottomed flask were added 2.70 (750 mg, 2.96 mmol), anhydrous THF 
(10 mL), and a stir bar.  The flask was placed in a -78 ºC bath (dry ice and acetone) and 
nBuLi (2.71 mL, 2.50 M solution in hexane, 6.78 mmol) was added over a 20 minute 
period. The solution was allowed to stir for 1 h in the -78 °C and then tributyltin chloride 
(928 µL, 3.26 mmol) was added dropwise over 5 minutes to the flask.  The solution was 
left in the cooling bath for 15 minutes and then allowed to warm to room temperature.  
The solution was kept at room temperature for 1 h and then carefully (initially dropwise) 
quenched with H2O (25 mL).  The aqueous layer was separated and extracted with 
EtOAc (2 x 25 mL).  The organic layer and extracts were pooled, washed with H2O (1 x 
25 mL) and saturated NaCl solution (1 x 25 mL), dried with MgSO4, and filtered.  
Removal of the solvents in vacuo gave an oil which was purified by flash column 
chromatography (4 cm x 14 cm; silica) with 20% Et2O in hexanes (250 mL) followed by 
60% Et2O in hexanes (500 mL) to give 1.27 g (79%) of 2.72 (Rf = 0.4; 50% Et2O in 
hexanes; silica) as a white solid: mp 46-48 °C; 1H NMR (400 MHz, CDCl3) δ 7.26 (d, J = 
8.4 Hz, 1H), 6.79 (d,  J = 8.4 Hz, 1H), 6.06 (br s, 1H), 5.06 (s, 2H), 3.84 (s, 3H), 3.52 (s, 
3H), 3.34 (q, J = 6.8 Hz, 2H), 1.66-0.85 (m, 32 H); 13C NMR (100 MHz, CDCl3) δ 169.8, 
153.3, 151.0, 138.2, 135.8, 122.8, 111.3, 98.8, 57.6, 55.5, 41.9, 29.3, 27.5, 22.8, 13.7, 
12.9, 11.4; IR (KBr) ν 3319, 2957, 2852, 1615, 1558, 1463 cm-1; HRMS (ESI) calcd for 
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C25H46NO4Sn (MH+) 540.2444, found 540.2452; Anal. Calcd for C25H45NO4Sn: C, 
55.37; H, 8.36; N, 2.58.  Found: C, 55.32; H, 8.37; N, 2.58. 
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3-[3-Methoxy-2-(methoxymethoxy)-6-(propylcarbamoyl)phenyl]-N-phenyl-2-
pyridinecarboxamide   (2.74).  For a related procedure see: Kelly, T.R.; Xie, R.L. J. 
Org. Chem. 1998, 63, 8045–8048. Commercially available copper bronze (Atomergic 
Chemetals Corp., catalog number C340E61352) was activated following Kleiderer and 
Adams’ procedure.24  For a typical case, 5.36 g of copper bronze was treated with 50 mL 
of a 2% (w/v) solution of iodine in acetone at room temperature for 12 minutes.  The 
gray-colored copper was then collected by vacuum filtration (open to the air) and washed 
with acetone.  The copper was subsequently stirred with a mixture of acetone (32 mL) 
and HCl (32 mL, 12.0 N) at room temperature for 8 minutes.  The copper was collected 
by vacuum filtration (open to the air) and washed with copious amounts of acetone.  The 
shiny brown copper bronze was dried in a vacuum desiccator (ca. 0.05 Torr) with P2O5 
for 35 minutes and used immediately afterward.  
To a 100 mL airfree® round-bottomed flask (Chemglass, catalog no. AF-0528-02) 
was added 2.71 (750 mg, 1.98 mmol), 2.67 (1.15 g, 3.56 mmol), distilled (see general 
experimental remarks) DMF (35 mL), and a stir bar.  This solution was freeze-pump-
thaw degassed three times and backfilled with Ar.  Then were sequentially added 
tris(dibenzylideneacetone) dipalladium(0) (180 mg, 0.197 mmol, purchased from Strem, 
catalog number 46-3000) and activated (see above) copper bronze (1.00 g, 15.8 mmol).  
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The mixture was placed under an Ar balloon via a rubber septum, heated at 90 ºC for 3 h, 
and then cooled to room temperature.  The mixture was passed through a pad of Celite 
and the Celite was rinsed with EtOAc (50 mL).  The combined filtrate and wash were 
added to H2O (100 mL) and the resulting mixture was transferred to a separatory funnel.  
The organic layer was separated and the aqueous layer was extracted with EtOAc (2 x 50 
mL).  The organic layer and extracts were pooled, washed with H2O (4 x 75 mL) and 
saturated NaCl solution (1 x 75 mL), dried with MgSO4, and filtered.  Removal of the 
solvent in vacuo gave an oil.  The oil was purified by flash column chromatography (5 
cm x 13 cm; silica) with 50% EtOAc in hexanes (500 mL), 75% EtOAc in hexanes (500 
mL), 100% EtOAc (500 mL), and 100% MeOH (350 mL) to afford 245 mg (28%) of 
2.74 (Rf = 0.27; 75% Et2O in hexanes; neutral aluminum oxide) as a white solid: mp 56-
58 ºC; 1H NMR (400 MHz, CDCl3) δ 9.80 (br s, 1H), 8.61 (dd, J = 4.8, 1.6 Hz, 1H), 7.69 
(dd, J = 8.0, 1.6 Hz, 1H), 7.66-7.63 (m, 2H), 7.50 (dd, J = 8.0, 4.8 Hz, 1H), 7.40 (d, J = 
8.4 Hz, 1H), 7.35-7.31 (m, 2H), 7.15-7.10 (m, 1H), 6.99 (d, J = 8.4 Hz, 1H), 6.85 (t, J = 
5.2 Hz, 1H), 4.83 (d, J = 5.6 Hz, 1H), 4.77 (d, J = 5.6 Hz, 1H), 3.87 (s, 3H), 3.17-3.08 
(m, 1H), 2.89-2.81 (m, 4H), 1.07-0.98 (m, 2H), 0.57 (t, J = 7.6 Hz, 3H);  13C NMR (100 
MHz, CDCl3) δ 168.7, 164.0, 152.8, 148.8, 147.0, 142.1, 140.6, 137.4, 133.2, 131.9, 
129.9, 128.8, 125.4, 124.4, 123.8, 119.8, 111.5, 98.4, 56.4, 55.7, 41.1, 22.3, 11.1; IR 
(KBr) ν 3300, 2963, 1651, 1599, 1539, 1485, 1446 cm-1; HRMS (ESI) calcd for 
C25H28N3O5 (MH+) 450.2029, found 450.2024.  
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Also isolated, were 2.70 (78 mg, 16%), 2.66 (58 mg, 8%), and homocoupled products 
2.103 and 2.104. 
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5,5’-Dimethoxy-6,6’-bis(methoxymethoxy)-[1,1’-biphenyl]-2,2’-dicarboxaldehyde 
(2.103).  Isolated 200 mg (40%) of 2.103 (Rf = 0.22; 75% Et2O in hexanes; neutral 
aluminum oxide) as a white solid: mp 153-154 ºC (lit.10 148-149 °C); 1H NMR (400 
MHz, CDCl3) δ 7.41 (d, J = 8.4 Hz, 2H), 6.96 (d, J = 8.4 Hz, 2H), 6.94 (br s, 2H), 5.01 
(d, J = 5.6 Hz, 2H), 4.85 (d, J = 5.6 Hz, 2H), 3.87 (s, 6H), 3.14-3.02 (m, 4H), 2.88 (s, 
6H), 1.25-1.13 (m, 4H), 0.67 (t, J = 7.2 Hz, 6H); 13C NMR (100 MHz, CDCl3) δ 168.6, 
153.1, 143.3, 131.6, 129.1, 124.3, 111.6, 98.2, 56.3, 55.9, 41.4, 22.3, 11.2; HRMS (ESI) 
calcd for C26H36N2O8Na (MNa+) 527.2369, found 527.2365.  The spectra for 2.103 are in 
agreement with those reported in the literature.10 
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2.104  
N,N’-Diphenyl-[3,3’-bipyridine]-2,2’-dicarboxamide (2.104).  Isolated 350 mg (50%) 
of 2.104 (Rf = 0.52; 50% EtOAc in hexanes; silica) as a white solid: mp 196-197 ºC; 1H 
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NMR (400 MHz, CDCl3) δ 10.16 (br s, 2H), 8.65 (dd, J = 4.4, 1.6 Hz, 2H), 7.63 (dd, J = 
7.6, 1.6 Hz, 2H), 7.56-7.52 (m, 6H), 7.27-7.22 (m, 4 H), 7.05-7.01 (m, 2H); 13C NMR 
(100 MHz, CDCl3) δ 162.2, 146.7, 146.0, 138.7, 137.6, 136.7, 128.7, 125.5, 123.9, 120.0; 
IR (KBr) ν 3338, 3060, 1693, 1602, 1516 cm-1; HRMS (ESI) calcd for C24H18N4O2Na 
(MNa+) 417.1327, found 417.1347.  
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7-Methoxy-5-oxo-N-propyl-5H-[1]benzopyrano[3,4-b]pyridine-10-carboxamide 
(2.75).  To a 25 mL round-bottomed flask equipped with a reflux condenser were added 
2.74 (500 mg, 1.11 mmol), anhydrous THF (10 mL), distilled (see general experimental 
remarks) TFA (1 mL), and a stir bar.  The solution was stirred and the flask was placed in 
an oil bath heated at 75 °C.  After stirring for 8 h the white precipitate (2.75) which had 
formed was collected by suction filtration and washed with Et2O (2 x 5 mL).  The filtrate 
and washes were combined and the solvents were removed in vacuo to give a solid.  The 
solid was purified by flash column chromatography (3 cm x 13 cm; silica) with 100% 
EtOAc (300 mL) to afford a white solid (2.75).  Combined, the solid and precipitate 
collected produced 310 mg (90%) of 2.75 (Rf = 0.2; 100% EtOAc; silica): mp 262-264 
°C; 1H NMR (400 MHz, DMSO-d6) δ 8.92 (dd, J = 4.4, 1.2 Hz, 1H), 8.70 (t, J = 5.6 Hz, 
1H), 8.40 (dd, J = 8.4, 1.2 Hz, 1H), 7.89 (dd, J = 8.4, 4.4 Hz, 1H), 7.33 (d, J = 8.4 Hz, 
1H), 7.27 (d, J = 8.4 Hz, 1H), 3.96 (s, 3H), 3.29-3.24 (m, 2H), 1.61-1.52 (m, 2H), 0.91 (t, 
J = 7.4 Hz, 3H); 13C NMR (100 MHz, DMSO-d6) δ 168.7, 157.0, 151.0, 147.5, 140.0, 
137.7, 133.5, 130.5, 128.0, 127.5, 124.5, 114.3, 112.3, 56.2, 41.0, 21.7, 11.4; IR (KBr) ν 
3285, 2968, 1755, 1633 cm-1; HRMS (ESI) calcd for C17H17N2O4 (MH+) 313.1188, found 
313.1187; Anal. Calcd for C17H16N2O4: C, 65.38; H, 5.16; N, 8.97.  Found: C, 65.07; H, 
5.09; N, 8.86. 
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N-(1,1-Dimethylethoxy carbonyl)-7-Methoxy-5-oxo-N-propyl-5H-
[1]benzopyrano[3,4-b]pyridine-10-carboxamide (2.76).  A 25 mL round-bottomed 
flask was charged with 2.75 (780 mg, 2.50 mmol), distilled (see general experimental 
remarks) NEt3 (348 µL, 2.50 mmol), 4-(N,N-dimethylamino)pyridine (301 mg, 2.50 
mmol), anhydrous CH2Cl2 (8 mL), and a stir bar.  The solution was stirred and to the 
flask was added di-tert-butyl dicarbonate (1.09 g, 5.00 mmol) in one portion and the 
progress of the reaction was monitored by TLC (Rf of 2.76 = 0.6; 80% EtOAc in 
hexanes; silica).  Once reaction was complete (ca. 5 h) the flask was transferred to a 
rotary evaporator and the solvents were removed in vacuo to give an oil.  The oil was 
purified by flash column chromatography (3 cm x 15 cm; silica) with 50% EtOAc in 
hexanes (350 mL) followed by 75% EtOAc in hexanes (250 mL) to afford 866 mg (84%) 
of 2.76 as a white solid: mp 144-146 °C; 1H NMR (400 MHz, CDCl3) δ 8.96 (dd, J = 4.4, 
1.4 Hz, 1H), 8.29 (dd, J = 8.4, 1.4 Hz, 1H), 7.66 (dd, J = 8.4, 4.4 Hz, 1H), 7.08 (d, J = 8.4 
Hz, 1H), 7.05 (d, J = 8.4 Hz, 1H), 4.04-3.95 (m, 1H), 4.02 (s, 3H), 3.86-3.80 (m, 1H), 
1.87-1.75 (m, 2H), 1.08 (s, 9H), 1.06 (t, J = 8.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 
171.4, 157.6, 152.6, 151.3, 148.8, 141.5, 138.5, 133.5, 130.7, 128.6, 127.6, 122.1, 115.1, 
111.4, 84.0, 56.5, 46.8, 27.4, 21.8, 11.4; IR (KBr) ν 3442, 2971, 1739, 1667 cm-1; HRMS 
 131
(ESI) calcd for C22H25N2O6 (MH+) 413.1713, found 413.1699; Anal. Calcd for 
C22H24N2O6: C, 64.07; H, 5.87; N, 6.79.  Found: C, 63.99; H, 5.89; N, 6.61. 
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7-Methoxy-5-oxo-5H-[1]benzopyrano[3,4-b]pyridine-10-carboxylic acid (2.78).  A 50 
mL round-bottomed flask equipped with a reflux condenser was charged with 2.76 (866 
mg, 2.10 mmol), THF (25 mL), 1 M LiOH (8.4 mL, 8.4 mmol), and a stir bar.  The 
solution was stirred and the flask was placed in an oil bath heated at 85 °C.  After stirring 
for 11 h the solution was cooled to room temperature and the solvents were removed in 
vacuo to give a solid.  To the solid was added MeOH (ca. 20 mL) and the resulting 
suspension was filtered by gravity filtration.  The filtrate was collected into a 25 mL 
round-bottomed flask and evaporated in vacuo to give a white solid (presumably 2.77): 
1H NMR (400 MHz, CD3OD) δ 8.33 (d, J = 4.4 Hz, 1H), 7.60 (d, J = 7.6 Hz, 1H), 7.34-
7.31 (m, 1H), 6.76 (d, J = 8.0 Hz, 1H), 6.72 (d, J = 8.0 Hz, 1H), 3.73 (s, 3H).  To the 
flask containing the white solid (2.77) were added distilled (see general experimental 
remarks) trifluoroacetic acid (4 mL) and a stir bar.  The flask was equipped with a reflux 
condenser and placed in an oil bath heated at 95 °C.  The mixture was stirred and became 
homogeneous as the reaction progressed.  After stirring for 12 h the solution was cooled 
to room temperature and the solvents were removed in vacuo to give a solid.  The solid 
was stirred in CHCl3 (10 mL) and the suspension was filtered.  The solid collected by the 
filter paper was stirred in acetone (20 mL) and again the suspension was filtered.  The 
solid (200 mg, 35%) which was collected by the filter paper was assigned structure 2.78: 
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1H NMR (400 MHz, CD3OD) δ 8.57 (dd, J = 5.2, 1.8 Hz, 1H), 7.75 (d, J = 6.0 Hz, 1H), 
7.66 (d, J = 8.8 Hz, 1H), 7.67-7.63 (m, 1H), 7.04 (d, J = 8.8 Hz, 1H), 3.97 (s, 3H).  
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3-Hydroxy-2-iodo-4-methoxybenzaldehyde (2.87).39  A 250 mL round-bottomed flask 
was charged with isovanillin (2.86, 20.0 g, 132 mmol, purchased from Aldrich, catalog 
number 143685) and pyridine (75 mL).  The flask was immersed in a 0 ºC bath (ice and 
water) and to the solution was added iodine monochloride (1.0 M in CH2Cl2, 132 mL, 
130 mmol, purchased from Aldrich, catalog number 291048) over a 15 minute period.  
The flask was removed from the bath and allowed to warm to room temperature.  After 
stirring at room temperature for 4 days the solvents were removed in vacuo and to the 
resulting oil was added H2O (300 mL), 6 M HCl (until the aqueous phase had a pH = 5-
6), and EtOAc (100 mL).  The biphasic mixture was transferred to a separatory funnel, 
the layers were separated, and the aqueous layer was extracted with EtOAc (3 x 100 mL). 
The organic layer and extracts were pooled, washed with 5% sodium bisulfite solution (1 
x 100 mL), H2O (2 x 100 mL), saturated NaCl solution (1 x 100 mL), dried with MgSO4, 
and filtered.  Removal of the solvent in vacuo gave 34.0 g of 2.87 as a yellow solid which 
was ordinarily carried on without purification to the subsequent reaction.  Analytically 
pure 2.87 (Rf = 0.3; 33% EtOAc in hexanes; silica) was obtained by recrystallization 
from EtOAc to give yellow hairs: mp 168-171 ºC (lit.39 169-171.5 ºC); 1H NMR (400 
MHz, CDCl3) δ 10.03 (s, 1H), 7.55 (d, J = 8.4 Hz, 1H), 6.92 (d, J = 8.4 Hz, 1H), 6.33 (s, 
1H), 4.00 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 194.6, 150.6, 145.6, 128.6, 123.8 
109.9, 88.0, 56.6; IR (KBr) ν 3293, 1668 cm-1; HRMS (ESI) calcd for C8H8O3I (MH+) 
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278.9518, found 278.9510; Anal. Calcd for C8H7O3I: C, 34.56; H, 2.54.  Found: C, 34.83; 
H, 2.59.  The spectra for 2.87 are in agreement with those reported in the literature.39 
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2-Iodo-4-methoxy-3-(methoxymethoxy)benzaldehyde (2.88).  A 250 mL round-
bottomed flask was charged with NaH (60% dispersed in mineral oil, 5.52 g, 138 mmol).  
The NaH was washed with anhydrous hexanes (2 x 20 mL) and dried in vacuo to a gray 
powder.  The flask was immersed in a 0 ºC bath (ice and water), backfilled with Ar, 
charged with anhydrous (see general experimental remarks) DMF (150 mL), and fitted 
with a mineral oil bubbler.  Then 2.87 (34.0 g, 122 mmol) was added carefully 
(CAUTION:  Rapid evolution of H2 gas!) in 5 portions over a 25 minute period 
producing a deep yellow color.  The mixture was removed from the cooling bath, allowed 
to warm to room temperature, and stirred for 45 minutes. Then the flask was again cooled 
to 0 ºC and to the mixture was added chloromethyl methyl ether (10.2 mL, 134 mmol) 
dropwise over a 15 minute period.  The mustard-yellow solution was removed from the 
cooling bath, allowed to warm to room temperature, and the progress of the reaction was 
monitored by TLC (Rf of 2.88 = 0.35; 25% EtOAc in hexanes; silica).  Once the reaction 
was complete (ca. 2 h), the solution was quenched (CAUTION: residual NaH may be 
present) with H2O (250 mL), transferred to a separatory funnel, and extracted with 
EtOAc (3 x 200 mL).  The organic extracts were pooled, washed with H2O (4 x 200 mL) 
and saturated NaCl solution (1 x 200 mL), dried with MgSO4, and filtered.  Removal of 
the solvent in vacuo gave a yellow solid (37 g).  The crude yellow solid was purified in 
8.0 g batches by flash column chromatography (15 cm x 10 cm; silica) with 33% EtOAc 
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in hexanes (2 L).  All batches were pooled to give 28.5 g (67% over 2 steps) of 2.88 as a 
white solid: mp 91-93 ºC (lit.39 93-94 ºC); 1H NMR (400 MHz, CDCl3) δ 10.03 (s, 1H), 
7.72 (d, J = 8.8 Hz, 1H), 6.99 (d, J = 8.8 Hz, 1H), 5.20 (s, 2H), 3.94 (s, 3H), 3.70 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 194.9, 157.1, 145.7, 129.1, 127.3, 111.8, 100.5, 98.8, 
58.5, 56.2; IR (KBr) ν 1677, 1578, 1481 cm-1; HRMS (ESI) calcd for C10H12O4I (MH+) 
322.9780, found 322.9782; Anal. Calcd for C10H11O4I: C, 37.29; H, 3.44.  Found: C, 
37.37; H, 3.39.  The spectra for 2.88 are in agreement with those reported in the 
literature.39  
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N-[[2-Iodo-4-methoxy-3-(methoxymethoxy)phenyl]methylene]cyclohexanamine 
(2.90).  To a 100 mL round-bottomed flask containing activated 4 Å molecular sieves (ca. 
225 mg) were added 2.88 (10.0 g, 31.1 mmol) and anhydrous CH2Cl2 (60 mL).  To the 
yellow solution was added cyclohexylamine (14.4 mL, 125 mmol, purchased from 
Aldrich, catalog number C104665) in one portion.  The yellow solution was stirred at 
room temperature for 6 h, and then filtered through a pad of Celite.  The Celite was 
rinsed with CH2Cl2 (15 mL) and the filtrate and washes were evaporated in vacuo to give 
12.3 g (98%) of 2.90 (Rf = 0.5; 25% EtOAc in hexanes; silica; the product decomposes 
on silica to starting material) as a beige solid: mp 111-113 ºC; 1H NMR (400 MHz, 
CDCl3) δ 8.47 (s, 1H), 7.73 (d, J = 8.8 Hz, 1H), 6.90 (d, J = 8.8 Hz, 1H), 5.16 (s, 2H), 
3.87 (s, 3H), 3.69 (s, 3H), 3.28-3.24 (m, 1H), 1.85-1.26 (m, 10H); 13C NMR (100 MHz, 
CDCl3) δ 161.8, 153.7, 145.1, 131.1, 124.9, 112.3, 99.4, 98.8, 69.4, 58.5, 56.1, 34.5, 25.7, 
24.8; IR (KBr) ν 2918, 1625, 1585, 1484, 1448 cm-1; HRMS (ESI) calcd for C16H23NO3I 
(MH+) 404.0723, found 404.0726; Anal. Calcd for C16H22NO3I: C, 47.66; H, 5.50; N, 
3.47.  Found: C, 47.82; H, 5.58; N, 3.55.   
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3-[6-Formyl-3-methoxy-2-(methoxymethoxy)phenyl]-N-phenyl-2-
pyridinecarboxamide   (2.89).  For a related procedure see the preparation for 2.74.  To 
a 250 mL round-bottomed flask fitted with a glass stopcock flow control adaptor 
(Chemglass, catalog number CG-1028-01) were added 2.90 (4.00 g, 9.95 mmol), 2.67 
(4.40 g, 13.6 mmol), and anhydrous (see general experimental remarks) DMF (120 mL).  
This mixture was freeze-pump-thaw degassed three times and backfilled with Ar.  Then 
were sequentially added tetrakis(triphenylphosphine)palladium(0) (1.60 g, 1.40 mmol, 
purchased from Strem, catalog number 46-2150) and activated (see preparation for 2.74) 
copper bronze (5.06 g, 79.6 mmol).  The mixture was placed under an Ar balloon via a 
rubber septum, heated at 100-110 ºC in an oil bath for 3 h, and then cooled to room 
temperature.  The mixture was passed through a pad of Celite and the Celite was rinsed 
with EtOAc (125 mL).  The combined filtrate and wash were added to H2O (800 mL) and 
the resulting mixture was transferred to a separatory funnel.  The organic layer was 
separated and the aqueous layer was extracted with EtOAc (2 x 350 mL).  The organic 
layer and extracts were pooled, washed with H2O (4 x 300 mL) and saturated NaCl 
solution (1 x 300 mL), dried with MgSO4, and filtered.  Removal of the solvent in vacuo 
gave an oil.  The oil was purified by flash column chromatography (15 cm x 10 cm; 
silica) with 40% EtOAc in hexanes (2.5 L), 50% EtOAc in hexanes (1 L), and 100% 
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EtOAc (1.2 L) to afford 1.52 g (39%) of 2.89 (Rf = 0.16; 40% EtOAc in hexanes; silica) 
as a white foam: mp 109-111 ºC; 1H NMR (400 MHz, CDCl3) δ 10.14 (br s, 1H), 9.62 (s, 
1H), 8.68 (dd, J = 4.6, 1.6 Hz, 1H), 7.78 (d, J = 8.6 Hz, 1H), 7.69 (dd, J = 8.0, 1.6 Hz, 
1H), 7.62-7.59 (m, 2H), 7.55 (dd, J = 8.0, 4.6 Hz, 1H), 7.31-7.26 (m, 2H), 7.10-7.05 (m, 
2H), 4.98 (d, J = 5.6 Hz, 1H), 4.76 (d, J = 5.6 Hz, 1H), 3.96 (s, 3H), 2.88 (s, 3H); 13C 
NMR (100 MHz, CDCl3) δ 189.8, 161.6, 156.7, 147.7, 147.0, 142.5, 141.1, 137.6, 137.0, 
131.4, 128.6, 127.8, 127.3, 125.1, 123.8, 119.6, 111.0, 98.4, 56.4, 55.8; IR (KBr) ν 3331, 
3945, 2841, 2749, 2354, 1683, 1589 cm-1; HRMS (ESI) calcd C22H20N2O5Na (MNa+) 
415.1270, found 415.1255.  
 
Also isolated on an 80 mg scale of 2.90, were 2.104 (1mg, 1%) and 2.101. 
MOMO
MeO
2.101
O
O
OMOM
OMe
 
5,5’-Dimethoxy-6,6’-bis(methoxymethoxy)-[1,1’-biphenyl]-2,2’-dicarboxaldehyde 
(2.101).  Isolated 13 mg (33%) of 2.101 (Rf = 0.36; 50%  EtOAc in hexanes; silica) as a 
white solid: mp 98-100 ºC; 1H NMR (400 MHz, CDCl3) δ 9.57 (s, 2H), 7.90 (d, J = 8.8 
Hz, 2H), 7.13 (d, J = 8.8 Hz, 2H), 4.98 (d, J = 6.4 Hz, 2H), 4.83 (d, J = 6.4 Hz, 2H), 3.97 
(s, 6H), 2.88 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 189.8, 156.8, 144.1, 131.8, 128.9, 
125.3, 111.9, 98.4, 56.4, 56.1; IR (KBr) ν 1689 cm-1; HRMS (ESI) calcd C20H22O8Na 
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(MNa+) 413.1212, found 413.1208;  Anal. Calcd for C20H22O8: C, 61.53; H, 5.68.  Found: 
C, 61.55; H, 5.69.  
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3-[6-Ethenyl-3-methoxy-2-(methoxymethoxy)phenyl]-N-phenyl-2-
pyridinecarboxamide (2.91).  A 50 mL round-bottomed flask fitted with a reflux 
condenser was charged with K2CO3 (552 mg, 3.83 mmol) and flame-dried under vacuum.  
The system was backfilled with Ar and to the flask were added 2.89 (500 mg, 1.28 
mmol), methyltriphenylphosphonium iodide (775 mg, 1.92 mmol), 18-crown-6 (2-4 mg, 
cat.) and anhydrous (see general experimental remarks) DMF (20 mL).  The mixture was 
heated at 100 ºC under an Ar balloon and the progress of the reaction was monitored by 
TLC (Rf of 2.91 = 0.49; 40% EtOAc in hexanes; silica).  Once the reaction was complete 
(ca. 5 h), the mixture was cooled to room temperature, quenched in one portion with H2O 
(75 mL), and transferred to a separatory funnel.  The aqueous layer was extracted with 
EtOAc (3 x 50 mL).  The pooled organic extracts were washed with H2O (3 x 75 mL) and 
saturated NaCl solution (1 x 75 mL), dried with MgSO4, and filtered.  The oil obtained 
upon concentration in vacuo was purified by flash column chromatography (12 cm x 4 
cm; silica) with 30% EtOAc in hexanes to afford 394 mg (79%) of 2.91 as a white solid: 
mp 115-117 ºC; 1H NMR (400 MHz, CDCl3) δ 10.01 (br s, 1H), 8.65 (dd, J = 4.8, 1.8 Hz, 
1H), 7.68 (dd, J = 7.6, 1.8 Hz, 1H), 7.65-7.62 (m, 2H), 7.52 (dd, J = 7.6, 4.8 Hz, 1H), 
7.41 (d, J = 8.6 Hz, 1H), 7.31-7.26 (m, 2H), 7.08-7.04 (m, 1H), 6.98 (d, J = 8.6 Hz, 1H), 
6.20 (dd, J = 17.4, 11.0 Hz, 1H), 5.48 (dd, J = 17.4, 1.0 Hz, 1H), 4.99-4.96 (m, 2H), 4.78 
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(d, J = 6.0 Hz, 1H), 3.89 (s, 3H), 2.88 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 161.8, 
151.5, 148.5, 146.9, 142.2, 141.8, 137.9, 134.3, 133.4, 133.3, 129.3, 128.7, 125.2, 123.7, 
121.2, 119.6, 113.8, 111.8, 98.5, 56.4, 55.7; IR (KBr) ν 3346, 2935, 1693, 1520 cm-1; 
HRMS (ESI) calcd for C23H23N2O4 (MH+) 391.1658, found 391.1639.  
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9-Methoxy-10-(methoxymethoxy)benzo[h]isoquinoline (2.92).  General 
Considerations: For a related procedure and description see: Kelly, T.R.; Cai, X.; 
Damkaci, F.; Panicker, S.B.; Tu, B.; Bushell, S.M.; Cornella, I.; Piggott, M.J.; Salives, 
R.; Cavero, M.; Zhao, Y.; Jasmin, S.  J. Am. Chem. Soc. 2007, 129, 376–386.  The 
photoreactor, similar to Ace Glass catalog no. 7840, was a cylindrical glass vessel (6.5 
cm diameter x 23 cm tall; 250 mL total volume) with a quartz immersion well (5.2 cm 
diameter) connected through a standard taper 60/40 ground glass joint.  The immersion 
well was a double-walled quartz tube cooled by refrigerated isopropanol using a bath 
circulator (Thermo Neslab RTE 740).  A Hanovia 450-W medium pressure quartz Hg 
vapor lamp (Ace Glass, Inc. catalog no. 7825-34) was placed in the immersion well and 
connected to a power supply (Ace Glass catalog no. 7830-60). An 8 x 50 mm magnetic 
stir bar was placed in the cylindrical glass vessel.  The photoirradiation was monitored by 
electrospray ionization low resolution mass spectroscopy (LRMS) (aliquots were taken 
via the angle joint, evaporated to dryness, diluted to 0.1 mg/mL concentration with 
MeOH and submitted without any further work up). 
Specific Procedure: To the photochemical vessel containing a magnetically 
stirred solution of 2.91 (14.0 mg, 0.0359 mmol) in anhydrous benzene (200 mL, 
purchased from Aldrich, catalog number 401765) was added iodine (18.0 mg, 0.0718 
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mmol).  The resulting purple solution was deoxygenated by bubbling Ar through it for 2 
h, using a long syringe needle reaching to the bottom of the reaction vessel, after which 
time the reaction was kept under a static Ar balloon atmosphere.  A Neslab bath 
circulator, which was attached to the immersion well with Tygon tubing, was started; the 
temperature of the circulating coolant was 0 ºC.  Propylene oxide (300 μL, 4.31 mmol) 
was added, and the lamp was turned on.  An elapsed time of 1.5 h of irradiation was 
required for the completion of the reaction.  The resulting mixture was transferred into a 
flask and the solvent was removed using a rotary evaporator to give 43 mg of a brown 
residue.  The residue was purified by flash column chromatography (12 cm x 1 cm; 
silica) with 30% EtOAc in hexanes (75 mL) and 100% EtOAc (50 mL) to afford 8.0 mg 
(83%) of 2.92 (Rf = 0.61; 60% EtOAc in hexanes; silica): mp 175-178 °C; 1H NMR (400 
MHz, CDCl3) δ 10.06 (dd, J = 8.6, 1.4 Hz, 1H), 8.91 (dd, J = 4.2, 1.4 Hz, 1H), 7.87 (d, J 
= 9.2 Hz, 1H), 7.83 (d, J = 9.2 Hz, 1H), 7.69 (d, J = 8.8 Hz, 1H), 7.52 (dd, J = 8.6, 4.2 
Hz, 1H), 7.38 (d, J = 8.8 Hz, 1H), 5.30 (s, 2H), 4.02 (s, 3H), 3.51 (s, 3H); 13C NMR (100 
MHz, CDCl3) δ 151.0, 149.1, 149.0, 143.8, 136.1, 130.1, 128.8, 127.7, 126.7, 125.0, 
124.3, 120.6, 113.7, 99.4, 58.3, 56.5; IR (KBr) ν 3447, 2921, 1681, 1604 cm-1; HRMS 
(ESI) calcd for C16H16NO3 (MH+) 270.1130, found 270.1125.  
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3-[6-Formyl-2-hydroxy-3-methoxyphenyl]-N-phenyl-2-pyridinecarboxamide (2.94).  
To a 250 mL round-bottomed flask were added 2.89 (1.99 g, 5.08 mmol), anhydrous 
CH2Cl2 (75 mL), and a stir bar.  The flask was immersed in a 0 ºC bath (ice and water) 
and TMSBr (2.00 mL, 15.2 mmol) was added dropwise over a 5 minute period to the 
solution.  The yellow solution was stirred in the cooling bath for 50 minutes and then 
allowed to warm to room temperature.  The progress of the reaction was monitored by 
TLC (Rf of 2.94 = 0.26; 50% EtOAc in hexanes; silica; a small aliquot was removed from 
the mixture, quenched into sat. NaHCO3, acidified (ca. pH = 5-6) with 1 M HCl, 
extracted with CH2Cl2 and the organic layer was spotted).  Once the reaction was 
complete (ca. 2 h), the solution was quenched with sat. NaHCO3 (15 mL) and H2O (50 
mL), acidified (ca. pH = 5-6) with 1 M HCl, and transferred to a separatory funnel.  The 
organic layer was separated and the aqueous layer was extracted with CH2Cl2 (2 x 40 
mL). The organic layer and extracts were combined and extracted with 1 M NaOH (5 x 
25 mL) and the pooled aqueous layers were carefully neutralized (pH = 7) with 6 M HCl, 
and then extracted with EtOAc (3 x 50 mL).  The pooled organics were washed with 
saturated NaCl solution (1 x 75 mL), dried with MgSO4, and filtered. Removal of the 
solvent in vacuo gave 1.60 g (91%) of 2.94 as a white powder: mp 186-188 ºC; 1H NMR 
(400 MHz, CDCl3) δ 10.15 (br s, 1H), 9.66 (s, 1H), 8.69 (dd, J = 4.8, 1.6 Hz, 1H), 7.68-
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7.54 (m, 5H), 7.31-7.27 (m, 2H), 7.09-7.02 (m, 2H), 5.73 (s, 1H), 4.01 (s, 3H); 13C NMR 
(100 MHz, CDCl3) δ 190.4, 161.8, 150.7, 147.7, 147.2, 142.4, 141.1, 137.7, 131.0, 128.8, 
127.9, 127.6, 125.6, 124.3, 124.0, 119.8, 109.4, 56.2; IR (KBr) ν 3234, 2839, 2757, 1734, 
1670 cm-1; HRMS (ESI) calcd for C20H16N2O4Na (MNa+) 371.1008, found 371.0992.  
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3-(6-Ethenyl-2-hydroxy-3-methoxyphenyl)-N-phenyl-2-pyridinecarboxamide (2.95).  
A 250 mL round-bottomed flask fitted with a reflux condenser was charged with 
methyltriphenylphosphonium iodide (4.57 g, 11.3 mmol), anhydrous THF (150 mL), and 
a stir bar.  To the stirred white suspension was added potassium t-butoxide (2.05 g, 18.1 
mmol, purchased from ACROS, catalog number 16888 and purified by sublimation at ca. 
200-220 ºC under ca. 0.1 Torr) in one portion.  The bright yellow solution was stirred at 
room temperature for 1 h followed by the addition of 2.94 (1.57 g, 4.51 mmol) in one 
portion.  The mixture was heated at 55 ºC and the progress of the reaction was monitored 
by TLC (Rf of 2.95 = 0.23; 50% Et2O in hexanes; silica).  Once the reaction was 
complete (ca. 4 h), the solution was cooled to room temperature and quenched with sat. 
NH4+Cl- (50 mL), acidified (ca. pH = 5-6) with 1 M HCl, and placed on the rotary 
evaporator to remove the THF.  The aqueous mixture was transferred to a separatory 
funnel and extracted with CH2Cl2 (3 x 40 mL).  The organic extracts were pooled and 
washed with saturated NaCl solution (1 x 50 mL), dried with MgSO4, and filtered. 
Removal of the solvent in vacuo gave a white foam, which was purified by flash 
chromatography (15 cm x 4 cm; silica) with 40% EtOAc in hexanes (1 L) to afford 1.37 g 
(88%) of 2.95 as a white powder: mp 186-188 ºC; 1H NMR (400 MHz, CDCl3) δ 10.05 
(br s, 1H), 8.65 (d, J = 4.0 Hz, 1H), 7.68-764, (m, 3H), 7.53 (dd, J = 8.0, 4.0 Hz, 2H), 
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7.32-7.27 (m, 2H), 7.22 (d, J = 8.6 Hz, 1H), 7.09-7.05 (m, 1H), 6.91 (d, J = 8.6 Hz, 1H), 
6.25 (dd, J = 17.6, 10.8 Hz, 1H), 5.67 (br s, 1H), 5.50 (dd, J = 17.6, 1.2 Hz, 1H), 4.99 
(dd, J = 10.8, 1.2 Hz, 1H), 3.92 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 161.8, 148.2, 
146.9, 145.7, 141.9, 141.8, 138.0, 134.5, 132.7, 129.3, 128.7, 125.6, 125.2, 123.8, 119.6, 
116.8, 113.7, 110.0, 55.9; IR (KBr) ν 3506, 3322, 3007, 2937, 2842, 1689, 1601, 1525 
cm-1; HRMS (ESI) calcd C21H19N2O3 (MH+) 347.1398, found 347.1409; Anal. Calcd for 
C21H18N2O3: C, 72.82; H, 5.24; N, 8.09.  Found: C, 72.74; H, 5.33; N, 7.82. 
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3-(5-Bromo-6-ethenyl-2-hydroxy-3-methoxy)-N-phenyl-2-pyridinecarboxamide 
(2.96).  For a procedure and description of the preparation of bromine-1,4-dioxane see the 
preparation for 1.71.  To a 250 mL round-bottomed flask were added 2.95 (1.35 g, 3.90 
mmol), anhydrous CH2Cl2 (80 mL), distilled (see general experimental remarks) NEt3 
(5.40 mL, 39.0 mmol), and a stir bar.  The solution was cooled in a -78 ºC bath (dry ice 
and acetone).  To a separate 50 mL pear-shaped flask were added bromine–1,4-dioxane 
complex (1.07 g, 4.30 mmol) and anhydrous CH2Cl2 (30 mL) at room temperature.  The 
solution of the bromine–1,4-dioxane complex was transferred to the cooled solution of 
2.95 by syringe pump (Sage Instruments, model no. 341) at a rate of 0.92 mL/min.  The 
solution was stirred for 25 minutes in the -78 ºC bath and then placed into a 0 ºC bath.  
Upon warming to 0 ºC the color of the solution turned from orange to purple.  The 
solution was stirred for 30 minutes in the 0 ºC bath and then allowed to warm to room 
temperature.  After stirring at room temperature for 30 minutes the solvents were 
removed in vacuo to give a red solid.  The solid obtained was purified by flash column 
chromatography (15 cm x 5 cm; silica) with 40% EtOAc in hexanes (750 mL) followed 
by 50% EtOAc in hexanes (700 mL) to afford 1.48 g (89%) of 2.96 (Rf = 0.36; 60% Et2O 
in hexanes; silica) as a white solid: mp 133-135 ºC; 1H NMR (400 MHz, CDCl3) δ 10.03 
(br s, 1H), 8.60 (dd, J = 4.6, 1.8 Hz, 1H), 7.68-7.66 (m, 2H), 7.58 (dd, J = 7.8, 1.8 Hz, 
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1H), 7.49 (dd, J = 7.8, 4.6 Hz, 1H), 7.33-7.29 (m, 2H), 7.11 (s, 1H), 7.11-7.07 (m, 1H), 
6.46 (dd, J = 17.8, 11.2 Hz, 1H), 5.62 (br s, 1H), 5.13 (dd, J = 11.2, 1.6 Hz, 1H), 4.82 
(dd, J = 17.8, 1.6 Hz, 1H), 3.91 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 161.9, 148.1, 
146.7, 145.6, 141.7, 141.6, 137.9, 134.8, 133.3, 129.7, 128.8, 126.3, 125.7, 123.9, 121.2, 
119.7, 114.2, 113.1, 56.1; IR (KBr) ν 3346, 3086, 2937, 1677, 1597, 1531 cm-1; HRMS 
(ESI) calcd C21H17N2O3BrNa (MNa+) 447.0320, found 447.0318; Anal. Calcd for 
C21H17N2O3Br: C, 59.31; H, 4.03; N, 6.59.  Found: C, 59.35; H, 4.00; N, 6.51. 
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9-Bromo-10-ethenyl-7-methoxy-5H-[1]benzopyrano[3,4-b]pyridin-5-one (2.97).  To a 
100 mL round-bottomed flask fitted with a reflux condenser were added 2.96 (1.48 g, 
3.48 mmol), distilled (see general experimental) TFA (8.77 mL), anhydrous THF (65 
mL), and a stir bar.  The solution was heated at 80 ºC under an Ar balloon.  After stirring 
at 80 ºC for 22 h, the mixture was cooled to room temperature and the solvents were 
removed in vacuo to give an oil.  The oil was partioned between H2O (50 mL) and 
CH2Cl2 (30 mL).  The aqueous layer was basified (pH = 8) with sat. NaHCO3.  The 
mixture was transferred to a separatory funnel, the organic layer was separated, and the 
aqueous layer was extracted with CH2Cl2 (2 x 30 mL).  The organic layer and extracts 
were pooled, washed with H2O (1 x 30 mL) and saturated NaCl solution (1 x 30 mL), 
dried with MgSO4, and filtered.  Removal of the solvent in vacuo gave a foam.  The foam 
was purified by flash column chromatography (15 cm x 6 cm; silica) with 80% EtOAc in 
hexanes to afford 884 mg (76%) of 2.97 (Rf = 0.44, 100% EtOAc; silica) as a white solid: 
mp 226-228 ºC; 1H NMR (400 MHz, CDCl3) δ 9.06 (dd, J = 8.8, 1.6 Hz, 1H), 8.88 (dd, J 
= 4.4, 1.6 Hz, 1H), 7.61 (dd, J = 8.8, 4.4 Hz, 1H), 7.29 (s, 1H), 6.91 (dd, J = 17.8, 11.0 
Hz, 1H), 5.74 (dd, J = 11.0, 1.2 Hz, 1H), 5.40 (dd, J = 17.8, 1.2 Hz, 1H), 3.96 (s, 3H); 13C 
NMR (100 MHz, CDCl3) δ 157.6, 151.0, 147.3, 140.7, 138.9, 136.0, 135.8, 132.0, 128.6, 
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126.8, 123.3, 120.0, 117.0, 116.9, 56.6; IR (KBr) ν 1747, 1598, 1552 cm-1; HRMS (ESI) 
calcd C15H10NO3BrNa (MNa+) 353.9742, found 353.9747.                
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6-Bromo-8-methoxy-10H-[1]benzopyrano[5,4,3-hij]isoquinolin-10-one (2.98).  
General Considerations: For a related procedure and description see the preparation of 
2.92. Note, however, that this reaction utilizes a Hanovia 100-W medium pressure quartz 
Hg vapor lamp (Ace Glass, Inc. catalog no. 7825-30) instead of a 450-W lamp. 
Specific Procedure: To the photochemical vessel containing a magnetically 
stirred solution of 2.97 (100 mg, 0.301 mmol) in anhydrous CH2Cl2 (210 mL) was added 
iodine (191 mg, 0.753 mmol).  The resulting purple solution was deoxygenated by 
bubbling Ar through it for 2 h, using a long syringe needle reaching to the bottom of the 
reaction vessel, after which time the reaction was kept under a static Ar balloon 
atmosphere.  A Neslab bath circulator, which was attached to the immersion well with 
Tygon tubing, was started; the temperature of the circulating coolant was -37 ºC.  
Propylene oxide (2.50 mL, 36.1 mmol) was added, and the lamp was turned on.  The 
progress of the reaction was monitored by LRMS (op. cit.).  An elapsed time of 57 
minutes of irradiation was required for the completion of the reaction.  Over the course of 
the reaction the coolant temperature rose from -37 ºC to -18 ºC.  The resulting mixture 
was transferred into a flask along with 420 mg of silica gel and the solvent was removed 
using a rotary evaporator to give a brown powder.  The powder was transferred into a 
ZIF-SIM35™ (35 mL Zero Insertion Force-Sample Injection Module) Biotage barrel 
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(part number SBF-0035) and capped with a ZIF-SIM35™ Biotage frit (part number, 
0067).  Purification by MPLC (see general experimental remarks, 25 + M column, 
equilibrate with 150 mL of 0.1% MeOH in CH2Cl2, with flow rate set to 25 mL/min and 
solvent refill set to 2.0 s) with 0.1% to 1% MeOH in CH2Cl2 (150 mL; linear gradient) 
and 1% MeOH in CH2Cl2 (650 mL; isocratic elution) yielded 89 mg (89%) of 2.98 (Rf = 
0.33; 4% MeOH in CH2Cl2; silica) as a yellow solid which was normally carried on to the 
subsequent reaction without any further purification.  Analytically pure material was 
obtained by recrystallization from CHCl3 to give yellow hairs: mp 268-270 ºC; 1H NMR 
(400 MHz, CDCl3, poorly soluble) δ 9.20 (d, J = 5.2 Hz, 1H), 8.33 (d, J = 9.2 Hz, 1H), 
8.10 (d,  J = 5.2 Hz, 1H), 7.82 (d, J = 9.2 Hz, 1H), 7.80 (s, 1H), 4.15 (s, 3H);  1H NMR 
(400 MHz, CD2Cl2) δ 9.15 (d, J = 5.2 Hz, 1H), 8.26 (d, J = 9.2 Hz, 1H), 8.09 (d,  J = 5.2 
Hz, 1H), 7.80 (d, J = 9.2 Hz, 1H), 7.79 (s, 1H), 4.14 (s, 3H); 13C NMR (100 MHz, 
CD2Cl2) δ 155.4, 149.3, 146.2, 139.5, 137.9, 136.2, 131.1, 124.9, 124.6, 124.0, 123.6, 
119.1, 118.0, 115.8, 57.7; IR (KBr) ν 3474, 1743, 1456 cm-1; HRMS (ESI) calcd 
C15H8NO3BrNa (MNa+) 351.9585, found 351.9591;  Anal. Calcd for C15H8NO3Br: C, 
54.57; H, 2.44; N, 4.24.  Found: C, 54.05; H, 2.42; N, 4.21.   
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Also isolated were 5 mg (5%) of a compound identified as 8-methoxy-10H-
[1]benzopyrano[5,4,3-hij]isoquinolin-10-one (2.102).  Compound 2.102 (Rf = 0.7; 2% 
MeOH in CH2Cl2; neutral aluminum oxide) was isolated as a white solid: mp 228-230 
°C; 1H NMR (400 MHz, CDCl3) δ 9.17 (d, J = 5.4 Hz, 1H), 8.07 (d, J = 9.2 Hz, 1H), 8.06 
(d, J = 5.4 Hz, 1H), 7.88 (d, J = 9.2 Hz, 1H), 7.74 (d, J = 8.8 Hz, 1H), 7.58 (d, J = 8.8 Hz, 
1H), 4.16 (s, 3H); IR (KBr) ν 3458, 2926, 2844, 1740, 1585, 1511 cm-1; HRMS (ESI) 
calcd for C15H9NO3Na (MNa+) 274.0480, found 274.0482. 
 
Crystal data and structure refinement for 2.98. 
Identification code  2.98 
Empirical formula  C16 H9 Br Cl3 N O3 
Formula weight  449.50 
Temperature  193(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 13.344(4) Å a= 90°. 
 b = 17.307(5) Å b= 100.812(4)°. 
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 c = 7.109(2) Å g = 90°. 
Volume 1612.8(8) Å3 
Z 4 
Density (calculated) 1.851 Mg/m3 
Absorption coefficient 3.061 mm-1 
F(000) 888 
Crystal size 0.12 x 0.05 x 0.01 mm3 
Theta range for data collection 1.55 to 28.39°. 
Index ranges -17<=h<=14, -23<=k<=17, -9<=l<=9 
Reflections collected 11548 
Independent reflections 4032 [R(int) = 0.0474] 
Completeness to theta = 28.39° 99.5 %  
Absorption correction Empirical  
Max. and min. transmission 0.9700 and 0.7102 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4032 / 0 / 218 
Goodness-of-fit on F2 1.009 
Final R indices [I>2sigma(I)] R1 = 0.0461, wR2 = 0.1072 
R indices (all data) R1 = 0.0851, wR2 = 0.1229 
Largest diff. peak and hole 0.956 and -0.692 e.Å-3 
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Bond lengths [Å] and angles [°] for 2.98. 
 
Br(1)-C(4)  1.897(3) 
Cl(2)-C(1S)  1.753(4) 
Cl(3)-C(1S)  1.741(4) 
O(2)-C(15)  1.373(4) 
O(2)-C(14)  1.379(4) 
Cl(1)-C(1S)  1.735(4) 
C(13)-C(14)  1.378(5) 
C(13)-C(5)  1.411(5) 
C(13)-C(12)  1.432(4) 
N(1)-C(11)  1.333(4) 
N(1)-C(10)  1.337(5) 
O(3)-C(2)  1.343(4) 
O(3)-C(1)  1.435(4) 
C(2)-C(14)  1.391(5) 
C(2)-C(3)  1.400(5) 
C(8)-C(9)  1.403(5) 
C(8)-C(12)  1.404(5) 
C(8)-C(7)  1.435(5) 
O(1)-C(15)  1.197(4) 
C(11)-C(12)  1.400(5) 
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C(11)-C(15)  1.477(5) 
C(5)-C(4)  1.403(5) 
C(5)-C(6)  1.431(5) 
C(4)-C(3)  1.365(5) 
C(3)-H(3)  0.9500 
C(10)-C(9)  1.369(5) 
C(10)-H(10)  0.9500 
C(6)-C(7)  1.351(5) 
C(6)-H(6)  0.9500 
C(1)-H(1A)  0.9800 
C(1)-H(1B)  0.9800 
C(1)-H(1C)  0.9800 
C(7)-H(7)  0.9500 
C(9)-H(9)  0.9500 
C(1S)-H(1S)  1.0000 
 
C(15)-O(2)-C(14) 123.0(3) 
C(14)-C(13)-C(5) 121.8(3) 
C(14)-C(13)-C(12) 119.1(3) 
C(5)-C(13)-C(12) 119.1(3) 
C(11)-N(1)-C(10) 116.4(3) 
C(2)-O(3)-C(1) 117.6(3) 
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O(3)-C(2)-C(14) 117.4(3) 
O(3)-C(2)-C(3) 125.4(3) 
C(14)-C(2)-C(3) 117.3(3) 
C(9)-C(8)-C(12) 116.1(3) 
C(9)-C(8)-C(7) 124.7(4) 
C(12)-C(8)-C(7) 119.3(3) 
N(1)-C(11)-C(12) 123.3(3) 
N(1)-C(11)-C(15) 116.6(3) 
C(12)-C(11)-C(15) 120.1(3) 
C(11)-C(12)-C(8) 119.7(3) 
C(11)-C(12)-C(13) 119.5(3) 
C(8)-C(12)-C(13) 120.8(3) 
C(4)-C(5)-C(13) 115.9(3) 
C(4)-C(5)-C(6) 125.6(3) 
C(13)-C(5)-C(6) 118.4(3) 
O(2)-C(14)-C(13) 121.5(3) 
O(2)-C(14)-C(2) 117.1(3) 
C(13)-C(14)-C(2) 121.4(3) 
O(1)-C(15)-O(2) 117.5(3) 
O(1)-C(15)-C(11) 125.8(3) 
O(2)-C(15)-C(11) 116.7(3) 
C(3)-C(4)-C(5) 122.3(3) 
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C(3)-C(4)-Br(1) 117.4(2) 
C(5)-C(4)-Br(1) 120.3(3) 
C(4)-C(3)-C(2) 121.4(3) 
C(4)-C(3)-H(3) 119.3 
C(2)-C(3)-H(3) 119.3 
N(1)-C(10)-C(9) 125.0(3) 
N(1)-C(10)-H(10) 117.5 
C(9)-C(10)-H(10) 117.5 
C(7)-C(6)-C(5) 122.9(3) 
C(7)-C(6)-H(6) 118.6 
C(5)-C(6)-H(6) 118.6 
O(3)-C(1)-H(1A) 109.5 
O(3)-C(1)-H(1B) 109.5 
H(1A)-C(1)-H(1B) 109.5 
O(3)-C(1)-H(1C) 109.5 
H(1A)-C(1)-H(1C) 109.5 
H(1B)-C(1)-H(1C) 109.5 
C(6)-C(7)-C(8) 119.6(4) 
C(6)-C(7)-H(7) 120.2 
C(8)-C(7)-H(7) 120.2 
C(10)-C(9)-C(8) 119.5(4) 
C(10)-C(9)-H(9) 120.2 
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C(8)-C(9)-H(9) 120.2 
Cl(1)-C(1S)-Cl(3) 111.2(2) 
Cl(1)-C(1S)-Cl(2) 109.5(2) 
Cl(3)-C(1S)-Cl(2) 109.7(2) 
Cl(1)-C(1S)-H(1S) 108.8 
Cl(3)-C(1S)-H(1S) 108.8 
Cl(2)-C(1S)-H(1S) 108.8 
 
Torsion angles [°] for 2.98. 
 
C(1)-O(3)-C(2)-C(14) -173.5(3) 
C(1)-O(3)-C(2)-C(3) 7.0(5) 
C(10)-N(1)-C(11)-C(12) -0.4(5) 
C(10)-N(1)-C(11)-C(15) -179.9(3) 
N(1)-C(11)-C(12)-C(8) -0.3(5) 
C(15)-C(11)-C(12)-C(8) 179.2(3) 
N(1)-C(11)-C(12)-C(13) -179.5(3) 
C(15)-C(11)-C(12)-C(13) 0.0(4) 
C(9)-C(8)-C(12)-C(11) 0.8(4) 
C(7)-C(8)-C(12)-C(11) -179.0(3) 
C(9)-C(8)-C(12)-C(13) -180.0(3) 
C(7)-C(8)-C(12)-C(13) 0.2(5) 
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C(14)-C(13)-C(12)-C(11) -0.6(4) 
C(5)-C(13)-C(12)-C(11) 179.8(3) 
C(14)-C(13)-C(12)-C(8) -179.8(3) 
C(5)-C(13)-C(12)-C(8) 0.6(4) 
C(14)-C(13)-C(5)-C(4) 0.7(4) 
C(12)-C(13)-C(5)-C(4) -179.7(3) 
C(14)-C(13)-C(5)-C(6) 179.7(3) 
C(12)-C(13)-C(5)-C(6) -0.8(4) 
C(15)-O(2)-C(14)-C(13) 0.0(4) 
C(15)-O(2)-C(14)-C(2) -179.4(3) 
C(5)-C(13)-C(14)-O(2) -179.8(3) 
C(12)-C(13)-C(14)-O(2) 0.6(4) 
C(5)-C(13)-C(14)-C(2) -0.4(5) 
C(12)-C(13)-C(14)-C(2) -180.0(3) 
O(3)-C(2)-C(14)-O(2) 0.1(4) 
C(3)-C(2)-C(14)-O(2) 179.6(3) 
O(3)-C(2)-C(14)-C(13) -179.4(3) 
C(3)-C(2)-C(14)-C(13) 0.2(5) 
C(14)-O(2)-C(15)-O(1) 178.4(3) 
C(14)-O(2)-C(15)-C(11) -0.6(4) 
N(1)-C(11)-C(15)-O(1) 1.2(5) 
C(12)-C(11)-C(15)-O(1) -178.3(3) 
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N(1)-C(11)-C(15)-O(2) -179.8(3) 
C(12)-C(11)-C(15)-O(2) 0.6(4) 
C(13)-C(5)-C(4)-C(3) -0.9(4) 
C(6)-C(5)-C(4)-C(3) -179.8(3) 
C(13)-C(5)-C(4)-Br(1) 177.5(2) 
C(6)-C(5)-C(4)-Br(1) -1.3(4) 
C(5)-C(4)-C(3)-C(2) 0.8(5) 
Br(1)-C(4)-C(3)-C(2) -177.7(2) 
O(3)-C(2)-C(3)-C(4) 179.1(3) 
C(14)-C(2)-C(3)-C(4) -0.4(5) 
C(11)-N(1)-C(10)-C(9) 0.5(5) 
C(4)-C(5)-C(6)-C(7) 179.0(3) 
C(13)-C(5)-C(6)-C(7) 0.1(5) 
C(5)-C(6)-C(7)-C(8) 0.7(5) 
C(9)-C(8)-C(7)-C(6) 179.4(3) 
C(12)-C(8)-C(7)-C(6) -0.8(5) 
N(1)-C(10)-C(9)-C(8) 0.0(6) 
C(12)-C(8)-C(9)-C(10) -0.7(5) 
C(7)-C(8)-C(9)-C(10) 179.1(3) 
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6-(2-Propenyl)-8-methoxy-10H-[1]benzopyrano[5,4,3-hij]isoquinolin-10-one (2.99).  
A 100 mL airfree® round-bottomed flask (Chemglass, catalog no. AF-0528-02) was 
charged with 2.98 (100 mg, 0.303 mmol), allyltributyltin (137 μL, 0.455 mmol), 
anhydrous (see general experimental remarks) DMF (20 mL), and a stir bar.  The mixture 
was freeze-pump-thaw degassed three times under vacuum and backfilled with Ar.  To 
the mixture was added bis(tri-t-butylphosphine)palladium(0) (9.1 mg, 0.018 mmol, 
purchased from Strem, catalog number 46-0252) in one portion.  The flask containing the 
mixture was placed in an oil bath heated at 85 ºC.  After stirring at that temperature for 13 
h, the black mixture was cooled to room temperature and passed through a plug of Celite.  
The Celite was rinsed with CH2Cl2 (30 mL).  The combined filtrate and wash were added 
to H2O (75 mL) and transferred to a separatory funnel. The organic layer was separated 
and the aqueous layer was extracted with CH2Cl2 (3 x 50 mL).  The organic layer and 
extracts were pooled, washed with H2O (4 x 50 mL) and saturated NaCl solution (1 x 50 
mL), dried with MgSO4, and filtered.  Removal of the solvent in vacuo gave a crude 
yellow solid. The solid obtained was purified by flash column chromatography (12 cm x 
3 cm; silica) with 2% MeOH in CH2Cl2 (500 mL) to afford 71.0 mg (81%) of 2.99 (Rf = 
0.42; 4% MeOH in CH2Cl2; silica) as a yellow solid: mp 173-175 ºC; 1H NMR (400 
MHz, CDCl3) δ 9.15 (d, J = 5.2 Hz, 1H), 8.19 (d, J = 9.6 Hz, 1H), 8.04 (d,  J = 5.2 Hz, 
 166
1H), 7.72 (d, J = 9.6 Hz, 1H), 7.41 (s, 1H), 6.17-6.07 (m, 1H), 5.18 (dd, J = 10.4, 1.6 Hz, 
1H), 5.07 (dd, J = 16.8, 1.6 Hz, 1H), 4.14 (s, 3H), 3.93 (d, J = 6.0 Hz, 2H); 13C NMR 
(100 MHz, CDCl3) δ 158.5, 148.1, 145.4, 139.0, 136.7, 136.1, 135.6, 133.9, 128.8, 124.6, 
123.8, 122.6, 121.7, 117.0, 116.2, 114.8, 57.0, 36.7; IR (KBr) ν 3452, 2930, 1743, 1617, 
1586, 1508 cm-1; HRMS (ESI) calcd C18H13NO3Na (MNa+) 314.0793, found 314.0800.  
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6-(2-Oxoethyl)-8-methoxy-10H-[1]benzopyrano[5,4,3-hij]isoquinolin-10-one (2.100).  
To a 50 mL round-bottomed flask under an Ar balloon were added 2.99 (35 mg, 0.120 
mmol), CCl4 (5.0 mL), t-BuOH (2.25 mL), H2O (7.0 mL), CH2Cl2 (5.0 mL), and a stir 
bar.  To the biphasic mixture was added OsO4 (3.1 mg, ca. 0.012 mmol, 4 wt% in H2O, 
purchased from Strem, catalog number 76-2952) in one portion.  The mixture was stirred 
at room temperature for 2 minutes, the color turning from yellow to black.  To the 
mixture was added NaIO4 (64.0 mg, 0.300 mmol) in one portion.  The mixture was 
stirred vigorously at room temperature and the progress of the reaction was monitored by 
TLC (Rf of 2.100 = 0.41; 5% MeOH in CH2Cl2; silica).  Once the reaction was complete 
(ca. 15 h), the yellow precipitate formed (crude 2.100) was collected by vacuum filtration 
and washed with CH2Cl2 (5.0 mL) and H2O (5.0 mL).  Because 2.100 tends to 
decompose upon attempted purification this material (30.0 mg) was carried on to the next 
reaction without further purification: mp 166-170 ºC (dec); 1H NMR (400 MHz, CDCl3) δ 
9.90 (t, J = 2.0 Hz, 1H), 9.19 (d, J = 5.0 Hz, 1H), 8.08 (d, J = 5.0 Hz, 1H), 8.06 (d, J = 
9.2 Hz, 1H), 7.80 (d, J = 9.2 Hz, 1H), 7.46 (s, 1H), 4.28 (d, J = 2.0 Hz, 2H), 4.17 (s, 3H);  
IR (KBr) ν 2927, 2852, 1754, 1621, 1587, 1510, 1437 cm-1; HRMS (ESI) calcd for 
C17H11NO4Na (MNa+) 316.0586, found 316.0595.  
 
 168
N
O
MeO
O
O
2.100
N
O
MeO
O
NMe2
2.1  
6-[2-(Dimethylamino)ethyl]-8-methoxy-10H-[1]benzopyrano[5,4,3-hij]isoquinolin-
10-one (Santiagonamine, 2.1).  A 50 mL round-bottomed flask was charged with 2.100 
(30.0 mg, 0.102 mmol), anhydrous CH2Cl2 (25 mL), and a stir bar.  To the mixture was 
added HNMe2 (53.5 μL, 2.0 M in THF, 0.11 mmol, purchased from Aldrich, catalog 
number 391956) turning the solution from yellow to orange.  Then was immediately 
added NaHB(OAc)3 in several portions (ca. 4 mg each) over a period of 10 minutes until 
a total of 25 mg (0.118 mmol) had been added. The progress of the reaction was 
monitored by TLC (Rf of 2.1 = 0.2; 50% MeOH in CH2Cl2; silica).  Once reaction was 
complete (ca. 3 h), the solvents were removed in vacuo to give a crude yellow residue. 
The residue was purified by flash column chromatography (15 cm x 1 cm; silica) with 
10% MeOH in CH2Cl2 (60 mL), 20% MeOH in CH2Cl2 (80 mL), and 40% MeOH in 
CH2Cl2 (80 mL) to afford 10 mg (26% from 2.99) of santiagonamine (2.1) as an orange 
solid: mp 151-153 ºC; 1H NMR (400 MHz, CDCl3) δ 9.17 (d, J = 5.2 Hz, 1H), 8.25 (d, J 
= 9.2 Hz, 1H), 8.06 (d, J = 5.2 Hz, 1H), 7.77 (d, J = 9.2 Hz, 1H), 7.46 (s, 1H), 4.15 (s, 
3H), 3.35 (t, J = 8.2 Hz, 2H), 2.68 (t, J = 8.2 Hz, 2H), 2.40 (s, 6H); 13C NMR (100 MHz, 
CDCl3) δ 158.5, 148.1, 145.4, 139.0, 136.7, 135.6, 134.7, 128.5, 124.7, 123.8, 122.5, 
121.7, 116.2, 114.9, 61.3, 57.0, 45.6, 31.3; UV (MeOH) λmax, nm (log ε): 225 (5.08), 254 
(5.02), 274 sh (4.72), 300 (4.58), 310 (4.59), 364 (4.41) nm; (MeOH + H3O+) λmax, nm 
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(log ε): 228 (5.16), 257 (5.10), 298 (4.70), 308 (4.71), 332 (4.60), 366 (4.64), 430 (4.46); 
IR (CHCl3) ν 1753 cm-1; HRMS (ESI) calcd C19H19N2O3 (MH+) 323.1396, found 
323.1407.  Spectral data for synthetic 2.1 are in agreement with those reported for the 
natural product.1   
 
 
  
 
 
 
 
 
 
 
Chapter 3: 
Troubleshooting a Molecular Motor:  
A Remarkably Stable N-Acyl Pyridnium Salt 
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Introduction 
Molecular Motors 
What would the properties of materials be if we could really 
arrange the atoms the way we want them?  They would be very 
interesting to investigate theoretically.  I can’t see exactly what 
would happen, but I can hardly doubt that when we have some 
control of the arrangement of things on a small scale we will 
get an enormously greater range of possible properties that 
substances can have, and of different things we can do. 
     
        Richard P. Feynman1 (1959) 
 
 
 In 1959, Nobel laureate Richard Feynman posted1 a $1000 reward2 for the first 
“rotating electric motor [that] is only 1/64 inch cube,” during his talk, “There’s Plenty of 
Room at the Bottom.”  Since this time, many advances3,4 have been made in 
miniaturizing machines and motors–particularly from a “bottom-up” approach.  Aside 
from their use as tools for nanotechnology,5 molecular machines and motors may help us 
to understand how biological machinery achieves controlled movement.6  In 1999, our 
                                                 
(1) Feynman, R. P. Eng. Sci. 1960, 23, 22–36.  The article is also available on the internet: 
http://www.zyvex.com/nanotech/feynman.html. 
(2) The $1000 reward posted by Richard Feynman for an operating electric motor that is only 1/64 inch 
cube was claimed in 1960 by William McLellan, see: Gribbin, J.; Gribbin, M.  Richard Feynman: A Life in 
Science; Dutton: New York, 1997; p 170. 
(3) (a) Balzani, V.; Credi, A.; Venturi, M. Molecular Devices and Machines, 2nd ed.; Wiley-VCH: 
Winheim, Germany, 2008. (b) Molecular Machines; Kelly, T. R., Ed.; Topics in Current Chemistry 262; 
Springer: Berlin, 2005. (c) Molecular Machines and Motors; Sauvage, J.-P., Ed.; Structure & Bonding 99; 
Springer-Verlag: Berlin, 2001. 
(4) For recent reviews on molecular devices, see: (a) Kay, E. R.; Leigh, D. A.; Zerbetto, F. Angew. 
Chem., Int. Ed. 2007, 46, 72–191. (b) Mateo-Alonso, A.; Guldi, D. M.; Paolucci, F.; Prato, M. Angew. 
Chem., Int. Ed. 2007, 46, 8120–8126. (c) Kottas, G. S.; Clarke, L. I.; Horinek, D.; Michl, J. Chem. Rev. 
2005, 105, 1281–1376. (d) Balzani, V.; Credi, A.; Raymo, F. M.; Stoddart, J. F. Angew. Chem., Int. Ed. 
2000, 39, 3348–3391. 
(5) Micromachines as Tools for Nanotechnology; Fujita, H., Ed.; Springer: Berlin, 2003. 
(6) Kelly, T. R.; Cai, X.; Damkaci, F.; Panicker, S. B.; Tu, B.; Bushell, S. M.; Cornella, I.; Piggott, M. J.; 
Salives, R.; Cavero, M.; Zhao, Y.; Jasmin, S. J. Am. Chem. Soc. 2007, 129, 376–386 and references therein. 
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lab reported7 a successful prototype (3.2) of a rationally designed and chemically 
powered molecular motor.  Below is a brief introduction to the development of 3.2 from 
molecular “ratchet” 3.1, how prototype 3.2 was modified so as to achieve a continuously 
rotating molecular motor (3.3),8 the attempts that were made to chemically power and 
continuously rotate 3.3, and my contributions to understand why 3.3 did not rotate like 
prototype 3.2.  
NH2
O
Me
3.2
OH
NH2
O
H2N
H2N
N
Me
NMe2
3.3
OH
Me
3.1
 
 
Molecular Ratchet 
 In 1997, the quest for a rationally designed, chemically powered, and 
continuously rotating molecular motor began with molecular “ratchet” 3.1.9  “Ratchet” 
3.1 consists of two main components, a three-bladed triptycene (rotor) and a [4]helicene 
(stator).  The triptycene and helicene are connected by a single bond (axle) where the 
barrier to rotation around this bond was found to be ca. 25 kcal/mol.9  The helicene in 3.1 
                                                 
(7) (a) Kelly, T. R.; De Silva, H.; Silva, R. A. Nature 1999, 401, 150–152. (b) Kelly, T. R.; Silva, R. A.; 
De Silva, H.; Jasmin, S.; Zhao, Y. J. Am. Chem. Soc. 2000, 122, 6935–6949. (c) Kelly, T. R.  Acc. Chem. 
Res. 2001, 34, 514–522.   
(8) For a photochemically powered molecular motor, see: (a) Koumura, N.; Zijlstra, R. W. J.; van 
Delden, R. A.; Harada, N.; Feringa, B. L. Nature 1999, 401, 152–155.  (b) Feringa, B. L. Acc. Chem. Res. 
2001, 34, 504–513.  For a chemically powered molecular motor, see: (c) Fletcher, S. P.; Dumur, F.; Pollard, 
M. M.; Feringa, B. L. Science 2005, 310, 80–82.  For related work, see (d) references cited in ref 6. 
(9) For the synthesis of and experimental determination of the barrier to rotation for 3.1, see: (a) Kelly, 
T. R.; Tellitu, I.; Sestelo, J. P. Angew. Chem., Int. Ed. 1997, 36, 1866–1868.  (b) Kelly, T. R.; Sestelo, J. P.; 
Tellitu, I. J. Org. Chem. 1998, 63, 3655–3665. 
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may be regarded as a stiff (but not entirely rigid) pawl that resists deformation and 
prevents easy rotation.10  It was originally hoped that the chiral nature of the helicene in 
3.1 would favor rotation of the triptycene blade in only one direction.  When thermally 
stimulated,9 however, rotation of the triptycene in 3.1 occurs in both a clockwise and 
counterclockwise direction to an equal extent.  This observation confirms the principle of 
microscopic reversibility which states that the direction of the triptycene rotation depends 
on the energy of the transition state and not on the relative energy of the system as it 
approaches the transition state.  
 In order to obtain unidirectional rotation of 3.1, rotation in one direction must be 
repeatedly favored over rotation in the counter direction.  The concept7 to induce 
unidirectional rotation around the triptycene/helicene bond in 3.1 is shown graphically in 
Figure 3.1.  In its ground state conformation,11 a single molecule related to 3.1 
(represented by the black circle) is ca. 25 kcal/mol below the barrier to rotation (Figure 
3.1 b).  It is possible for ambient thermal energy to elevate and rotate each molecule to an 
excited state with respect to the ground state conformation (Figure 3.1 b→c).12  If each 
molecule can be trapped in this excited state (figuratively by placing a wall as shown in 
Figure 3.1 d) then the molecule’s new ground state conformation would be closer in 
energy to the summit and ambient thermal energy could propel each molecule to the  
                                                 
(10) According to the Arrhenius equation, a barrier to rotation of ca. 25 kcal/mol corresponds to only 
about half of 3.1 rotating one 120° step in 63.2 h.  For details about this calculation, see: Scudder, P. H. 
Electron Flow in Organic Chemistry; Wiley & Sons: New York, 1992; pp 39–40.  
(11) The ground state conformation of a single molecule related to 3.1 is shown in Figure 3.1 b as 120° 
(= 0° and 240° because of the 3-fold symmetry of the triptycene) around the triptycene/helicene bond. 
(12) For example, according to the Arrhenius equation, the t1/2 for thermally exciting molecules 15 
kcal/mol above ground state at 25 °C is 0.01 s. For details about this calculation, see ref 10. 
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Figure 3.1. Schematic representation of the concept to induce 120° of unidirectional
rotation around the triptycene/helicene bond in 3.1.  
summit (Figure 3.1 d→e).13 Descent from the summit to the next energy minimum 
(Figure 3.1 e→f) is easy and virtually irreversible, because the reverse reaction would 
have an energy requirement of 25 kcal/mol.10  
 
Rationally Designed Prototype of a Molecular Motor 
 The issue then becomes how one chemically modifies 3.1 so that it can be trapped 
in an excited state.  The solution was realized with compound 3.27 (Scheme 3.1) which 
extends “ratchet” 3.1 by attaching an amino group to one blade of the triptycene and a 
hydroxyalkyl tether to the helicene.  If the amino group can be chemically activated to 
react with the hydroxyalkyl tether then an intramolecular reaction between the two 
groups would irreversibly trap the system in an excited state. 
                                                 
(13) For example, according to the Arrhenius equation, the t1/2 for thermally exciting molecules 10 
kcal/mol above ground state at 25 °C is 2.3 x 10-6 s. For details about this calculation, see ref 10. 
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 As reported7 in 1999 and shown in Scheme 3.1, motor prototype 3.2 does achieve 
120° of phosgene-fueled unidirectional rotation.  First, phosgene reacts with the amino 
group in motor prototype 3.214 to give isocyanate 3.4.  Ambient thermal energy then 
rotates isocyanate 3.4, now chemically ‘armed’ to react with the hydroxyl group in the 
hydroxypropyl tether, clockwise to adopt conformation 3.5 (see Figure 3.1 b→c).  In 
conformation 3.5 the isocyanate and the hydroxyl group are sufficiently close to react and 
subsequently form urethane 3.6.15  Formation of urethane 3.6 irreversibly traps the 
triptycene in a relatively high (compared to 3.4; conceptually, see Figure 3.1 d) energy 
conformation around the triptycene/helicene axle.  Finally, ambient thermal energy drives 
the exoergic unidirectional rotation from 3.6 to 3.7 (see Figure 3.1 d→f) where 
                                                 
(14) Rotamer 3.2 is one of three possible low-energy conformations for the motor prototype.  Rotamer 
3.8 is a second possible conformation. 
(15) Urethane formation is not possible with a comparable counterclockwise rotation of isocyanate 3.4. 
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cleavage16 of the urethane completes the chemically driven rotation of 3.2 to 3.8.  The 
series of events and structures assigned in Scheme 3.1 were validated with 1H NMR and 
real-time infrared (ReactIR™ technology)17 spectrometry.   
 
Proposal for a Rationally Designed, Chemically Powered Molecular Motor 
 Having achieved unidirectional rotation with motor prototype 3.2, our lab 
sought18 to advance 3.2 to a continuously rotating motor as summarized conceptually 
with compound 3.9.  The system (3.9) extends the prototype 3.2 by: (i) having an amino 
group on each blade of the triptycene; (ii) providing a means [(dimethylamino)pyridine, 
DMAP] for delivering phosgene (or its equivalent) to the amine (bold arrow in 3.9) in the 
‘firing position’; (iii) achieving a phosgene-powered, 120° rotation of the triptycene by 
formation of an intramolecular urethane in analogy to Scheme 3.1; (iv) affording a means  
                                                                                                          
                                                  3.9, X = H2O, OH-, or Cl-
NH2
O
H2N
H2N
N
Me
NMe2
N
OH
N
NM
X
OH2
XMe
n+
                                                                          
                                                 
(16) The use of NaBH4 in ethanol was employed to cleave the urethane in 3.7.  
(17) Given the paucity of 3.2, a ReactIR™ microcell was required to monitor the reaction on a 1-3 mg 
scale.  For the details of the cell and examples of reaction monitoring using it, see: Kelly, T. R.; Silva, R. 
A.; Finkenbeiner, G.; Tetrahedron Lett. 2000, 41, 9651–9654. 
(18) Kelly, T. R. Boston College, Chestnut Hill, MA.  Unpublished work, 2000. 
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for removing the remains of the phosgene by cleavage of the urethane with metal-bound 
water,19 thereby allowing continuous rotation by repetition of the three preceding steps. 
 Scheme 3.2 illustrates the proposed18 operation of the system (3.9) for one 360°  
revolution.  Starting with motor rotamer 3.10, one equivalent of phosgene could be 
captured by DMAP (to give 3.11) and then transferred intramolecularly to the only amino 
group in the vicinity, affording carbamoyl chloride 3.12.  Ambient thermal energy could  
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(19) For a related metal-bound water hydrolysis of a urethane, see: Kelly, T. R.; Cavero, M.; Zhao, Y. 
Org. Lett. 2001, 3, 3895–3898 and references therein. 
 177
then rotate and position the carbamoyl carbon proximal to the hydroxyl group20 on the 
pyridine ring and allow for urethane (3.13) formation to occur.  Formation of urethane 
3.13 would irreversibly trap the triptycene in a relatively high energy conformation 
(compared to 3.12) where ambient thermal energy could propel 3.13 over the barrier to 
rotation to give, after hydration of the metal, urethane 3.14.  With the tension on the 
tether released (as in 3.14), the carbonyl carbon would now be within easy reach of the 
metal-bound water.  Hydrolysis of urethane 3.14 by the metal-bound water19 would give 
motor rotamer 3.15, which would complete the first 120° of unidirectional rotation.  Now 
the system (3.15) is primed and ready for another 120° of rotation with the addition of 
another equivalent of phosgene and water (added at appropriate intervals).  Subsequent 
addition of a third equivalent of phosgene and water would initiate the third cycle and 
regenerate motor rotamer 3.10, thus completing 360° of unidirectional rotation and also 
priming the motor to continue phosgene-fueled unidirectional rotation. 
 
Progress toward a Rationally Designed, Chemically Powered Molecular Motor 
 Compound 3.3 (Scheme 3.3) was chosen6 as a molecular embodiment of the 
concepts shown in compound 3.9, specifically addressing the first three (i)-(iii) items 
enumerated above, with the DMAP unit intended to capture and deliver the phosgene to 
the amino group in the firing position.  The hope was to achieve the sequence of events 
given in Scheme 3.3, resulting in 120° of unidirectional rotation.  If successful, these  
                                                 
(20) Although 2-hydroxypyridines usually exist primarily as the pyridone tautomer, the oxygen of the 
pyridone can still be acylated by acid chlorides.  Also, it was believed18 that metal coordination of the 
pyridine ring system would favor the hydroxypyridine tautomer. 
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experimental conditions could be applied to motor 3.9 with the intent of achieving a 
continuously rotating molecular motor as depicted in Scheme 3.2.  In 2007, a major 
synthetic effort eventually made available limited, but sufficient, quantities of 3.3 to 
evaluate the design.6 
   Reaction of 3.3 with phosgene and triethylamine under the same conditions that 
were successful with the prototype (Scheme 3.1) led to immediate polymerization of 3.3 
by polyurea formation.  Polymerization could be avoided (at least initially) by conducting 
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the reaction at -78 °C under 100-fold more dilute conditions, but the phosgene seemed 
too reactive toward the triptycyl amines to give the DMAP time to function as desired, 
since a mixture of mono-, di-, and tri-‘phosgenylation’ was observed.  In order to give the 
DMAP time to accomplish its role, the phosgene was replaced with the less reactive 1,1’-
carbonyldiimidazole.  Reaction between 3.3 and 1,1’-carbonyldiimidazole gave only 
monoacylation of 3.3, as determined by quenching with methanol to give 3.23, whose 
structure was determined unambiguously.6  It was inferred6 from the isolation of 3.23 
from the methanol quench that the reaction between 3.3 and 1,1’-carbonyldiimidazole 
gave 3.24. 
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   Imidazoyl ureas of primary anilines are reported21 by Staab to be in equilibrium 
with the corresponding isocyanates (eq 3.1).  If that equilibrium occurred here and if the 
3.3-based system behaved in analogy to the prototype (3.2, Scheme 3.1), then the 
sequence of events in Scheme 3.3 should have unfolded.  But they did not. 
        
N
H
O
HN NC ON +N N
3.25 3.26 3.27
(3.1)
 
   The system in Scheme 3.3 differs from that in the prototype (Scheme 3.1) in two 
ways.  First, the motor molecules are different, and second, the fuels are different 
                                                 
(21) Stabb, H. A. Angew. Chem., Int. Ed. Engl. 1962, 1, 351–367. 
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(phosgene in Scheme 3.1; eventually 1,1’-carbonyldiimidazole in Scheme 3.3).  In order 
to determine whether the failure of the system in Scheme 3.3 was due to a different motor 
molecule or a different fuel, it was necessary to examine a case where only one rather 
than two variables had been changed. 
   To that end, compound 3.28, where two of the triptycyl amines were protected as 
trifluoroacetyl amides, was prepared.6  In this instance, there is only one free amine, the 
one in the firing position, so there is no need to enlist the DMAP to deliver the fuel to 
only one amine.  Consequently, it was possible to use phosgene rather than 1,1’-
carbonyldiimidazole as the fuel.  In this situation, the system differs from that in Scheme 
3.1 by only one variable, the structure of the motor molecule.  The reaction of 3.28 with 
phosgene would either lead to a functioning motor or indicate that the problem was with 
the precise structure of the motor molecule.  In fact,6 reaction of 3.28 with phosgene gave 
no intramolecular urethane (3.29 or 3.30) as judged by mass spectrometry.  Put briefly, 
despite the seemingly excellent precedent provided by the prototype system (3.2) in 
Scheme 3.1, the completely developed versions (3.3 and 3.28) did not function as motors. 
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Troubleshooting a Molecular Motor 
   Two explanations6 were suggested for why 3.3 and 3.28 did not behave as motors.  
One explanation was that the hydroxypropyl group adopts a conformation different from 
that in the prototype, possibly due to hydrogen-bonding interactions with the DMAP or 
the added substituents on the other two triptycene blades.  The second explanation was 
the intervention of a Bürgi-Dunitz22 (3.31) or even a covalent interaction, as in 3.32 and 
3.33, between the DMAP and either the isocyanate, the carbamoyl chloride 3.17, or 
carbamoyl imidazole 3.24.  Such an interaction would severely restrict rotation about the 
triptycene/helicene bond, precluding access to energetically excited rotamers analogous 
to 3.5.  Furthermore, such an interaction would attenuate the electrophilic nature of the 
phosgene-derived (or carbonyldiimidazole-derived) carbonyl in 3.31-3.33, making 
reaction with the hydroxypropyl less likely (if geometric constraints did not make it 
impossible). 
 
O
Me
OH
3.31
H
N
O
HN
HN
N
Me
NMe2
3.32
OH
O
CF3
CF3O O
Cl
N
O
HN
HN
N
Me
NMe2
3.33
OH
O
CF3
CF3O O
HN
O
CF3
HN
CF3O
N
NMe2
N C
O
 
                                                 
(22) Bürgi, H. B.; Dunitz, J. D. Acc. Chem. Res. 1983, 16, 153–161. 
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   In order to determine if the interactions suggested in 3.31-3.33 were credible, we 
sought to examine the reaction of 3.34 with phosgene23 to see if there were any 
indications of analogous interactions, such as those shown in 3.35 and 3.36. 
N
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N O
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   It might be objected that 3.34 is not a good model24 for 3.3/3.28 because the two 
nitrogens of interest in 3.34 are separated by only four bonds, while a dozen or so bonds 
separate the analogous nitrogens in 3.3/3.28.  But, because of 3.3/3.28’s inherent rigidity, 
there are no more degrees of freedom associated with 3.3/3.28 (apart from the 
triptycene/helicene bond, whose rotation is severely constrained by a ca. 25 kcal/mol 
barrier7a,b to rotation) than with 3.34.  Accordingly, the synthesis of 3.34 was undertaken 
and its reaction with phosgene was tested.23 
 
 
                                                 
(23) Markey, M. D.; Kelly, T. R. Tetrahedron 2008, 64, 8381–8388. 
(24) Secondary amine 3.34 was chosen in preference to the unalkylated primary amine 3.37 because if 
3.37 were to form 3.38 (from 3.34 and phosgene), 3.38 could suffer loss of a proton and electron 
reorganization to give pyridoquinazolinone 3.39, a compound whose tricyclic ring system is known to be 
stable, see: Molina, P.; Lorenzo, A.; Aller, E. Tetrahedron 1992, 48, 4601–4616. 
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Results and Discussion 
 The synthesis23 of 3.34, shown in Scheme 3.4, began with a Stille cross-
coupling25 reaction between commercially available 1-bromo-2-nitrobenzene (3.40) and 
stannane 3.4126 to give biaryl 3.42.  The nitro group was reduced and the resulting aniline 
product (3.37) was converted to its tert-butoxycarbonyl (BOC) derivative 3.43.  
Treatment of the latter (3.43) with sodium hydride and ethyl iodide followed by exposure 
of the crude product to 3 M hydrochloric acid, which cleaved the BOC, afforded 3.34. 
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(25) For a recent review of the Stille reaction, see: (a) Espinet, P.; Echavarren, A. M. Angew. Chem., Int. 
Ed. 2004, 43, 4704–4734; See also: (b) Nicolaou, K. C.; Bulger, P. G.; Sarlah, D. Angew. Chem., Int. Ed. 
2005, 44, 4442–4489. 
(26) Stannane 3.41 is a known compound and can be obtained in one-step from 4-
(dimethylamino)pyridine, see: (a) Cuperly, D.; Gros, P.; Fort, Y. J. Org. Chem. 2002, 67, 238–241.  (b) 
Kelly, T. R.; Cavero, M. Org. Lett. 2002, 4, 2653–2656. 
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 With the model system in hand, the stage was set to determine the behavior of 
3.34 toward phosgene.  Accordingly, phosgene–as a solution in toluene–was added to a 
mixture of a deuterochloroform solution of 3.34 and an excess of an insoluble and 
polymer-bound tertiary amine.27  A precipitate formed immediately.  Addition of 
methanol (CH3OH) dissolved the precipitate.  The CDCl3/CH3OH solution was filtered 
through a plug of cotton to separate the insoluble polymer (presumably a mixture of 
polymer-bound tertiary amine and the corresponding amine hydrochloride), and the 
filtrate was evaporated.  The residue (a solid) was dissolved in CD3OD (it was only 
slightly soluble in CDCl3), and the 1H and 13C NMR spectra were recorded.  The spectra 
of the solid show it to be a single compound, but do not unequivocally distinguish 
between structures 3.35 and 3.36.  The spectra do exclude carbamoyl chloride 3.44 as a 
possible structure, because the two nitrogen-bound methyl groups are not equivalent in 
the NMR spectra.  Fortunately, diffraction-quality crystals of the solid could be grown 
from ethanol/diethyl ether.  X-ray crystallography revealed (Figure 3.2) the solid to be 
the cyclic acyl pyridinium salt 3.36. 
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(27) A polymer-bound tertiary amine rather than a ‘regular’ tertiary amine such as Et3N was used to 
facilitate separation of amine hydrochloride salts and 3.34-derived substances. 
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Figure 3.2.   ORTEP diagram of compound 3.36.  Compound 3.36 crystallized with a 
molecule of ethanol and chloride anion.  Both are omitted for clarity.  
 It is remarkable to us28,29 that 3.36 is so stable that it can be recrystallized from 
even initially hot ethanol or isopropanol.  In fact, 3.36 is unchanged by heating in CH3OH 
at 100 °C for 19 h, exhibiting no detectable tendency to convert to carbamate 3.45. 
                                                 
(28) For reviews of carbonic acid derivatives, see: Hegarty, A. F. Comprehensive Organic Chemistry; 
Barton, D., Ollis, W. D., Sutherland, I. O., Eds.; Pergamon: Oxford, 1979; Vol. 2, pp 1067–1118; See also: 
Methoden der Organischen Chemie (Houben-Weyl); Hagemann, H., Ed.; Georg Thieme: Stuttgart, New 
York, NY, 1983; Vol. E4. 
(29) For reviews of 4-(dimethylamino)pyridine-catalyzed reactions, see: (a) Sheinkman, A. K.; Suminov, 
S. I.; Kost, A. N. Russ. Chem. Rev. 1973, 42, 642–661; (b) Hassner, A.; Krespki, L. R.; Alexanian, V. 
Tetrahedron 1978, 34, 2069–2076; (c) Höfle, G.; Steglich, W.; Vorbrüggen, H. Angew. Chem., Int. Ed. 
Engl. 1978, 17, 569–583; (d) Ragnarsson, U.; Grehn, L. Acc. Chem. Res. 1998, 31, 494–501; (e) Spivey, 
A.; Maddaford, A.; Redgrave, A. J. Org. Prep. Proced. Int. 2000, 32, 333–365; (f) Murugan, R.; Scriven, 
E. F. V. Aldrichimica Acta 2003, 36, 21–27; (g) Spivey, A. C.; Arseniyadis, S. Angew. Chem., Int. Ed. 
2004, 43, 5436–5441; (h) France, S.; Guerin, D. J.; Miller, S. J.; Lectka, T. Chem. Rev. 2003, 103, 2985–
3012; (i) Fu, G. C. Acc. Chem. Res. 2004, 37, 542–547. 
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 In order to preclude the possibility that 3.36 converts to 3.45 at 100 °C in CH3OH 
but that 3.45 cyclizes back to 3.36 upon cooling, 1H NMR spectra of 3.36 (Figure 3.3) in  
25 °C
50 °C
60 °C
70 °C
80 °C
85 °C
90 °C
95 °C
100 °C
110 °C
25 °C
1.21.41.61.82.02.22.42.62.83.03.23.43.63.84.0
Figure 3.3.   1H NMR spectra (500 MHz, CD3OD) of the two N-methyl resonances of 
3.36 at varying temperatures.  The bottom 25 °C spectrum was recorded after allowing 
the 110 °C sample to cool.  The peaks from the ethyl group serve as a reference.
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CD3OD were recorded first at 25 °C and then at 100 °C.  The spectra were identical 
except that the two sharp peaks for the N-methyl protons at 25 °C had coalesced to a 
broad singlet at 100 °C.  Cooling of the sample back to 25 °C decoalesced the peak for 
the N-methyl protons and restored the 25 °C spectrum.  Prompted by this serendipitous 
observation of coalescence, the actual coalescence temperature was measured and 
determined to be 95 °C (Figure 3.3).  Based on this information, the barrier to rotation 
about the Me2N-pyridinium bond in 3.36 was calculated30 with the Eyring equation (eq 
3.2): 
k = (kBT/h)e-(∆G
‡/RT)                                                (3.2) 
where k is the rate of exchange between the two N-methyl groups (i.e. rate of bond 
rotation) at temperature T (K), kB is Boltzmann’s constant (1.3805 x 10-23 J/K), h is 
Planck’s constant (6.6256 x 10-34 J s), ∆G‡ is the free energy of activation (or barrier to 
rotation), and R is the universal gas constant (8.31 J/K).   
 At the coalescence temperature (Tc), the rate of exchange (kcoal.) between the two 
N-methyl groups can be approximated30 to 2.22δν (eq 3.3): 
kcoal. = πδν/√2 = 2.22δν                                               (3.3) 
where δν is the difference between the resonance frequencies (Hz or s-1) of the two N-
methyl groups at room temperature.  Substituting equation 3.3 into equation 3.2 yields 
equation 3.4: 
∆G‡ = RTc[22.96 + ln(Tc/δν)] (J/mol)                                 (3.4) 
                                                 
(30) Günther, H. NMR Spectroscopy: Basic principles, concepts, and applications in chemistry, 2nd ed.; 
Wiley & Sons: New York, 1995; pp 342–344. 
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which directly relates the barrier to rotation (∆G‡) to the coalescence temperature (Tc) 
and δν (the difference between the resonance frequencies of the two N-methyl groups at 
room temperature).  With a coalescence temperature (Tc) of 95 °C (368 K) and a 
difference in the frequencies (δν) of the two N-methyl resonances of 35.5 Hz (a 500 MHz 
spectrometer was employed) at 25 °C, equation 3.4 solved for the barrier to rotation 
(∆G‡) about the Me2-N-pyridinium bond in 3.36 is 18.5 kcal/mol,31 indicating that there 
is substantial double bond character (as in 3.46) to that bond.  To our knowledge, this is 
the first experimental determination of the barrier to rotation around the Me2N-
pyridinium bond in an N-acyl (dimethylamino)pyridinium derivative.  1H NMR spectra of 
unsymmetrical but neutral DMAP derivatives such as 3.34, 3.37, 3.42, and 3.43 show 
(see the Experimental Section) the N-methyl protons to be equivalent at room 
temperature. 
N
N
NMe2
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3.46  
 
 The studies described above indicated that 3.36 was stable when dissolved in 
CH3OH.  Put differently, the equilibrium in equation 3.5 lies far to the left. 
                                                 
(31) For reference, the barrier to rotation for the two N-methyl groups in N,N-dimethylformamide (DMF) 
is about 21 kcal/mol.  Günther, H. NMR Spectroscopy: Basic principles, concepts, and applications in 
chemistry, 2nd ed.; Wiley & Sons: New York, 1995; p 336. 
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3.36
N
N O
NMe2
Cl N
N
NMe2
3.45
OMe
O
CH3OH HCl++ (3.5)
 
 The reactivity of 3.36 toward two nucleophiles other than CH3OH, namely water 
and dimethylamine, was also examined.  When a mixture of 3.36 and water was heated to 
55 °C for 16 h, about 20% of 3.36 was converted to 3.34 (eq 3.6), presumably by way of 
an unfavorable equilibrium to give carbamic acid 3.47 followed by decarboxylation32 of 
3.47.  The decarboxylation provides a means for driving the conversion of 3.36 → 3.34 to 
completion; no comparable driving force is available to drive the conversion of 3.36 and 
CH3OH to 3.45 (eq 3.5). 
3.36
N
N O
NMe2
Cl N
N
NMe2
3.47
OH
O
H2O C 2+ + O
N
NH
NMe2
3.34
(3.6)
 
 In contrast to the situation with 3.36 and CH3OH, where equilibrium (e.g. eq 3.5) 
favors N-acyl pyridinium species 3.36 and CH3OH rather than urethane 3.45, reaction of 
3.36 with dimethylamine in CD3OD to give urea 3.48 proceeded virtually to completion 
in 3 h at room temperature (eq 3.7), reflecting the greater stability of amides (ureas) 
                                                 
(32) For a review of carbamic acids, see: Petersen, U. Methoden der Organischen Chemie (Houben-
Weyl); Hagemann, H., Ed.; Georg Thieme: Stuttgart, New Yor, NY, 1983; Vol. E4, pp 142–293. 
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versus esters (urethanes).  Here too, however, the proximity of the DMAP unit to the urea 
carbonyl in 3.48 bestows reactivity on the urea unlike that of typical ureas: the 
equilibrium in equation 3.7 can be driven to the left at room temperature simply by 
several cycles of dissolving the mixture of 3.36 and 3.48 in CD3OD and removing 
volatiles under vacuum, with all of 3.48 being converted back to 3.36. 
3.36
N
N O
NMe2
Cl N
N
NMe2
3.48
NMe2
O
(CH3)2NH HCl+ + (3.7)
 
 In line with the above observations, aniline 3.37 reacted with phosgene (eq 3.8) to 
produce the 6H-pyrido[1,2-c]quinazolin-6-one 3.39.  This ring system was previously 
synthesized by a different route.24  
N
N O
NMe2
N
NH2
NMe2
Cl
O
Cl
CHCl3, 25 °C
(63%)
, NEt3,
(3.8)
3.37 3.39   
 The reactivity of compound 3.39 towards water and methanol was also studied.  If 
a mixture of 3.39 and water was heated33 at 100 °C for 20 hours then 3.39 was 
completely converted (eq 3.9), presumably by way of carbamic acid 3.49, to aniline 3.37.  
However when a solution of compound 3.39 in methanol was stirred at either room  
                                                 
(33) If compound 3.39 was stirred as a suspension in water at room temperature then no reaction was 
observed. 
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3.39
N
N O
NMe2
N
H
N
NMe2
3.49
OH
O
H2O C 2+ + O
N
NH2
NMe2
3.37
(3.9)
 
temperature or at 100 °C then 3.39 was partially converted (eq 3.10) to a 1:2 mixture at 
room temperature and 1:4 mixture at 100 °C of 3.39 and urethane 3.50.34  Again, the 
attached DMAP unit (as in 3.45 and 3.48) transformed the urethane (3.50) back into 3.39 
when the excess methanol was azeotropically removed with chloroform.  This same 
equilibrium (eq 3.9) was not observed between 3.39 and 3.49 because decarboxylation of 
3.49 provided a means for driving the conversion of 3.39 to 3.37 to completion.  
N
N O
NMe2
(3.10)
3.39
N
NH
NMe2
MeO
3.50
O
MeOH+
 
 As mentioned previously, the work described above was carried out with the aim 
of troubleshooting the non-functioning molecular motors 3.3 and 3.28. The discovery of 
the stability of 3.36 and 3.39 as well as the instability of 3.45, 3.48, and 3.50 lead us to 
conclude that a potential problem with motor 3.3 is the intrusion into Scheme 3.3 of the 
Bürgi-Dunitz or covalent interactions depicted in 3.31, 3.32, and 3.33.  The obvious 
question is: ‘how might one modify 3.3 to achieve a functioning motor?’ 
                                                 
(34) The structure of urethane 3.50 was assigned based on crude 1H NMR analysis.  
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 The consensus mechanism for the catalytic role of DMAP in the acylation of 
alcohols (and, presumably, other substrates) is shown in Scheme 3.5.29g,35  The second 
step, the reaction of the acyl pyridinium salt 3.53 with R’OH, is the rate-determining 
step.29g,35  According to Hassner et al.29b and Spivey and Arseniyadis,29g 4-amino-
substituted pyridines such as DMAP are more effective catalysts than pyridine itself 
because they are better at stabilizing the intermediate acyl pyridinium species 3.53 (by a 
contribution from resonance structure 3.56).  It may seem counterintuitive that stabilizing 
the starting material for a rate-determining step would accelerate the rate for the overall 
reaction.  But stabilizing 3.53 results in more 3.53 being present, because the position of 
the 3.51 + 3.52  3.53 equilibrium is shifted to the right.  Evidently, the increased 
concentration of 3.53 plays a greater role in accelerating the overall reaction than the 
stabilization of 3.53 does in decelerating the rate-limiting step. 
 
RCX N
+ RCN X
R'OH
HN
(slow step)
+ X
3.523.51 3.53
3.553.54
O O
RCOR'
O
Scheme 3.5
NMe2 NMe2
NMe2
 
                                                 
(35) (a) Xu, S.; Held, I.; Kempf, B.; Mayr, H.; Steglich, W.; Zipse, H. Chem.–Eur. J. 2005, 11, 4751–
4757; (b) Singh, S.; Das, G.; Singh, O. V.; Han, H. Org. Lett. 2007, 9, 401–404. 
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RCN
3.56
O
NMe2
 
 From the standpoint of ‘repairing’ the molecular motor, it would appear that 
replacing the DMAP in 3.3 or 3.28 with a less participatory unit, perhaps just a pyridine, 
would be sufficient to attenuate the interfering Bürgi-Dunitz (3.31) or covalent (3.32 or 
3.33) interaction.  The concern with adopting such an approach is that it might also 
diminish the system’s ability to capture and deliver the carbonylimidazole unit to the 
requisite aniline group.  Perhaps a better way to walk this molecular tightrope is to 
include a unit that can interfere with the behavior of the DMAP unit, but only after the 
DMAP has delivered the carbonylimidazole group.  Two possibilities are 3.57 and 3.58, 
where, after the carbonylimidazole moiety has been delivered, one adds a metal ion 
(M++), with metal-ion coordination–as in 3.59 and 3.60–disengaging the dimethylamine 
group from stabilizing the Bürgi-Dunitz (3.31) or covalent (3.32 or 3.33) interactions.   
             
NH2
O
H2N
H2N
N
Me
Me2N
3.57
OH
NMe2
NH2
O
H2N
H2N
N
Me
Me2N
OH
NMe2
3.58
NH2
O
H2N
H2N
N
Me
Me2N
3.59
OH
NMe2
NH2
O
H2N
H2N
N
Me
Me2N
OH
NMe2
3.60
M ++ ++ M
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Whether such a metal-coordination strategy would be effective in the current instance 
remains to be determined, but the use of metal-ion coordination stood our lab in good 
stead to effectively engage a molecular brake (equation 3.11).36 
N
OMe
N
OMe
M++N
OMe
N
OMe
3.61 (brake off) 3.62 (brake on)
add metal
ion (M++) (3.11)
 
 In conclusion, the foregoing studies appear to have identified a possible source for 
the problem with the non-functioning of 3.3 and 3.28.  Unfortunately, however, for 
reasons that have been given elsewhere,37 it is unlikely that the proposed cures will ever 
be examined. 
 
 
 
 
 
 
 
 
 
 
                                                 
(36) Kelly, T. R.; Bowyer, M. C.; Bhaskar, K. V.; Bebbington, D.; Garcia, A.; Lang, F.; Kim, M. H.; 
Jette, M. P. J. Am. Chem. Soc. 1994, 116, 3657–3658. 
(37) See final paragraph of work cited in ref 6. 
 195
Experimental Section 
For general experimental remarks see pages iii-vi. 
 
N
NMe2
(nBu)3SnN
NMe2
3.52 3.41  
4-(N,N-Dimethylamino)-2-(tributylstannyl)pyridine (3.41).  4-(N,N-
Dimethylamino)pyridine (3.52, 1.80 g, 14.8 mmol, 99%) was converted to 3.41 (5.69 g, 
93%) by a known26 procedure to give the product as a white solid: mp 68-70 °C.  1H 
NMR (400 MHz, CDCl3) δ 8.32-8.29 (m, 1H), 6.79 (d, J = 2.8 Hz, 1H), 6.53 (dd, J = 7.2, 
2.8 Hz, 1H), 3.14 (s, 6H), 1.57-0.87 (m, 27H); 13C NMR (100 MHz, CDCl3) δ 165.5, 
153.6, 144.0, 115.5, 105.2, 39.3, 28.9, 27.3, 13.7, 12.1; HRMS (ESI) calcd for 
C19H37N2Sn (MH+) 409.1974, found 409.1971.  The spectra of 3.41 are in agreement with 
those previously reported.26 
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N
NO2
NMe2
NO2
Br
N
NMe2
(nBu)3Sn
3.41
3.40
3.42
+
 
4-(N,N-Dimethylamino)-2-(-2-nitrophenyl)pyridine (3.42).  Commercially available 
cuprous iodide (Aldrich, catalog number 20,554-0) was purified following Dieter’s 
procedure.38  For a typical case, 5.00 g of cuprous iodide was added in one portion, open 
to the air, to a saturated aqueous NaI solution (20 mL) immersed in a warm oil bath (100 
°C).  The homogenous solution was maintained in the warm oil bath (100 ºC) for 30 min, 
then removed from the bath, diluted with H2O (20 mL) and allowed to cool to room 
temperature.  Upon cooling, a precipitate formed. The precipitate was collected by 
vacuum filtration and washed sequentially with H2O, ethanol, ethyl acetate (EtOAc), 
diethyl ether (Et2O), and finally hexanes.  The purified cuprous iodide was both dried (ca. 
24 h) and stored over P2O5 in a vacuum desiccator (ca. 0.05 torr).  
For a related procedure see reference 26b.  A 100 mL airfree® round-bottomed 
flask (Chemglass, catalog number AF-0528-02) was charged with cesium fluoride (1.62 
g, 10.7 mmol, purchased from Strem, catalog number 93-5519), a rubber septum, and a 
stir bar.  The flask and its contents were flame-dried under vacuum and backfilled with 
Ar.  To the flask was added 1-bromo-2-nitrobenzene (3.40, 1.08 g, 5.35 mmol, purchased 
from Aldrich, catalog number 365424), 3.41 (2.20 g, 5.35 mmol), and anhydrous (see 
general experimental remarks) DMF (50 mL).  The mixture was freeze-pump-thaw 
                                                 
(38) Dieter, R. K.; Silks, L. A., III; Fishpaugh, J. R.; Kastner, M. E. J. Am. Chem. Soc. 1985, 107, 4679–
4692.  
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degassed three times under vacuum and backfilled with Ar.  To the mixture was added 
tetrakis(triphenylphosphine)palladium(0) (310 mg, 0.268 mmol, purchased from Strem, 
catalog number 46-2150) followed by purified (see above) cuprous iodide (153 mg, 0.803 
mmol), each in a single portion.  The flask was fitted with an Ar balloon and the mixture 
was heated at 110 ºC.  After stirring at 110 ºC for 19 h, the black mixture was cooled to 
room temperature and passed through a plug of Celite.  The Celite was rinsed with 
EtOAc (100 mL).  The combined filtrate and wash were added to 9 M NH4OH (150 mL) 
and transferred to a separatory funnel. The organic layer was separated and the aqueous 
layer was extracted with EtOAc (2 x 50 mL).  The organic layer and extracts were 
pooled, washed with 9 M NH4OH (50 mL portions; washed until the blue/green color no 
longer persisted in the aqueous layer: ca. 3 washes), H2O (2 x 150 mL) and saturated 
NaCl solution (1 x 100 mL), dried with MgSO4, and filtered.  Removal of the solvent in 
vacuo gave a red oil. The oil obtained was purified by flash column chromatography (12 
cm x 4 cm; Brockman III neutral aluminum oxide) with 40% EtOAc in hexanes to afford 
795 mg (61%) of 3.42 (Rf = 0.4; 50% EtOAc in hexanes; neutral aluminum oxide) as a 
brown solid: mp 110-112 ºC; 1H NMR (400 MHz, CDCl3) δ 8.25 (d, J = 6.0 Hz, 1H), 
7.85 (d, J = 8.0 Hz, 1H), 7.63-7.61 (m, 2H), 7.53-7.48 (m, 1H), 6.64 (d,  J = 2.4 Hz, 1H), 
6.51 (dd,  J = 6.0, 2.4 Hz, 1H), 3.05 (s, 6H);  13C NMR (100 MHz, CDCl3) δ 155.6, 154.6, 
149.5, 149.4, 136.3, 131.9, 131.0, 128.5, 123.8, 105.7, 105.2, 39.1; IR (KBr) ν 3447, 
2917, 1601, 1539, 1456, 1374, 1303 cm-1; HRMS (ESI) calcd for C13H14N3O2 (MH+) 
244.1086, found 244.1089. 
 
 198
N
NO2
NMe2
3.42
N
NH2
NMe2
3.37  
2-[4-(N,N-Dimethylamino)-2-pyridinyl]benzenamine (3.37). For a related procedure 
see reference 26b.  To a 100 mL round-bottomed flask fitted with a reflux condenser was 
added 3.42 (795 mg, 3.27 mmol) and methanol (45 mL). To the flask was added, in one 
portion, a freshly prepared solution of sodium sulfide nonahydrate (3.15 g, 13.1 mmol) 
and sodium hydroxide (1.30 g, 32.7 mmol) in H2O (15 mL).  The flask was placed in an 
oil bath and the oil bath was heated to 85 ºC.  The oil bath was maintained at 85 ºC and 
the contents of the flask were stirred open to the air as the progress of the reaction was 
monitored by TLC (Rf of 3.37 = 0.3; 50% Et2O in hexanes; neutral aluminum oxide).  
Once complete (ca. 5 h), the solution was cooled to room temperature and the solvents 
were removed in vacuo to give a yellow residue.  The residue obtained was dissolved in a 
mixture of CH2Cl2 (50 mL) and 1 M NaOH (50 mL).  The mixture was transferred to a 
separatory funnel, the organic layer was separated, and the aqueous layer was extracted 
with CH2Cl2 (2 x 50 mL).  The organic layer and extracts were pooled, washed with 1 M 
NaOH (2 x 75 mL), dried with MgSO4, and filtered.  Removal of the solvent in vacuo 
gave a yellow residue. The residue was purified by flash column chromatography (12 cm 
x 4 cm; Brockman III neutral aluminum oxide) with 55% EtOAc in hexanes to afford 527 
mg (75 %) of 3.37 as a white solid: mp 88-90 ºC; 1H NMR (400 MHz, CDCl3) δ 8.24 (d, 
J = 6.0 Hz, 1H), 7.43 (dd, J = 7.6, 1.6 Hz, 1H), 7.16-7.11 (m, 1H), 6.78-6.72 (m, 3H), 
6.44 (dd,  J = 6.0, 2.6 Hz, 1H), 5.45 (br s, 2H), 3.03 (s, 6H);  13C NMR (100 MHz, 
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CDCl3) δ 159.5, 155.2, 148.2, 146.2, 129.3, 129.2, 124.3, 117.5, 116.7, 105.4, 104.8, 
39.2; IR (KBr) ν 3451, 3326, 2922, 1597, 1537, 1492, 1445 cm-1; HRMS (ESI) calcd for 
C13H16N3 (MH+) 214.1344, found 214.1353. 
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N
NMe2
O
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NH2
NMe2
3.37  
9-(N,N-Dimethylamino)-6H-pyrido[1,2-c]quinazolin-6-one (3.39).  To a 15 mL round-
bottomed flask under Ar were added 3.37 (25 mg, 0.12 mmol), reagent grade (see general 
experimental remarks) chloroform (1.5 mL), and a stir bar.  The solution was stirred at 
room temperature and to the flask was added phosgene (68 μL, ca. 0.13 mmol; purchased 
as a 20% w/w solution in toluene from Fluka, catalog number 79830; CAUTION: 
extremely toxic!) in one portion followed by distilled (see general experimental remarks) 
NEt3 (35 μL, 0.25 mmol) in one portion.  After stirring for 20 min the yellow precipitate 
which had formed was collected by vacuum filtration, washed with CH2Cl2 (2 x 5 mL), 
and dried under vaccuum.  The precipitate collected (18 mg, 63%) was assigned structure 
3.39 (Rf = 0.4; 15% methanol in CH2Cl2; neutral aluminum oxide) based on its spectral 
data and method of preparation: mp 290 ºC (dec); 1H NMR (400 MHz, CDCl3) δ 9.26 (d, 
J = 8.0 Hz, 1H), 7.82 (d, J = 8.0 Hz, 1H), 7.52 (t, J = 6.8 Hz, 1H), 7.42 (d, J = 8.0 Hz, 
1H), 7.07-7.03 (m, 2H), 6.68 (dd, J = 8.0, 2.8 Hz, 1H), 3.29 (s, 6H); IR (KBr) ν 3421, 
1638, 1607, 1555, 1522, 1468, 1437 cm-1; HRMS (ESI) calcd for C14H14N3O (MH+) 
240.1137, found 240.1131.   
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N
NH
NMe2
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N
NH2
NMe2
3.37 3.43  
1,1-Dimethylethyl 2-[4-(N,N-dimethylamino)-2-pyridinyl]phenyl carbamate (3.43).  
A 100 mL round-bottomed flask was charged with 3.37 (1.04 g, 4.88 mmol), NEt3 (3.45 
mL, 24.4 mmol), and CH2Cl2 (35 mL).  To the solution was added di-tert-butyl 
dicarbonate (1.13 g, 5.12 mmol) in six portions (ca. 200 mg each) over a 5 minute period.  
The solution was allowed to stir at room temperature.  After stirring for 20 h the yellow 
precipitate which had formed was collected by vacuum filtration and washed with 
CH2Cl2 (3 x 10 mL). The combined filtrate and washes were diluted with CH2Cl2 (50 
mL), transferred to a separatory funnel, washed with H2O (2 x 50 mL) and saturated 
NaCl solution (1 x 50 mL), dried with MgSO4, and filtered.  Removal of the solvent in 
vacuo gave an oil. The oil obtained was purified by flash column chromatography (12 cm 
x 3 cm; silica gel) with 40% Et2O in hexanes to afford 600 mg (39%) of 3.43 (Rf = 0.4; 
60% Et2O in hexanes; silica) as a white solid: mp 114-116 ºC; 1H NMR (400 MHz, 
CDCl3) δ 10.99 (br s, 1H), 8.28-8.27 (ap d, 2H), 7.54 (dd, J = 8.0, 1.6 Hz, 1H), 7.36-7.32 
(m, 1H), 7.07-7.03 (m, 1H), 6.79 (d, J = 2.4 Hz, 1H), 6.48 (dd,  J = 6.4, 2.4 Hz, 1H), 3.05 
(s, 6H), 1.50 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 158.5, 155.3, 153.3, 147.8, 137.9, 
129.2, 128.7, 127.0, 121.8, 119.9, 105.7, 105.0, 79.4, 39.2, 28.4; IR (KBr) ν 3227, 2974, 
2560, 2252, 1917, 1715, 1600, 1538, 1435 cm-1; HRMS (ESI) calcd for C18H23N3O2Na 
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(MNa+) 336.1688, found 336.1685; Anal. Calcd for C18H23N3O2: C, 68.98; H, 7.40; N, 
13.41.  Found: C, 69.01; H, 7.50; N, 13.36.     
 
The precipitate collected (239 mg, 21%) was identified as compound 3.39 (see above). 
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3.43 3.34
N
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NMe2
Boc
3.63  
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N-Ethyl-2-[4-(N,N-dimethylamino)-2-pyridinyl]benzenamine (3.34). To a 50 mL 
round-bottomed flask equipped with an Ar mineral oil bubbler was added 3.43 (600 mg, 
1.92 mmol) and anhydrous (see general experimental remarks) DMF (15 mL).  To the 
stirred solution was added (CAUTION:  Rapid evolution of H2 gas!) NaH (60% 
dispersed in mineral oil, 112 mg, 2.87 mmol) in three portions (ca. 40 mg each) followed 
by heating to 30 ºC.  The solution was maintained at 30 ºC for 2 h and then cooled to 
room temperature.  To the solution was added ethyl iodide (158 μL, 2.02 mmol) in one 
portion and the progress of the reaction was monitored by TLC (Rf of 3.63 = 0.2; 40% 
Et2O in hexanes; neutral aluminum oxide).  Once the reaction was complete (ca. 30 
minutes), the mixture was quenched (CAUTION: residual NaH may be present!) with 
H2O (50 mL) and the mixture was transferred to a separatory funnel.  The aqueous layer 
was extracted with EtOAc (3 x 50 mL), the extracts were pooled, washed with H2O (4 x 
100 mL) and saturated NaCl solution (1 x 200 mL), dried with MgSO4, and filtered.  
Removal of the solvent in vacuo gave 650 mg of 3.63 as a white solid: mp 102-104 °C; 
1H NMR (400 MHz, CDCl3) δ 8.31 (d, J = 6.0 Hz, 1H), 7.70-7.59 (m, 1H), 7.35-7.31 (m, 
2H), 7.24-7.12 (m, 1H),  6.77-6.68 (m, 1H), 6.47 ( dd, J = 6.0, 2.6 Hz, 1H ), 3.78-3.69 
(m, 1H), 3.00 (s, 6H), 2.87-2.80 (m, 1H), 1.49-1.31 (m, 9H), 1.03-0.95 (m, 3H); IR (KBr) 
ν 2970, 2932, 1693, 1606, 1594, 1540, 1452 cm-1; HRMS (ESI) calcd for C20H28N3O2 
(MH+) 342.21815, found 342.21886.    
The white solid obtained (3.63) was dissolved in EtOAc (10 mL) and transferred 
to a 50 mL round-bottomed flask.  To the solution was added 3 M HCl (10 mL) and the 
biphasic mixture was allowed to stir open to the air.  The mixture was placed in a 40 ºC 
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oil bath and the progress of the reaction was monitored by TLC (stirring was stopped and 
the EtOAc layer was spotted; Rf of 3.34 = 0.5; 50% EtOAc in hexanes; silica).  Once 
complete (ca. 4 h), 10 M NaOH was slowly added to the mixture until (ca. 5 mL) the pH 
of the aqueous layer was approximately 10.  The contents of the flask were transferred to 
a separatory funnel, the EtOAc layer was separated, and the aqueous layer was extracted 
with EtOAc (2 x 40 mL).  The organic layer and extracts were pooled, washed with H2O 
(2 x 40 mL) and saturated NaCl solution (1 x 50 mL), dried with MgSO4, and filtered.  
Removal of the solvent in vacuo gave an oil.  The oil obtained was purified by flash 
column chromatography (12 cm x 3 cm; Brockman III neutral aluminum oxide) with 
15% EtOAc in CH2Cl2 to afford 316 mg (68% from 3.43) of 3.34 as a white solid: mp 94-
96 ºC; 1H NMR (400 MHz, CDCl3) δ 8.24 (d, J = 5.6 Hz, 1H), 7.43 (dd, J = 7.6, 1.6 Hz, 
1H), 7.39 (br s, 1H), 7.25-7.21 (m, 1H), 6.76 (d,  J = 2.8 Hz, 1H ), 6.71-6.67 (m, 2H), 
6.44 (dd, J = 5.6, 2.8 Hz, 1H), 3.19 (q, J = 7.2 Hz, 2H), 3.04 (s, 6H), 1.27 (t, J = 7.2 Hz, 
3H); 13C NMR (100 MHz, CDCl3) δ 159.9, 155.1, 147.9, 147.4, 129.6, 129.3, 123.6, 
115.4, 110.8, 105.6, 104.6, 39.2, 37.9, 14.7; IR (KBr) ν 3314, 2970, 2849, 1894, 1609, 
1506, 1437 cm-1; HRMS (ESI) calcd for C15H20N3 (MH+) 242.1657, found 242.1666.    
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9-(N,N-Dimethylamino)-5-(N-ethyl)-6-oxo-6H-pyrido[1,2-c]quinazolinium chloride 
(3.36).  Reagent grade (see general experimental remarks) chloroform was purified 
according to Perrin and Armarego.39  For a typical case, chloroform (180 mL) was 
washed with H2O (3 x 100 mL), dried over anhydrous potassium carbonate (10 g), 
refluxed with CaCl2 (35 g), and distilled prior to use.   
To a 25 mL round-bottomed flask were added polymer-supported 
diisopropylamine (PS-DIA) beads (669 mg, 0.336-1.00 mmol; 50-90 mesh, 1% cross-
linked, 0.5-1.5 mmol/g, purchased from Aldrich, catalog number 538469) and distilled 
chloroform (6 mL, see above).  After stirring for 10 min under Ar, the chloroform was 
removed with a syringe and a narrow (21 gauge) needle.  This process was repeated a 
total of three times after which the beads were dried under vacuum (ca. 0.05 torr) for 30 
min.  To the flask were added 3.34 (75.0 mg, 0.311 mmol) and distilled chloroform (10 
mL).  The mixture was allowed to stir for 30 min at room temperature and then phosgene 
(327 μL, 0.62 mmol; purchased as a 20% w/w solution in toluene from Fluka, catalog 
number 79830; CAUTION: extremely toxic!) was added in one portion.  The mixture 
initially took on a deep yellow color and then quickly (ca. 2 minutes) turned to a cloudy 
white color.  After stirring for 30 minutes at room temperature, the flask was quenched 
with methanol (10 mL), turning the reaction mixture from a cloudy white suspension to a 
transparent mixture.  The mixture was filtered through a plug of cotton and the beads 
were rinsed with methanol (3 x 5 mL).  The combined filtrate and rinses were transferred 
to a 50 mL round-bottomed flask and removal of the solvents in vacuo gave 110 mg of a 
                                                 
(39) Perrin, D. D.; Armarego, W. L. F. Purification of Laboratory Chemicals, 3rd ed.; Pergamon: Oxford, 
England, 1988; p 121. 
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white solid.  This white solid was recrystallized from isopropanol (ca. 10 mL) to give 76 
mg (81%) of 3.36 as white prisms.  X-ray quality crystals were obtained by slow vapor 
diffusion using ethanol as the dissolving solvent and diethyl ether as the precipitating 
solvent: mp 306-309 ºC (dec); 1H NMR (500 MHz, CD3OD) δ 9.12 (d, J = 8.5 Hz, 1H), 
8.62 (d, J= 8.5 Hz, 1H), 7.86 (t, J = 8.0 Hz, 1H), 7.71 (s, 1H), 7.66 (d, J = 8.5 Hz, 1H), 
7.51 (t, J = 8.0 Hz, 1H), 7.34 (dd, J = 8.5, 2.5 Hz, 1H), 4.42 (q, J = 7.0 Hz, 2H), 3.52 (s, 
3H), 3.45 (s, 3H), 1.43 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CD3OD) δ 158.7, 146.1, 
145.5, 137.4, 136.1, 136.0, 127.1, 125.9, 116.7, 114.6, 109.5, 100.2, 41.8, 41.3, 41.2, 
12.4; IR (KBr) ν 3404, 3084, 2972, 1728, 1705, 1651, 1645, 1607, 1574, 1556, 1504, 
1470, 1446 cm-1; HRMS (ESI) calcd for C16H18N3O (M+) 268.1450, found 268.1448; 
Anal. Calcd for C16H18N3OCl: C, 61.44; H, 6.12; N, 13.43.  Found: C, 61.16; H, 6.04; N, 
13.29.  
 
 
 
 
 
 
Crystal data and structure refinement for 3.36. 
 
Identification code  3.36 
Empirical formula  C18 H24 Cl N3 O2 
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Formula weight  349.85 
Temperature  193(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 12.345(2) Å a= 90°. 
 b = 9.4968(17) Å b= 111.833(3)°. 
 c = 16.284(3) Å g = 90°. 
Volume 1772.1(6) Å3 
Z 4 
Density (calculated) 1.311 Mg/m3 
Absorption coefficient 0.231 mm-1 
F(000) 744 
Crystal size 0.08 x 0.06 x 0.01 mm3 
Theta range for data collection 1.78 to 28.34°. 
Index ranges -16<=h<=15, -12<=k<=12, -11<=l<=21 
Reflections collected 13062 
Independent reflections 4412 [R(int) = 0.0402] 
Completeness to theta = 28.34° 99.6 %  
Absorption correction Empirical 
Max. and min. transmission 0.9977 and 0.9817 
Refinement method Full-matrix least-squares on F2 
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Data / restraints / parameters 4412 / 0 / 222 
Goodness-of-fit on F2 1.049 
Final R indices [I>2sigma(I)] R1 = 0.0563, wR2 = 0.1319 
R indices (all data) R1 = 0.0838, wR2 = 0.1473 
Largest diff. peak and hole 0.415 and -0.418 e.Å-3 
 
Bond lengths [Å] and angles [°] for 3.36. 
 
N(3)-C(14)  1.372(2) 
N(3)-C(10)  1.375(2) 
N(3)-C(1)  1.437(2) 
N(2)-C(1)  1.355(2) 
N(2)-C(4)  1.395(2) 
N(2)-C(2)  1.479(2) 
O(1)-C(1)  1.207(2) 
C(10)-C(11)  1.379(3) 
C(10)-C(9)  1.452(2) 
C(11)-C(12)  1.415(3) 
C(11)-H(10)  0.9500 
C(9)-C(8)  1.398(3) 
C(9)-C(4)  1.400(3) 
C(4)-C(5)  1.401(3) 
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N(1)-C(12)  1.334(2) 
N(1)-C(15)  1.458(3) 
N(1)-C(16)  1.461(3) 
C(14)-C(13)  1.338(3) 
C(14)-H(12)  0.9500 
C(7)-C(8)  1.379(3) 
C(7)-C(6)  1.384(3) 
C(7)-H(8)  0.9500 
C(2)-C(3)  1.509(3) 
C(2)-H(1A)  0.9900 
C(2)-H(2B)  0.9900 
C(13)-C(12)  1.423(3) 
C(13)-H(11)  0.9500 
C(8)-H(9)  0.9500 
C(5)-C(6)  1.374(3) 
C(5)-H(6)  0.9500 
C(6)-H(7)  0.9500 
C(16)-H(17A)  0.9800 
C(16)-H(16B)  0.9800 
C(16)-H(18C)  0.9800 
C(15)-H(15A)  0.9800 
C(15)-H(13B)  0.9800 
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C(15)-H(14C)  0.9800 
C(3)-H(4A)  0.9800 
C(3)-H(5B)  0.9800 
C(3)-H(3C)  0.9800 
C(1S)-C(2S)  1.466(5) 
C(1S)-H(7S)  0.9800 
C(1S)-H(5S)  0.9800 
C(1S)-H(6S)  0.9800 
C(2S)-O(1S)  1.435(5) 
C(2S)-H(3S)  0.9900 
C(2S)-H(4S)  0.9900 
O(1S)-H(2S)  0.8400 
 
C(14)-N(3)-C(10) 120.05(16) 
C(14)-N(3)-C(1) 115.87(15) 
C(10)-N(3)-C(1) 124.08(15) 
C(1)-N(2)-C(4) 123.21(16) 
C(1)-N(2)-C(2) 115.41(16) 
C(4)-N(2)-C(2) 121.09(15) 
N(3)-C(10)-C(11) 119.29(16) 
N(3)-C(10)-C(9) 116.82(16) 
C(11)-C(10)-C(9) 123.89(17) 
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C(10)-C(11)-C(12) 121.45(17) 
C(10)-C(11)-H(10) 119.3 
C(12)-C(11)-H(10) 119.3 
C(8)-C(9)-C(4) 119.26(17) 
C(8)-C(9)-C(10) 121.45(17) 
C(4)-C(9)-C(10) 119.28(16) 
N(2)-C(4)-C(9) 119.91(16) 
N(2)-C(4)-C(5) 120.63(17) 
C(9)-C(4)-C(5) 119.45(18) 
C(12)-N(1)-C(15) 121.37(16) 
C(12)-N(1)-C(16) 120.72(17) 
C(15)-N(1)-C(16) 117.85(16) 
C(13)-C(14)-N(3) 122.16(18) 
C(13)-C(14)-H(12) 118.9 
N(3)-C(14)-H(12) 118.9 
O(1)-C(1)-N(2) 124.46(18) 
O(1)-C(1)-N(3) 119.44(17) 
N(2)-C(1)-N(3) 116.03(16) 
C(8)-C(7)-C(6) 119.55(18) 
C(8)-C(7)-H(8) 120.2 
C(6)-C(7)-H(8) 120.2 
N(2)-C(2)-C(3) 111.23(17) 
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N(2)-C(2)-H(1A) 109.4 
C(3)-C(2)-H(1A) 109.4 
N(2)-C(2)-H(2B) 109.4 
C(3)-C(2)-H(2B) 109.4 
H(1A)-C(2)-H(2B) 108.0 
C(14)-C(13)-C(12) 120.47(18) 
C(14)-C(13)-H(11) 119.8 
C(12)-C(13)-H(11) 119.8 
C(7)-C(8)-C(9) 120.73(19) 
C(7)-C(8)-H(9) 119.6 
C(9)-C(8)-H(9) 119.6 
C(6)-C(5)-C(4) 119.94(19) 
C(6)-C(5)-H(6) 120.0 
C(4)-C(5)-H(6) 120.0 
C(5)-C(6)-C(7) 121.02(18) 
C(5)-C(6)-H(7) 119.5 
C(7)-C(6)-H(7) 119.5 
N(1)-C(12)-C(11) 122.67(17) 
N(1)-C(12)-C(13) 120.77(17) 
C(11)-C(12)-C(13) 116.56(17) 
N(1)-C(16)-H(17A) 109.5 
N(1)-C(16)-H(16B) 109.5 
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H(17A)-C(16)-H(16B) 109.5 
N(1)-C(16)-H(18C) 109.5 
H(17A)-C(16)-H(18C) 109.5 
H(16B)-C(16)-H(18C) 109.5 
N(1)-C(15)-H(15A) 109.5 
N(1)-C(15)-H(13B) 109.5 
H(15A)-C(15)-H(13B) 109.5 
N(1)-C(15)-H(14C) 109.5 
H(15A)-C(15)-H(14C) 109.5 
H(13B)-C(15)-H(14C) 109.5 
C(2)-C(3)-H(4A) 109.5 
C(2)-C(3)-H(5B) 109.5 
H(4A)-C(3)-H(5B) 109.5 
C(2)-C(3)-H(3C) 109.5 
H(4A)-C(3)-H(3C) 109.5 
H(5B)-C(3)-H(3C) 109.5 
C(2S)-C(1S)-H(7S) 109.5 
C(2S)-C(1S)-H(5S) 109.5 
H(7S)-C(1S)-H(5S) 109.5 
C(2S)-C(1S)-H(6S) 109.5 
H(7S)-C(1S)-H(6S) 109.5 
H(5S)-C(1S)-H(6S) 109.5 
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O(1S)-C(2S)-C(1S) 111.6(3) 
O(1S)-C(2S)-H(3S) 109.3 
C(1S)-C(2S)-H(3S) 109.3 
O(1S)-C(2S)-H(4S) 109.3 
C(1S)-C(2S)-H(4S) 109.3 
H(3S)-C(2S)-H(4S) 108.0 
C(2S)-O(1S)-H(2S) 109.5 
 
Torsion angles [°] for 3.36. 
 
C(14)-N(3)-C(10)-C(11) 0.0(3) 
C(1)-N(3)-C(10)-C(11) 179.74(17) 
C(14)-N(3)-C(10)-C(9) 179.75(17) 
C(1)-N(3)-C(10)-C(9) -0.5(2) 
N(3)-C(10)-C(11)-C(12) -1.2(3) 
C(9)-C(10)-C(11)-C(12) 179.03(17) 
N(3)-C(10)-C(9)-C(8) 175.83(17) 
C(11)-C(10)-C(9)-C(8) -4.4(3) 
N(3)-C(10)-C(9)-C(4) -5.1(3) 
C(11)-C(10)-C(9)-C(4) 174.66(18) 
C(1)-N(2)-C(4)-C(9) 3.4(3) 
C(2)-N(2)-C(4)-C(9) 176.94(17) 
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C(1)-N(2)-C(4)-C(5) -176.07(18) 
C(2)-N(2)-C(4)-C(5) -2.6(3) 
C(8)-C(9)-C(4)-N(2) -177.05(17) 
C(10)-C(9)-C(4)-N(2) 3.9(3) 
C(8)-C(9)-C(4)-C(5) 2.5(3) 
C(10)-C(9)-C(4)-C(5) -176.60(17) 
C(10)-N(3)-C(14)-C(13) 0.6(3) 
C(1)-N(3)-C(14)-C(13) -179.18(18) 
C(4)-N(2)-C(1)-O(1) 174.38(18) 
C(2)-N(2)-C(1)-O(1) 0.5(3) 
C(4)-N(2)-C(1)-N(3) -8.7(3) 
C(2)-N(2)-C(1)-N(3) 177.46(15) 
C(14)-N(3)-C(1)-O(1) 4.1(3) 
C(10)-N(3)-C(1)-O(1) -175.67(18) 
C(14)-N(3)-C(1)-N(2) -172.96(16) 
C(10)-N(3)-C(1)-N(2) 7.2(3) 
C(1)-N(2)-C(2)-C(3) 94.0(2) 
C(4)-N(2)-C(2)-C(3) -79.9(2) 
N(3)-C(14)-C(13)-C(12) 0.0(3) 
C(6)-C(7)-C(8)-C(9) -1.4(3) 
C(4)-C(9)-C(8)-C(7) -0.6(3) 
C(10)-C(9)-C(8)-C(7) 178.40(18) 
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N(2)-C(4)-C(5)-C(6) 177.26(18) 
C(9)-C(4)-C(5)-C(6) -2.3(3) 
C(4)-C(5)-C(6)-C(7) 0.2(3) 
C(8)-C(7)-C(6)-C(5) 1.6(3) 
C(15)-N(1)-C(12)-C(11) -0.4(3) 
C(16)-N(1)-C(12)-C(11) 176.70(18) 
C(15)-N(1)-C(12)-C(13) 179.70(18) 
C(16)-N(1)-C(12)-C(13) -3.2(3) 
C(10)-C(11)-C(12)-N(1) -178.13(18) 
C(10)-C(11)-C(12)-C(13) 1.8(3) 
C(14)-C(13)-C(12)-N(1) 178.71(18) 
C(14)-C(13)-C(12)-C(11) -1.2(3) 
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1H NMR 400 MHz, CDCl3 (1.66) 
  219   
 
13C NMR 100 MHz, CDCl3 (1.66) 
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1H NMR 400 MHz, CDCl3 (1.67) 
  221   
 
13C NMR 100 MHz, CDCl3 (1.67) 
  222   
 
1H NMR 400 MHz, CDCl3 (1.69) 
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13C NMR 100 MHz, CDCl3 (1.69) 
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1H NMR 400 MHz, CDCl3 (1.70) 
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13C NMR 100 MHz, CDCl3 (1.70) 
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1H NMR 400 MHz, CDCl3 (1.71) 
  227   
 
13C NMR 100 MHz, CDCl3 (1.71) 
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1H NMR 400 MHz, CDCl3 (1.72) 
  229   
 
13C NMR 100 MHz, CDCl3 (1.72) 
  230   
 
1H NMR 400 MHz, CDCl3 (1.73) 
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13C NMR 100 MHz, CDCl3 (1.73) 
  232   
 
1H NMR 400 MHz, CDCl3 (1.81) 
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13C NMR 100 MHz, CDCl3 (1.81) 
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1H NMR 400 MHz, CDCl3 (1.75) 
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13C NMR 100 MHz, CDCl3 (1.75) 
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1H NMR 400 MHz, CDCl3 (1.76) 
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13C NMR 100 MHz, CDCl3 (1.76) 
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1H NMR 400 MHz, CDCl3 (1.77) 
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13C NMR 100 MHz, CDCl3 (1.77) 
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1H NMR 400 MHz, CDCl3 (1.78) 
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13C NMR 100 MHz, CDCl3 (1.78) 
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1H NMR 400 MHz, CDCl3 (1.79) 
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13C NMR 100 MHz, CDCl3 (1.79) 
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1H NMR 400 MHz, CDCl3 (1.80) 
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13C NMR 100 MHz, CDCl3 (1.80) 
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1H NMR 400 MHz, CDCl3 (1.82) 
  247   
 
1H NMR 400 MHz, CDCl3 (1.1) 
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13C NMR 100 MHz, CDCl3 (1.1) 
  249   
 
1H NMR 400 MHz, CDCl3 (1.85) 
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13C NMR 100 MHz, CDCl3 (1.85) 
  251   
 
1H NMR 400 MHz, DMSO-d6 (1.86) 
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13C NMR 100 MHz, DMSO-d6 (1.86) 
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1H NMR 400 MHz, CDCl3 (1.87) 
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13C NMR 100 MHz, CDCl3 (1.87) 
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1H NMR 400 MHz, CDCl3 (1.88) 
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13C NMR 100 MHz, CDCl3 (1.88) 
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1H NMR 400 MHz, CDCl3 (1.92) 
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13C NMR 100 MHz, CDCl3 (1.92) 
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1H NMR 400 MHz, CDCl3 (1.93) 
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13C NMR 100 MHz, CDCl3 (1.93) 
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1H NMR 400 MHz, CDCl3 (1.99) 
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13C NMR 100 MHz, CDCl3 (1.99) 
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1H NMR 400 MHz, CDCl3 (1.94) 
  264   
 
13C NMR 100 MHz, CDCl3 (1.94) 
  265   
 
1H NMR 400 MHz, CDCl3 (1.95) 
  266   
 
13C NMR 100 MHz, CDCl3 (1.95) 
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1H NMR 400 MHz, CDCl3 (1.96) 
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13C NMR 100 MHz, CDCl3 (1.96) 
  269   
 
1H NMR 400 MHz, CDCl3 (1.97) 
  270   
 
13C NMR 100 MHz, CDCl3 (1.97) 
  271   
 
1H NMR 400 MHz, DMSO-d6 (1.98) 
  272   
 
1D NOE Difference 400 MHz, DMSO-d6 (1.98) 
Irradiation of the quartet at 4.15 ppm 
  273   
 
NOESY 500 MHz, DMSO-d6 (1.98) 
  274   
 
NOESY-Expansion 1 500 MHz, DMSO-d6 (1.98) 
  275   
 
NOESY-Expansion 2 500 MHz, DMSO-d6 (1.98) 
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1H NMR 400 MHz, DMSO-d6 (2.66) 
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13C NMR 100 MHz, DMSO-d6 (2.66) 
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1H NMR 400 MHz, CDCl3 (2.67) 
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13C NMR 100 MHz, CDCl3 (2.67) 
 
  281   
 
1H NMR 400 MHz, CDCl3 (2.73) 
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13C NMR 100 MHz, CDCl3 (2.73) 
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1H NMR 400 MHz, CDCl3 (2.69) 
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13C NMR 100 MHz, CDCl3 (2.69) 
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1H NMR 400 MHz, CDCl3 (2.70) 
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13C NMR 100 MHz, CDCl3 (2.70) 
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1H NMR 400 MHz, CDCl3 (2.71) 
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13C NMR 100 MHz, CDCl3 (2.71) 
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1H NMR 400 MHz, CDCl3 (2.72) 
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13C NMR 100 MHz, CDCl3 (2.72) 
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1H NMR 400 MHz, CDCl3 (2.74) 
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13C NMR 100 MHz, CDCl3 (2.74) 
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1H NMR 400 MHz, CDCl3 (2.103) 
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13C NMR 100 MHz, CDCl3 (2.103) 
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1H NMR 400 MHz, CDCl3 (2.104) 
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13C NMR 100 MHz, CDCl3 (2.104) 
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1H NMR 400 MHz, DMSO-d6 (2.75) 
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13C NMR 100 MHz, DMSO-d6 (2.75) 
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1H NMR 400 MHz, CDCl3 (2.76) 
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13C NMR 100 MHz, CDCl3 (2.76) 
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1H NMR 400 MHz, CD3OD (2.77) 
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1H NMR 400 MHz, CD3OD (2.78) 
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1H NMR 400 MHz, CDCl3 (2.87) 
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13C NMR 100 MHz, CDCl3 (2.87) 
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1H NMR 400 MHz, CDCl3 (2.88) 
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13C NMR 100 MHz, CDCl3 (2.88) 
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1H NMR 400 MHz, CDCl3 (2.90) 
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13C NMR 100 MHz, CDCl3 (2.90) 
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1H NMR 400 MHz, CDCl3 (2.89) 
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13C NMR 100 MHz, CDCl3 (2.89) 
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1H NMR 400 MHz, CDCl3 (2.101) 
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13C NMR 100 MHz, CDCl3 (2.101) 
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1H NMR 400 MHz, CDCl3 (2.91) 
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13C NMR 100 MHz, CDCl3 (2.91) 
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1H NMR 400 MHz, CDCl3 (2.92) 
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13C NMR 100 MHz, CDCl3 (2.92) 
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1H NMR 400 MHz, CDCl3 (2.94) 
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13C NMR 100 MHz, CDCl3 (2.94) 
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1H NMR 400 MHz, CDCl3 (2.95) 
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13C NMR 100 MHz, CDCl3 (2.95) 
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1H NMR 400 MHz, CDCl3 (2.96) 
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13C NMR 100 MHz, CDCl3 (2.96) 
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1H NMR 400 MHz, CDCl3 (2.97) 
 
  324   
 
13C NMR 100 MHz, CDCl3 (2.97) 
 
  325   
 
1H NMR 400 MHz, CDCl3 (2.98) 
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1H NMR 400 MHz, CD2Cl2 (2.98) 
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13C NMR 100 MHz, CD2Cl2 (2.98) 
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1H NMR 400 MHz, CDCl3 (2.102) 
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1H NMR 400 MHz, CDCl3 (2.99) 
 
  330   
 
13C NMR 100 MHz, CDCl3 (2.99) 
 
  331   
 
1H NMR 400 MHz, CDCl3 (2.100) 
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1H NMR 400 MHz, CDCl3 (2.1) 
 
  333   
 
13C NMR 100 MHz, CDCl3 (2.1) 
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1H NMR 400 MHz, CDCl3 (3.41) 
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13C NMR 100 MHz, CDCl3 (3.41) 
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1H NMR 400 MHz, CDCl3 (3.42) 
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13C NMR 100 MHz, CDCl3 (3.42) 
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1H NMR 400 MHz, CDCl3 (3.37) 
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13C NMR 100 MHz, CDCl3 (3.37) 
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1H NMR 400 MHz, CDCl3 (3.39) 
 
  342   
 
1H NMR 400 MHz, CDCl3 (3.43) 
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13C NMR 100 MHz, CDCl3 (3.43) 
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1H NMR 400 MHz, CDCl3 (3.63) 
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1H NMR 400 MHz, CDCl3 (3.34) 
 
  346   
 
13C NMR 100 MHz, CDCl3 (3.34) 
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1H NMR 500 MHz, CD3OD (3.36) 
 
  348   
 
13C NMR 125 MHz, CD3OD (3.36) 
 
